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 With an increasingly active and aging population, injury to ligaments and 
tendons poses a serious issue to the healthcare system. For ruptures of these ligaments 
and tendons which cannot be treated conservatively, surgical intervention may be 
required for an adequate return to health. Current reconstruction options require 
autologous tissue which can prolong the rehabilitation period and cause inadvertent 
pain at the donation site. While allografts avoid pain at donation site, they may cause 
foreign body responses and there is a finite availability of allograft tissue. Therefore, 
a regenerative therapeutic solution is required that can overcome the known issues of 
current available grafts for ligament and tendon repair. Recent advances within tissue 
engineering have led to a deeper understanding of the ligament repair process while 
circumventing the concerns of autografts and allografts. Challenges arise in creating a 
scaffold that properly assimilates the ligamentization process while simultaneously 
offering adequate mechanical strength and tissue formation. Further challenges 
emerge in recreating the natural graded mineralization of the ligament into 
fibrocartilage and bone found at the enthesis, or bony insertion region, that is necessary 
for stress dispersal. 
 The overall aim of this research was to develop a hydrogel scaffold made from 
sustainable biomaterials for use in a ligament tissue engineering application that can 
withstand physiological loading while influencing a fibroblastic response at the 
midsubstance and an osteoblastic response at the entheses. A cost-effective approach 
was taken in this research by incorporating materials that are either routinely used in 
cell culture or readily available at low cost.  
 The work reported in this thesis describes the development of a chitosan-
gelatin hydrogel into a ligament construct, or sinew, consisting of a soft, ligamentous 
midsubstance and a stiff, bony interface that could be implemented in a tensile loading 
bioreactor. The thickness of the chitosan-gelatin hydrogel was optimised to promote 
cell proliferation and production of ligament-like ECM using the NIH-3T3 fibroblast 
cell line and a primary ovine fibroblast culture. A novel method was developed to 
fabricate the hydrogel into a detached form that allowed its use in a tensile loading 
bioreactor system. The method of producing the detached hydrogel scaffolds did not 
affect the cytocompatibility of the hydrogel but was found to decrease the internal 





gelatin hydrogel created a composite hydrogel suitable for enthesis engineering that 
prompted an osteogenic response from the primary fibroblast culture.   
 The responses of the two fibroblast cultures were analysed on the chitosan-
gelatin hydrogel and composite hydrogel to determine their suitability as a cell source 
for ligament tissue engineering applications. Both cultures showed a fibroblastic 
response on the chitosan-gelatin hydrogel, which would maintain the ligament 
phenotype in the midsubstance of the scaffold. The 3T3 cell line was vital in the early 
investigation of the chitosan-gelatin hydrogel, however its response was limited on the 
composite hydrogel. The primary cell culture demonstrated an osteogenic response on 
the composite hydrogel. Due to this, it was determined that the primary fibroblast 
culture was a more suitable cell source for a ligament tissue engineering application. 
 The hydrogel sinews were successfully implemented into a tensile loading 
bioreactor system capable of applying physiological strain and seeded with the 
primary fibroblast culture. The effect of the tensile strain on the attached fibroblasts 
was analysed in comparison with a static culture system. This custom tensile loading 






3T3: NIH-3T3 cell line 
ACL: Anterior Cruciate Ligament of Knee 
ALP: Alkaline Phosphatase 
AM: Anteromedial Bundle of ACL 
CA: Composite Hydrogel Coated Acetal Anchor 
CaCO3: Calcium Carbonate 
CaHPO4: Dibasic Calcium Phosphate 
dH2O: Distilled Water (Not Sterilized) 
DMMB: 1,9-dimethylmethylene Blue 
DNA: Deoxyribonucleic Acid 
ECM: Extracellular Matrix 
EDTA: Ethylenediaminetetraacetic acid 
ESEM: Environmental Scanning Electron Microscopy 
FBS: Foetal Bovine Serum 
GAG: Glycosaminoglycan 
HBSS: Hank’s Balanced Salt Solution 
HCl: Hydrochloric Acid 
IMS: Industrial Methylated Spirits (diluted with deionized water to 70% v/v) 
MA4C: Composite Hydrogel Anchor Dried at 4°C 
MAFD: Freeze-dried Composite Hydrogel Anchor  
Medium: Cell Culture Medium 
MG63: Human Sarcoma Osteoblast Cell Line 
MH: Detached Hydrogel Scaffolds Made on Cell Culture Medium 
NaOH: Sodium Hydroxide 
NAP-XPS: Near Ambient Pressure X-Ray Photoelectron Spectroscopy 
NH: Hydrogel Cast without an Intermediate Layer 
OPC: Oligomeric Proanthocyanidin 
PBS: Phosphate Buffered Saline 
PCL: Posterior Cruciate Ligament of Knee 
PFib: Primary Ovine Fibroblasts 
PH: Detached Hydrogel Scaffolds Made on PBS 





PLA: Poly(lactic acid) 
PLGA: Poly(lactic-co-glycolic acid) 
PLLA: Poly(l-lactic acid); A Derivative of PLA 
Poly-HEMA: Poly(2-hydroxyethyl methacrylate) 
PTFE: Polytetrafluoroethylene 
PU: Polyurethane 
SDW: Sterile Distilled Water 
TCP: Tissue Culture Polystyrene 
THF: Tetrahydrofuran 
UV: Ultraviolet 
XPS: X-Ray Photoelectron Spectroscopy 
MSC: Mesenchymal Stem Cells 
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1.1. Ligament Injury 
Injury to ligaments and tendons that require surgical intervention for repair 
have become more prominent within the increasingly active and aging population [9]. 
Each year 32 million musculoskeletal injuries occur in the United States and tendon, 
ligament, and capsular joint injuries represent 45% of these cases, with numbers for 
surgical repair of the Achilles tendon and rotator cuff tendons reaching nearly 100,000 
[10]. In the US, the occurrence of these injuries costs $1billion to the healthcare system 
annually [11].  
Of the commonly injured ligaments and tendons, damage to the anterior 
cruciate ligament (ACL) within the knee is often a devastating injury for career 
athletes and imposes long term health risks, such as osteoarthritis even when repaired 
surgically. The ACL is a unique ligament within the body that has poor healing 
capacities, due to its intra-articular yet extra-synovial position which causes a lack of 
blood and nutrient supply [12]. The ACL is a key component in the stability of the 
knee during many weight-bearing movements, specifically quick turning motions and 
sharp changes of direction [13].  
Current replacement treatments for ligament and tendon rupture exhibit 
limitations—primarily the availability of tissue for autografts and allografts and the 
durability and longevity of synthetic prosthetics. In addition, the repaired tissue fails 
to replicate the mechanical and structural qualities of the native tissue [14]. The 
demand for an alternative solution is at an all-time high.  
Bioengineering has made advances towards a tissue engineered ligament 
solution that negates the limited availability of donor tissue and more closely 
resembles the native tissue structure by combining biological, mechanical, and 
biomaterial methodologies [15]. Possibilities exist for creating a scaffold out of a 
biodegradable and cytocompatible biomaterial that promotes cellular ingrowth and is 
capable of producing a similar mechanical strength of the native tissue. Challenges in 
ligament tissue engineering arise in optimizing the mechanical strength of the 
prosthesis and regenerating the graded mineralization of the enthesis, or bony interface 
[16, 17].  
A potential solution would be to manipulate a biomaterial so it consists of two 





single cell source into ligamentous and osteoblastic lineages, further increasing the 
chance of success at the enthesis [18]. The implementation of tensile strain to a 
biomaterial of this capacity would further strengthen the tissue engineered construct 
[19]. The characterisation of this ligamentous scaffold would include analysis of the 
collagen content and organisation, as these are determining factors of tissue strength 
and function [20, 21]. Additional genetic analysis could also be explored to optimise 
the ECM production and tissue growth on the scaffold [22, 23]. The development of 
sustainable biomaterials to create a scaffold that could support the adequate tissue 
growth and a tensile bioreactor system to optimise the mechanical loading of the tissue 
could provide an alternative solution to ligament reconstruction grafts and provide a 
model for further ligament tissue engineering research.  
1.2. General Project Aims 
This goal of this research is to use a cost-effective approach to develop a 
hydrogel scaffold that is representative of a ligament, consisting of a midsubstance 
and two bony interfaces, and can be used in ligament tissue engineering research. The 
aim of this research is to optimise the use of sustainable biomaterials that can influence 
the proliferation and growth of fibroblasts to produce an extracellular matrix (ECM) 
that is similar to the ligamentous midsubstance and osseous interface of a ligament. 
Further, this project aims to develop a tensile bioreactor system that can transmit 
physiological strain to the fibroblasts seeded on the hydrogel scaffold and analyse the 
effect of the tensile strain on both the hydrogel scaffold and attached fibroblasts.  
1.3. Experimental Objectives 
The experimental objectives of this project were to: 
1. Develop and optimise the thickness of a cost-effective chitosan-gelatin 
hydrogel that is conducive to fibroblast proliferation and production of ECM 
similar to that of a ligament. 
2. Establish an appropriate cell source, either a fibroblast cell line or primary 
fibroblast culture, for this ligament tissue engineering application.  
3. Develop a method of fabricating the chitosan-gelatin hydrogel into a detached 
form that does not have adverse effects on the cytocompatibility of the 
hydrogel and determine the effects of this fabrication method on the physical 
characteristics of the hydrogel. 
4. Determine if the creation of a composite hydrogel, through the integration of 





chitosan-gelatin hydrogel, stimulates an osteogenic response from the 
fibroblasts. 
5. Develop a design using the composite hydrogel to act as an anchor for the 
detached hydrogel scaffold within the bioreactor. 
6. Manufacture a bioreactor suitable for tissue engineered ligament applications 
capable of transmitting a physiological strain and simultaneously housing 
multiple samples with the same tensile loading regime. 
7. Examine the effect of tensile strain on both the chitosan-gelatin hydrogel 





2. Literature Review 
 This literature review will use the anterior cruciate ligament (ACL) as a clinical 
example to give a background understanding of the nature of ligament and tendon 
injury and repair. The anatomical structure and variations between ligament and 
tendons will be discussed, as well as how the anatomy of the ACL contributes to its 
healing properties. The current available options for ACL reconstruction will be 
described in detail. 
 The current reconstruction options cause several areas of concern which have 
led to advances within tissue engineering to regenerate ligaments and tendons in vitro. 
Ligament tissue engineering is a complex field involving many variables that have an 
impact on the tissue formation and remodelling. The scaffold, cell source, and 
mechanical stimulation are discussed within this literature review, including the 
challenge of engineering the bony attachment. There are several other components 
such as variation of cell culture medium and the addition of specific growth factors 
that can influence tissue regeneration but are not discussed within this review.  
2.1. Ligament and Tendon Injury 
 Ligaments and tendons are soft connective tissue that are similar in structure 
and function within joints [24, 25]. Damage to ligaments and tendons has become an 
increasingly common injury as the aging population remains active, which can range 
from a slight sprain to a full rupture. Such injury can occur from repetitive strain 
lesions or trauma [26]. There may also be a genetic factor that predisposes some 
individuals to ligament and tendon injury [27]. 
 The healing process of ligaments and tendons is relatively slow due to their 
low metabolic requirements [25, 28]. Most soft tissue injury will repair without 
intervention, however there are several instances where surgery is required to repair, 
or even replace, the damaged tissue, such as rupture of the anterior cruciate ligament 
(ACL) in the knee, the Achilles tendon in the ankle, or the rotator cuff in the shoulder.  
2.2. Anterior Cruciate Ligament Injury 
 It is estimated that ACL ruptures account for 100,000-400,000 operations per 
year in the United States [29]. Ruptures can occur from unnatural movements, such as 
trauma, or instability of the joint caused from lack of strength from surrounding 
tissues. Ruptures of the ACL are commonly seen in sports that involve a large amount 





many cases occurring due to sports, contact with an opponent has not occurred and is 
a result of individual load bearing movements [31].  
 In addition to operation needed for ACL repair, the progression of 
osteoarthritis in the joint can be debilitating [32]. Øiestad et al. have reported the 
occurrence of osteoarthritis after ACL repair at 0-13% while the occurrence increases 
to 21-48% if there is a combination injury within the joint [33]. Prior to the review by 
Øiestad et al., it was reported that the incidence of osteoarthritis after ACL rupture 
was a larger range of 10-90% [34]. The large variation in prevalence of osteoarthritis 
after ACL injury demonstrates the little understanding there is regarding the healing 
of the ACL and the associated development of arthritis [29]. 
2.2.1. General Structure of the Knee 
The knee is one of the most complex weight bearing joints in the human body 
and is comprised of the articulation of the femur on the tibia with the patella 
articulating with the femur anteriorly [35]. The surrounding muscles, tendons, and 
ligaments provide the necessary strength and attachment to allow for flexion and 
extension, the two key movements of the knee, Figure 2.1 [36]. The quadriceps are a 
group of four muscles that attach the femur to the patella, continuing into the patellar 
tendon and inserting into the tibia, that produce extension of the knee. The hamstrings, 
on the dorsal side of the femur, attach from the pelvic bone to the tibia producing 
flexion of the knee. The associated tendons of these muscles surround the knee 
providing support to the joint. The ligaments, connecting bone to bone, are important 
in maintaining stability of the joint and reducing internal rotation [37].  
There are several ligaments within the knee attaching from the femur to the 
tibia that support the joint. The collateral ligaments are on the medial and lateral sides 
of the joint, aptly named the medial and lateral collateral ligaments [38]. Within the 
joint, the more complicated cruciate ligaments create a ‘crucifix’ shape as they cross 
one another. The anterior and posterior cruciate ligaments are essential in keeping the 






Figure 2.1: Diagram of the knee indicating the ligaments, bones, and some muscles. Image taken 
from: [https://www.hopkinsmedicine.org/health/conditions-and-diseases/ligament-injuries-to-the-
knee]. 
2.2.2. ACL Anatomical Location 
The close proximity of ligaments to joints typically promotes an abundant 
blood supply [39]. Additionally, the synovial sheath that encloses the joints assists in 
the nutrient availability to ligaments. The synovial sheath also contributes to the 
frictionless articulation of the bones within the joint [39].  
The anatomical location of the ACL differs in its availability of blood and 
nutrient supply. The insertion of the ACL on the anterior portion of the articular 
surface of the tibia and attachment to the posterior region of the articulating surface of 
the femur create an intra-articular location [40]. This location inhibits the blood and 
nutrient supply to the ACL [41, 42]. Further, the synovial sheath encloses the joint but 
excludes the ACL, producing an extrasynovial position and further decreasing nutrient 
availability [43, 44]. Consequently, the intra-articular and extrasynovial location of 
the ACL reduces blood supply and nutrient availability, thereby restricting the healing 
capacity of the tissue should any damage occur.  
The attachments sites of the ACL to the femur and tibia are exceptionally 
important regarding the restored function and mechanical stability after reconstruction 
[45-50]. The attachment site of ligament to bone is known as the enthesis and 
encompasses the transition between the soft tissue of the ligament to the mineralized 
bone tissue known to disperse the great stresses of movement [18, 51, 52]. The enthesis 
is a complex region due to the differences in micro- and nano-level structure relating 





2.2.3. Role and Function of ACL 
The primary purpose of the ACL is to prevent anterior tibial displacement and 
internal rotation [55, 56]. The ACL works in conjunction with the posterior cruciate 
ligament (PCL), which prevents posterior tibial displacement. These two cruciate 
ligaments are critical factors in the stability of the knee. The presence of 
mechanoreceptors in the ACL have a proprioceptive function which aid in stability of 
the knee [57, 58]. 
The hamstrings work to protect the ACL as they apply a posterior force on the 
proximal portion of the tibia, while the quadriceps function as antagonists to the ACL 
and increase the strain on the ACL when fully flexed [59]. The attachments of the 
ACL at the femur and tibia cause a rotation producing a 90° lateral spiral which 
contributes to the ligament having two functional portions, as seen in Figure 2.2 [30, 
59-61]. These functional portions are characterized as bundles and named the 
anteromedial bundle (AM) and the posterolateral (PL) bundle. These bundles function 
near independently based on the movement of the knee joint; whether the knee is in 
flexion or extension and if the movement is passive or active [62]. These bundles also 
cause differing tensile forces to be loaded onto the femoral and tibial entheses sites 
[63]. 
 
Figure 2.2: Left: A schematic of the ACL showing how the two different bundles interact during 
extension, E, and flexion, F. During flexion the AM bundle (A-A’) becomes taught and thin 
whereas the PL bundle (B-B’) becomes loose and thick. Image adapted from Girgis et al. [30]. 
Right: An MRI image of the ACL during full extension to highlight the AM and PL bundles. Image 
adapted from Siebold and Fu [64]. 
2.2.4. Biochemical Structure of Ligaments  
The terms ‘ligament’ and ‘tendon’ are often used interchangeably when 






differences between the two [24, 65]. While ligaments attach bone to bone, tendons 
attach muscle to bone. The biochemistry of ligaments and tendons varies due to the 
functional nature of each tissue. The structure and function of these tissues are highly 
linked as the function will dictate the structure and vice versa [65]. That being said, 
not all ligaments have the same biochemical content [66]. This is also true for tendons. 
The extracellular matrix (ECM) of both ligaments and tendons is composed of 
a high proportion of organised collagen type I and lesser amounts of other proteins, 
such as elastin, that contribute to its strength and elasticity with a relatively small 
number of cells in the mature tissue [67]. The difference between the two tissues lies 
in the collagen type I and type III content in the midsubstance; tendons have nearly 
95% collagen type I with 5% other collagen types whereas ligaments can have up to 
12-40% collagen type III in the midsubstance [24, 67, 68]. There is also a notable 
difference in the crosslinking effects of collagen within these tissues [69, 70]. The 
crosslinking and organisation of the collagen fibrils creates crimp patterns that differ 
between ligaments and tendons [65]. 
Ligaments typically have a higher glycosaminoglycan (GAG) content than 
tendons, which may be due to the more intimate location of ligaments within joints, 
whereas tendons typically surround joints [24]. Deoxyribonucleic acid (DNA) is also 
typically found in higher concentrations in ligaments than tendons due to higher cell 
numbers [71].  
The cruciate ligaments of the knee have nearly twice the DNA content and 
three times the GAG content than the patellar tendon and Achilles tendon, however 
the total collagen content between these tissues is similar, Table 2.1 [24, 72]. The ACL 
specifically has been shown to have less mature collagen fibres, with around 10% 
collagen type III, when compared to the patellar tendon and collateral ligaments, 
which may explain the higher DNA content [61, 70]. As collagen type III is seen in a 
higher proportion in the foetus and decreases with age, it can be said that the 
biochemical structure of the ACL is relatively immature compared to the mature 
structure of other ligaments and tendons [73]. 
Proteoglycans are composed of a core protein and one or more covalently 
attached GAG [74]. Proteoglycans play an important role in mediating fibrillogenesis, 
resistance of compressive and tensile forces, and cell signalling [75]. The 
proteoglycan-rich matrix and associated collagen and elastin fibres contribute to the 





the main proteoglycan constituents of ligaments and tendons [77, 78]. Decorin is found 
in higher percentages in the midsubstance of ligaments than tendons, whereas tendons 
have a higher aggrecan content [79]. Qu et al. found that the proteoglycan content of 
the ACL is limited to the ligament and fibrocartilage regions, responsible for the 
organised collagen fibres [80]. The compressive forces felt near the entheses of 
ligaments and tendons dictate an increased GAG content and the increased content of 
aggrecan and decorin, indicating that mechanical loading of these regions is essential 
in the development of the associated fibrocartilage [81, 82].  
The structure-function relationship of ligaments and tendons contributes to the 
matrix composition of proteoglycan and collagen content [72, 79, 83]. Several studies 
have reported genetic variability in the genes that encode these proteoglycans can lead 
to higher susceptibility of ACL ruptures [78, 84]. Additionally, Young et al. found that 
ruptured ACLs contained less collagen and proteoglycan content than intact ACLs, 
potentially indicating a difference in ECM prior to rupture reducing the ACLs ability 
to manage mechanical loading [85]. These studies highlight the important role 
proteoglycans play in collagen fibre organisation and mechanical strength of tissues. 
 
Table 2.1: Concentrations of total collagen, DNA, and GAG content in selected ligaments and 
tendons. Adapted from Amiel et. al [24, 66]. 
 Collagen Content 





(mg/g dry tissue) 
Cruciate Ligaments 802.6±9.8 2.73±0.05 9.89±0.56 
Achilles Tendon 868.2±10.2 1.74±0.04 2.75±0.20 
Patellar Tendon 867.2±8.9 1.40±0.05 3.92±0.16 
Medial Collateral 
Ligament 
797.1±11.1 2.56±0.06 4.56±0.26 
  
2.2.4.1. Crimp Pattern 
The complex biochemistry of ligaments and tendons causes a crimp pattern to 
form throughout the tissue. The crimp pattern is a result of the organisation of collagen 
fibres and the fibroblast density which aids in transmission of tensile forces [86-89]. 
The ACL has a fluctuating crimp pattern throughout its midsubstance due to the 
differing tensile loading in each bundle, as seen in Figure 2.3 [86].  
The understanding of the relationship of the microstructure of ligaments and 





92]. Lane et al. have reported that 4 years after implantation of a hamstring graft for 
ACL reconstruction, the crimp length shortened and the amplitude lessened to 
resemble a similar crimp pattern as the intact ACL [93]. The assimilation of the 
hamstring graft further identifies the impact mechanical loading has on the crimp 
pattern of ligaments and tendons. However, the regeneration of the molecular structure 
of the tissue after injury is still mostly unknown with research investigating the use of 
crimped scaffolds and other methods to fully restore the crimp pattern [88, 94]. 
 
Figure 2.3: The complex crimp pattern of the ACL at the proximal one quarter of the ligament 
(left) and distal three quarters (right) using a high-resolution microscope and polarized light. Note 
the tighter crimping pattern found in the proximal portion as compared to the distal portion of the 
ACL, indicating that the strain may be higher at the proximal portion of the ligament, or PL bundle. 
Images adapted from Weiss et al. [86]. 
2.2.5. Stages of Ligament Healing 
 The typical healing process of ligaments and tendons is complex and regulated 
by a variety of molecules which may last from several weeks up to several years after 
injury and often leaves the repaired tissue weaker than the native tissue [95]. The 
injury site goes through 4 phases: inflammation, proliferation, reparative, and 
remodelling [95-97]. The understanding of the stages of healing of ligaments and 
tendons helps to optimise the reconstruction and repair.  
2.2.6. Healing Properties of ACL 
 The inability of the ACL to heal on its own is attributed to the factors 
previously discussed; the complex anatomy, the extrasynovial location leading to poor 
vascularization and nutrient supply, the mechanical loading, and intrinsic properties. 
Therefore, surgery is required to reconstruct the ruptured ligament. The most 
successful reconstruction options are to completely remove the ruptured ligament and 
replace it. There are several surgical options to replace the damaged tissue; autografts, 






2.3. Current Strategies for ACL Reconstruction 
 There are several strategies to replace a ruptured ACL including autografts, 
allografts, and synthetic grafts. There are considerable benefits and disadvantages to 
each approach.  
2.3.1. Autografts 
 The ‘gold standard’ of ACL reconstruction remains the implementation of the 
autograft, due to its relatively high success rate and limited adverse reactions [98, 99]. 
The bone-patellar tendon-bone graft has been the most commonly used autograft but 
the hamstring graft has also been increasingly used [50, 100].  
 The patellar tendon graft takes the middle third of the patellar tendon and a 
small portion of bone at the attachment to the patella and tibia, creating ‘bony plugs’ 
on either side of the tendon [98]. The hamstring tendon graft combines portions of the 
tendons of the semitendinosus, gracilis, and sartorius muscles into a single tendinous 
graft [101]. A depiction of these grafts can be seen in Figure 2.4. 
 There are several drawbacks to using an autograft such as donor site morbidity 
and pain, increased incision size, increased operative time, prolonged rehabilitation 
time, decreased range of motion, risk of nerve damage, and a finite supply of tissue 
[102]. The donor site pain and skin incision can be significantly lowered when using 
the hamstring tendons rather than using the bone-patellar tendon-bone graft [98]. Graft 
fixation is an important consideration in graft choice as a tendinous graft may require 
buttons or sutures for fixation while bone-tendon-bone grafts may not require further 
interference [99]. Further, in both cases the tendon midsubstance of the autografts 
must undergo ligamentization, a process in which the tendinous graft assimilates to a 
tissue resembling the native ligament [103]. Janssen and Scheffler have found that 
during the remodelling of hamstring tendon grafts, the process of ligamentization 
occurs however the graft does not reach a biological or biomechanical similarity of 
the intact ACL [104]. 
 An additional concern in using hamstring tendon autografts is the role that 
hamstring strength plays in protecting the ACL during activity [101]. Pandy et al. 
found that the co-contraction of the hamstrings can reduce the forces in the ACL by 
altering the balance of shear forces within the leg, ultimately leading to reduced injury 
to the ACL [59]. Leiter et al. reports decreased strength during extension and a greater 
incidence of osteoarthritis after implementation of an autologous hamstring graft 





quadriceps muscle [11]. In using a hamstring graft, there is potential that the strength 
of the hamstrings may be reduced which could lead to an increased risk of secondary 
rupture. 
 
Figure 2.4: Illustrations of the origin of the patellar tendon autograft (left) and the hamstring tendon 
autograft (right). The black outline in the hamstring tendon autograft indicates the portion of tissue 
to be removed for the graft. Image taken from: [https://eorthopod.com/hamstring-tendon-graft-
reconstruction-of-the-acl/]. 
 The patellar tendon graft produces greater static knee stability and significantly 
lower graft failure rate when compared to hamstring grafts [105]. However, the 
harvesting of the patellar tendon results in great pain around the donor site, a loss of 
extensor strength, and increased risk of future patellar injuries including fracture [106, 
107].  
 In recent years, the practice of using a multiple bundle hamstring tendon graft 
has been growing in popularity due to the more realistic resemblance to the functional 
AM and PL bundles, leading to increased graft strength and decreased donor site pain, 
rehabilitation time, and extension deficit [99, 108-110]. Siebold et al. discovered that 
the surgical technique for a double bundle graft with four attachment sites improved 
rotational stability and allowed a more accurate representation of the functional 
bundles of the native ACL [111]. A clear impediment of creating a double bundle 
hamstring graft, is the requirement of four attachments to the femur and tibia which 
significantly increases the chance of poor placement and requires additional sites of 
osteogenesis. 
2.3.2. Allografts 
 An allograft eliminates the donor site morbidity found with autografts in 
addition to reducing the incision size and operative time [112]. Allograft tissue for 





tendons of the hamstrings and tibialis [11, 102]. There has been increasing research 
into removing the cellular material from allografts to utilize the optimal architecture 
of the tissue while removing possible immunogenic factors [113, 114]. 
 The main concerns using allografts are sterilization, disease transmission, graft 
incorporation, cost, availability of tissue, immunogenic response, and failure rate [100, 
112, 115-117]. Allografts may have the distinct benefit of not causing further damage 
to surrounding tissue however the failure rate of allografts remains significantly higher 
than autografts [116, 118, 119]. Due to these shortcomings, autografts remain the more 
common choice for ACL reconstruction. 
2.3.3. Synthetic Grafts 
 Synthetic grafts were heavily researched beginning in the 1980s and 
continuing into the 1990s, increasing in popularity due to their abundance, mechanical 
strength, ease of storage, and lack of harvest site morbidity [5, 120, 121]. The aim of 
synthetic grafts was to eliminate donor site morbidity, deliver a mechanically strong 
construct, and decrease rehabilitation time ultimately leading to decreased failure and 
revision rates. 
 Synthetic grafts have strict requirements in that they need to be 
cytocompatible, provide adequate mechanical strength, assimilate into the native 
environment, and provide lasting results [5, 89]. Throughout the years, many 
prosthetics have entered the commercial market, and several have been withdrawn. 
Some popular synthetic grafts have been the Ligament Augmentation and 
Reconstruction System (LARS), the Gore-Tex device—withdrawn from the market in 
1993, the Dacron ligament—withdrawn from the market in 1994, the Kennedy 
Ligament Augmentation Device (LAD), and the Leeds-Keio device [1, 3, 5]. The 
LARS appears to have the highest rates of success of the synthetic devices, however 
its sustainability in the long term needs to be evaluated [122, 123]. Table 2.2 
summarizes the material composition, failure rate, and commercial availability of a 
selection of synthetic grafts. 
 Some synthetic grafts were shown to provide the initial strength to the joint but 
long-term studies revealed the slow degradation of the mechanical properties over 
time leading to failure [89, 121]. The mechanical properties of selected synthetic grafts 
compared to a natural ACL are shown in Table 2.3. An understanding of the long-term 
mechanical relaxation of the synthetic construct is especially important in the 





grafts have been unable to maintain their favourability due to long-term effects such 
as chronic foreign-body inflammation, pain, synovitis, and osteoarthritis at implant 
site [5]. Overall, the high failure rates of the majority of the synthetic grafts have 
deterred their use in clinical practice [2]. 
 Synthetic grafts create ideal prosthetics for ACL reconstruction by avoiding 
the donor site morbidity and finite tissue availability but the long term function of 
these devices has yet to be substantiated [120]. Despite the resurgence of interest in 
synthetic grafts for ACL repair, a prosthetic that accurately replicates the physiological 






























































































































































































































































































































































































































































































































































2.4. Tissue Engineering 
 To reduce the risks associated with autografts, allografts, and synthetic grafts, 
there has been a drive towards engineering a hybrid ligament prosthesis combining 
biological, engineering, and material sciences [4]. This has involved the development 
of a scaffold that fulfils the mechanical requirements and provides a suitable 
environment for cellular growth and differentiation. The biochemistry and the 
anatomical location of the ligament or tendon influence the tissue engineering strategy 
for scaffold design and construction [15]. 
 This portion of the literature review will discuss ligament and tendon tissue 
engineering and will give detail regarding advances and studies regarding ligament 
tissue engineering aimed towards ACL regeneration.  
2.4.1. Aims 
 The aim of tissue engineering is to influence the cellular and biochemical 
factors of the healing process affecting protein synthesis, leading to enhanced ECM 
remodelling and tissue repair [15]. Tissue engineering manipulates the repair process 
on increasing levels of organisation and complexity, as seen in Figure 2.5. The basic 
components of tissue engineering are the scaffold, the cell source, and the environment 
providing appropriate nutrients and mechanical stimuli [118, 124]. The combination 
of these components, in theory, creates a functional tissue if applied within reason. 
The motivation in tissue engineering research is to find the optimal combination of 
these factors and then translate the in vitro results to in vivo use, and further into 
clinical practice.  
 
Figure 2.5: A structural scale showing the increasing hierarchy from the cellular to tissue level. At 
the cellular level, interactions within the ECM, surrounding proteins, and stimuli influence cell 
response. As the hierarchical structure increases, there are increasingly more components affecting 
the cellular interactions, such as the cell-cell interaction. At each of the levels, tissue engineering 
research has developed methods to explore and understand the cellular interactions. Image taken 





2.4.2. Ligament and Tendon Tissue Engineering  
 Ligament tissue engineering is a demanding field due to the multiple cell 
phenotypes within the tissue and great mechanical requirements of the native tissue 
[126]. There has been extensive research into a variety of biomaterials and synthetic 
materials to create the optimal scaffold for cell proliferation and ECM organisation [4, 
7, 127-131]. The cell source for ligament tissue engineering has been heavily debated 
due to the complexity of the nature of ligaments [118, 132-134]. Min et al. have 
reported that the donor cells of allografts are no longer evident beyond 12 weeks while 
the graft is repopulated by host cells, potentially reducing the importance of the initial 
cell population [71]. The environment of the seeded scaffold has been manipulated to 
include a variety of growth factors to promote different aspects of cell maturation and 
a range of stimuli to compliment the cell growth [124, 135-139]. The evidence of 
positive fibroblast response to mechanical stimuli has directed ligament tissue 
engineering research toward the application of tensile strain to the cell construct [8, 
136, 140]. In addition to mechanical conditioning, the scaffold architecture has been 
manipulated through modification of the surface chemistry and the incorporation of 
growth factors, or their retention during the decellularization process, to promote 
ligament-like ECM production and direct cell growth [4, 141-143]. 
2.4.3. Cell Source for Ligament Tissue Engineering 
 As mentioned previously, the cell source for tissue engineered ligaments is a 
hotly debated subject and there is no definitive answer to the optimal cell source for a 
tissue engineered ACL. The abundance, availability, ease of acquirement, and 
maturity of the cell source are all factors to consider when making a selection for 
ligament tissue engineering. The most commonly used cells for ACL tissue 
engineering are mesenchymal stem cells (MSCs) or primary fibroblasts derived from 
the ACL [126].  
2.4.3.1. Mesenchymal Stem Cells 
 Many researchers use MSCs due to their high capacity for tissue repair and 
ease of access [132, 134, 144-146]. MSCs are also favourable for their capability of 
differentiation into fibroblasts and collagen production [15, 147]. The availability of 
MSCs throughout the body, such as from adipose tissue and bone marrow, is also a 
factor that positively influences their use. The direct lineage of each of the MSC cell 
sources is unclear and requires further investigation to understand the differentiation 





factors are necessary when culturing with MSCs to facilitate ligament or tendon 
remodelling [147]. The ideal type of MSCs for ligament repair has not yet been 
identified. 
2.4.3.2. Primary Fibroblasts 
 There has been interest in using the cells from the ACL itself in the expectation 
that these cells would have the innate capability of producing the complex ACL 
biochemical and anatomical structure, leading to a more functional tissue [148-152]. 
Several studies have reported the successful migration of ACL derived cells into 
scaffolds and the subsequent matrix proteins synthesized [66, 153-155]. These primary 
fibroblasts are an interesting alternative cell source to MSCs as the cells already 
possess the necessary characteristics to produce the desired ECM and tissue of the 
ACL. Additionally, fibroblasts have the ability to differentiate into several cell 
lineages, which proves useful for the midsubstance and enthesis requirements of 
ligament and tendon repair, Figure 2.6 [156]. However, the availability of cells from 
ACLs remains an issue regarding the adequate storage of explanted cells and pre-
transplantation seeding onto the scaffold.  
 The age of the donor and cell may also be a contributing factor to success of 
ACL derived cells after seeding onto the graft as several studies suggest that cells 
sourced from foetal subjects showed better migration, collagen type I secretion, and 
ECM organisation [150, 157, 158]. However, fibroblasts from ruptured ACLs were 
found to synthesize and produce collagen up to one year after rupture providing a 
wider time span to retrieve cells from the donor [150, 153].  
 
Figure 2.6: Primary fibroblasts have the ability to differentiate into several mature cell types, and 






2.4.4. Challenges of Ligament and Tendon Tissue Engineering 
 Ligament tissue engineering continues to advance with the development of 
new technology and the increased knowledge of ligament healing and cell response to 
biomaterials. Aside from the continual research into scaffold construction and 
optimisation, cell source, and environmental cues there have been challenges within 
ligament repair surrounding the confluence of the soft ligamentous midsubstance and 
the stiff mineralized bony region.  
2.4.4.1. Enthesis Engineering 
 A current challenge in ligament and tendon bioengineering is the development 
of the enthesis, the junction between the soft tissue of the ligament or tendon 
midsubstance and the osseous end region [137, 139, 159]. The enthesis interface is 
composed of tissues with varied biomechanical properties that allow for the stress 
dispersal during movement [160]. The enthesis interface is either classed as a fibrous 
insertion, where the collagen fibres of the ligament connect into the periosteum of the 
bone, or a direct insertion, consisting of a fibrocartilaginous region [161]. Direct 
insertions of ligament into bone are more susceptible to injury and damage from 
overuse [162].  
 The entheses of direct insertions, such as found in the ACL, consist of 4 regions 
of graded mineralized tissue with distinct matrix compositions: a ligament/tendon 
region, an unmineralized fibrocartilaginous region, a mineralized fibrocartilaginous 
region, and a bony region, as seen in Figure 2.7 [52]. Each of these regions contains a 
related cell phenotype; osteoblasts are found within the bony region, 
fibrochondrocytes within the fibrocartilaginous regions, and fibroblasts in the 
ligament region [18]. The organisation of the cells within each region also changes, as 
the cells found in the ligament or tendon region are sparse and elongated towards the 
axis of tension and the cells in the fibrocartilage are rounded, as seen in Figure 2.8 
[163].  
 Within each of these regions, the collagen type and content differs, as collagen 
type I is found in an ordered structure within the ligament, collagen types I, II, and III 
are found within the unmineralized fibrocartilage, collagen types II and X are found 
within the mineralized fibrocartilage, and mineralized collagen type I is found within 
the bone matrix [164]. Additionally, an increasing calcium and phosphorus content is 
seen along the mineralization gradient of these regions [165-167]. A higher content of 





due to the increased sulfated proteoglycan content in this region [165, 168]. The 
compositional changes, namely the organisation and type of collagen and the mineral 
content, between these regions create a gradient of mechanical stiffness that helps to 
disperse the mechanical loading of the joint during movement [169]. Despite the 
distinct composition of each these regions, they are structurally continuous enabling a 
strong biomechanical interface.  
 
Figure 2.7: The natural ACL enthesis, consisting of a ligament region, unmineralized fibrocartilage 
region, mineralized fibrocartilage region, and bone. Each of these regions can be seen as 
compositionally distinct yet structurally fluid. Image taken from Lu et al. [164]. 
 
Figure 2.8: The morphology of cells found at the Achilles tendon enthesis. The cells are depicted 
in cyan. Within the interface region, the cells are rounded and typically found in pairs. In the 
tendon, the cells are found aligned along the axis of tension between tendon fibres. Scale bar 
represents 150 µm. Image taken from Kuntz et al. [163]. 
 It has been shown that the entheses of the ACL have deep integrations of the 
fibrocartilaginous zone into the bone region resulting in a direct insertion of ligament 
into bone, which is related to the mechanical loading [53, 162, 170]. The ACL enthesis 





the alignment of the collagen fibrils into the bone, as seen in Figure 2.9 [161, 169, 
171]. The ‘surgical juxtaposition’ between the soft tissue and bone does not allow the 
natural re-establishment of the organised fibrocartilaginous zone and mechanical 
stability, leading to increased occurrence of ‘tendon pull-out’ [172, 173]. The direct 
insertion of the ACL enthesis has proven challenging to restore in research, resulting 
in the engineered enthesis being mechanically weaker than the native junction [52, 63, 
174]. The change in viscoelastic properties of the ACL enthesis further complicates 
the enthesis engineering in in vitro and in vivo studies [175, 176]. Additionally, the 
two entheses of a ligament may differ in stress dispersal leading to varied rates of 
injury and repair, such as the femoral and tibial entheses of the ACL [177]. 
 
 
Figure 2.9: The enthesis region shown with the bone in yellow, mineralized fibrocartilage in dark 
blue, unmineralized fibrocartilage in light blue, and the ligament/tendon in the tan. (A) Shows the 
relaxed ligament with the crimping pattern intact. (B) The ligament is under tension and the 
crimping pattern has disappeared due to the collagen fibrils being stretched. (C) The ligament 
under tension as seen from a side view. In both B and C, the fibrocartilaginous regions are able to 
dissipate the stress from the applied forces. Schematic taken from Locke et al. [174]. 
 The fibrocartilaginous region has shown to be incapable of natural healing 
after injury, where fibrous scar tissue is produced that has inferior mechanical 
properties of the original tissue [167]. Injury to this tissue could cause permanent 
damage to the enthesis [178]. The decreased healing capacity of enthesis fibrocartilage 
has prompted the need for intervention. The largely unknown phenotype of 
fibrochondrocytes and the production of a mineralized gradient have caused 
difficulties in enthesis engineering [169, 179]. Fibrochondrocytes are phenotypically 
similar to chondrocytes, however their ability to produce compressive load-bearing 
ECM is inferior, including the synthesis of proteoglycans such as aggrecan [18, 168]. 
Spalazzi et al. have found that compression of a tendon graft induced the upregulation 
of several fibrocartilage markers, such as collagen type II and aggrecan, indicating that 
fibrochondrocytes can be recruited from the tendon or ligament midsubstance [180]. 





studies have identified that the mineralization potential of fibrochondrocytes is 
through the hedgehog signalling pathway, however this originates in prenatal 
development and would require further investigation to implement the correct signals 
within a tissue engineered construct [178, 181]. Sun et al. found that the 
fibrochondrocytes at the ACL entheses had a higher mineralization potential than the 
fibrochondrocytes found in the articular cartilage or menisci of the knee [179]. The 
complexity of the ACL fibrochrondrocytes is still widely unknown as research into 
the derivation and response of these cells continues [169, 182, 183].  
 To increase the mineralization potential of engineered entheses for ligament or 
tendon reconstruction, several studies have investigated the incorporation of ceramics 
as a bone tunnel filler or coating, such as hydroxyapatite, brushite, or calcium 
phosphate cements [184-190]. Hydroxyapatite is a clear choice for bone grafts due to 
its crystalline presence in bone matrix, however it is has little resorption potential in 
vivo and its brittle nature can cause implant failure [191]. Brushite has become 
preferable over hydroxyapatite due to its increased resorption potential, however 
brushite has shown to be hydrolysed into hydroxyapatite crystals [192]. This has led 
to the investigation of calcium phosphate salts in the form of ß-tricalcium phosphate 
and its derivatives [193-196]. The increased availability of calcium and phosphate ions 
have shown to increase the osteogenic potential of these materials for enthesis 
engineering [197]. However, these engineered entheses have shown limited potential 
for biological fixation [184].  
 Several studies have attempted to build on the success of calcium phosphate 
salts by creating hybridized tendon grafts from animal models that maintain the 
biomechanical strength of the native tendon [171, 198-200]. These studies have shown 
great success in promoting the growth of an interface similar to that of the native ACL 
enthesis. However, the long-term stability of these hybridized grafts has not yet been 
reported.  
 To further increase the biomechanical similarity of the enthesis, recent studies 
have investigated the use of decellularized tendon-bone grafts to preserve the optimal 
biomechanical strength of the natural enthesis [173, 201]. The decellularization of 
tendon-bone constructs is complicated due to the different cell densities of the tissues 
limiting the access of chemical agents [202]. These decellularized models have shown 
to preserve the biomechanical properties of the natural enthesis after implantation 





potential to be adapted to cadaveric allografts. In fact, Fox et al. have investigated the 
use of decellularized tendon-bone grafts for reconstruction of hands and found that the 
mechanical strength of the decellularized graft was not compromised during 
decellularization and was suitable for post-reconstruction therapy [203].  
 The enthesis is a key factor to a successful insertion of a ligament. There has 
been exceptional research into creating mineralized scaffolds for an engineered 
enthesis but there has been little to report on the functional outcome of the 
mineralization [204]. There is still much knowledge to be learned from the enthesis 
complex and the improvement in reconstruction. 
2.5. Scaffolds in Tissue Engineering 
 Tissue engineering aims to create a biomimetic scaffold to simulate the natural 
environment of the tissue in a structural and mechanical sense. The ideal scaffold for 
ligament repair should permit the necessary cellular ingrowth and matrix deposition 
while maintaining the mechanical strength of the native tissue [9, 130, 138, 205-207].  
 The function and application of the scaffold often dictates the structure, as 
described in Table 2.4 [141, 208-210]. In this manner, each design parameter can 
significantly affect the linked function. The choice of material can have a profound 
impact on several structural aspects of the scaffold, such as the architecture, 
mechanical strength, and degradation. The study by Dunn et al. highlights the 
importance of scaffold design for cell maturation, as they found a tenfold increase of 
collagen synthesis on ligament analogs compared to the tissue culture plastic (TCP) 
control [211]. In their study, the fibroblasts showed high proliferation on the TCP, 
however the ligament analog provided a more suitable environment for synthesis of 
collagen and ligament-like ECM production. The design of a scaffold for tissue 
engineering must consider the function and application for an ideal material choice 













Table 2.4: Scaffold function and design parameters. Each function has a linked design parameter. 
Adapted from Edwards et al. [141]. 
Function Design Parameters 
Not to provoke an inflammatory or 
immunogenic response 
Must be cytocompatible and non-toxic 
Allow significant cell surface 
interactions 
High surface-area to volume ratio 
Give way to uniform high cell seeding 
density 
High porosity and pore interconnectivity 
Provide appropriate surface for cell 
attachment, proliferation, and 
differentiation 
Optimum surface chemistry and 
topography 
Promote cell proliferation and 
migration, leading to tissue growth 
throughout the scaffold 
Optimum pore size to allow for cell 
penetration 
Allow for movement of nutrients and 
waste 
High porosity and pore interconnectivity 
Direct orientation of cells and ECM Correct fibre orientation within the 
scaffold 
Scaffold may degrade to leave only 
natural tissue 
Rate of degradation to match rate of 
tissue formation (degradation products 
must not be toxic or promote 
inflammatory response) 
Possess sufficient structural integrity 
and mechanical strength 
Scaffold should equal mechanical 
properties of developing tissue 
Assist in growth of 3D tissue 3D similarity to native tissue 
 
2.5.1. Scaffold Composition and Architecture 
 The composition of scaffolds is wide ranging and can consist of natural or 
synthetic polymers, or a combination of these, while the physical architecture of 
scaffolds can range from fibres, membranes, and hydrogels. Both the composition and 
architecture of the scaffold can influence cell response and mechanical strength [130]. 
The choice in biomaterial to create the necessary microstructure for cell response and 
macrostructure for mechanical strength is highly dependent upon application [141]. 
 One of the most widely used biomaterials for scaffold creation is collagen due 
to its presence in native tissues. Other prominent biomaterials include gelatin, 
polylactic acid (PLA) and its derivatives, chitosan, silks, and hyaluronic acid [212-
215]. Another increasingly popular natural biomaterial for ligament engineering is 
fibrin. Fibrin is a protein involved in blood clotting and has been shown to have 
contractile properties [216-218]. Due to its wound healing capacities, fibrin has seen 





of the mechanical strength of fibrin as a core material for ligamentous scaffolds for 
tissue engineering requires further investigation [220-222].  
 Many studies have examined fibres constructed of natural materials, such as 
silk and collagen, and synthetic polymers as a scaffold for ligament tissue engineering 
which demonstrate positive cellular ingrowth but have variable mechanical results 
[213, 223-226]. To improve the strength of fibrous scaffolds, several studies have 
explored the effect of a braided or woven assembly [227-229]. The increased 
complexity of the fibrous structure strengthened the scaffold and provided another 
structural level for cellular attachment [230-232]. These studies have shown the great 
consideration of the fibre organisation of the scaffold design encompassing the macro-
structure for mechanical strength and the micro-structure for a beneficial cell response 
[233]. The mechanical properties of several scaffold materials are described in Table 
2.5. 
 
Table 2.5: Mechanical properties of selected materials for ACL reconstruction. Adapted from Ge 












Human ACL [234] 2160 ± 157 242 ± 28 ~33 110 
Patellar-tendon Graft 
[226] 
 685 ± 86   
Hamstring Graft [235] 3790-4830 776   
Twisted Silk Cord 
[226] 
2337 ± 72 354 ± 26 38.6 ± 2.4  
Braided PLGA [227] 907 ± 132   100-400 
Braided PLLA [228] 21  70 55.0 ± 2.8 
Single Collagen Fibres 
[225] 
  17.5 359.6 ± 2.9 
Chitosan/Hyaluronan 
Fibre [213] 
  3.2 ± 0.6 217.6 ± 16.9 
 
2.5.1.1. Collagen 
 Collagen is the most abundant family of proteins in the human body and is a 
major structural component in all connective tissues [39, 40]. The ECM of connective 
tissues, vessels, and bone is composed of strong collagen fibres which are constantly 
undergoing remodelling [216]. The various types of collagen present in the ECM 





versatility of collagen in the native tissue makes it a model biomaterial for ligament 
tissue engineering.  
 The methods of using collagen as a biomaterial include the decellularization 
of existing tissues leaving the ECM structure, a xenograft, and the polymerization of 
collagen to create a functional scaffold [237, 238]. While decellularized ECM 
constructs have been considered for a ligament prosthesis, the sterilization and 
availability are factors to consider [114]. The effect the decellularization agent has on 
the biochemical structure of the scaffold is a key focus of several studies [205, 239-
242]. Xenografts are largely available, through the use of animal models, however the 
risk of disease transmission is increased [205, 243]. Whitlock et. al have shown 
preliminary success using a xenograft harvested from chicken tendons that did not 
have an immunological response when implanted in vivo and had an optimised 
porosity for cellular ingrowth without compromised cytocompatibility [113]. 
Decellularized collagen ECM scaffolds provide an alternative for ligament tissue 
engineering but more investigation into their sustainability and long-term 
immunogenic response is needed.  
 The purification and polymerization of collagen is more commonly used as a 
material for ligament scaffolds. Collagen has favourable biochemical, biocompatible, 
and biodegradable characteristics and can be widely used with a number of other 
biomaterials [130, 244]. Previous studies have used electrospun collagen scaffolds to 
promote cellular growth and maturity [245-247]. Other studies have produced 
collagen gels and membranes through lyophilization that aim to mimic the properties 
of native tissue [212, 248-250].  
 Collagen fibre constructs, membranes, and gels simply do not have the 
required strength to be used for ligament or tendon tissue engineering [214, 244]. 
Therefore, a collagen-based scaffold with the addition of a strengthening or 
crosslinking agent is commonly found in ligament tissue engineering. These 
incorporated agents may also help to control the rate of degradation of the collagen 
scaffold [251]. Physical and chemical crosslinking of the collagen polymers has been 
shown to improve the mechanical strength but some crosslinking agents, such as 
glutaraldehyde, result in cytotoxic residue in the scaffold [252-255]. Synthetic 
polymers have been added to collagen to create a blended scaffold to yield optimal 
mechanical properties. Some commonly used polymers with collagen are PLA, 





(ethylene glycol), chitosan, elastin, and hyaluronic acid [131, 138, 256-261]. These 
collagen-based scaffolds have not yet produced the complete ligament prosthesis 
suitable for ACL reconstruction but have provided a wealth of information on the 
cellular response, mechanical properties, and the physical characterisation of the 
scaffold.  
2.5.1.2. Gelatin 
 Gelatin shares structural similarity with collagen, as it is derived from partially 
hydrolysed collagens [262, 263]. The availability, biodegradability, and 
biocompatibility are all factors that have led to the use of gelatin-based scaffolds in a 
range of biomedical fields [264]. Gelatin has greater similarity to the 
microenvironment of the native tissue than various other synthetic and non-collagen 
derived materials [265]. 
 Like collagen, the mechanical strength of gelatin is low, making it a more 
suitable material for wound dressing or drug delivery. Many studies have investigated 
the processing of gelatin into nanofibrous scaffolds for increased mechanical strength 
[262, 266-268]. The biochemical structure of gelatin is compatible for tissue 
engineering however it requires further reinforcement to create a ligament scaffold. 
2.5.1.3. Chitosan 
 Chitosan is a versatile material that has natural antibacterial properties and is 
cytocompatible, biodegradable, easily accessible, and cost-effective [269]. Chitosan is 
derived from the deacetylation of chitin which can be found in the shells of 
crustaceans, Figure 2.10 [270]. The manufacturing ease of chitosan allows great 
control over the porosity of the desired scaffold [271, 272]. Additionally, the structural 
properties of chitosan are similar to GAG which may influence the synthesis of GAG 
by attached cells [273]. These natural properties of chitosan make it an ideal 
biomaterial for tissue engineering applications [274, 275]. 
 The cationic nature of chitosan has a beneficial impact on the interactions with 
GAG and proteoglycans and may also play a role in the adhesivity of fibroblasts to the 
scaffold [214, 276, 277]. These ionic interactions further accelerate the use of chitosan 
in cell culture scaffolds.  
 Chitosan is a versatile biomaterial that can be utilized in a number of different 
scaffold types. Modifications to the ionic structure of chitosan can allow mechanical 
and biological variation in the scaffold design [276]. It has been shown that the 





scaffold by slowing the rate of biodegradation [251, 256]. An increase in scaffold 
tensile strength was seen in a study by Tamura et al. who used chitosan-coated alginate 
filaments [278]. While Surakawa et al. recorded an enhanced fibroblast response on 
chitosan-coated PLA fibres [279]. Further developments in mechanical strength and 
fibroblast response were seen by Funakoshi et al. who blended chitosan with 
hyaluronan to create novel polymer fibres in comparison to chitosan alone [213]. 
These studies show promising results from the addition of chitosan to scaffolds; 
however, the mechanical integrity of chitosan is still lacking. 
 The degradation rate of chitosan decreases with the increasing degree of 
deacetylation, where highly deacetylated chitosan may remain in vivo for several 
months [280]. Chitosan-based scaffolds with a high deacetylation percentage may 
provide an adequate time period to allow cellular ingrowth during degradation. The 
degree of deacetylation also influences the reactivity of the chitosan functional groups 
and increases water retention [271]. 
 
Figure 2.10: The chemical structures of chitin and chitosan indicating the sites of deacetylation 
[274]. 
2.5.1.4. Crosslinking of Chitosan Scaffolds 
 The incorporation of natural crosslinking agents has become increasingly 





response [281, 282]. The physical properties of chitosan scaffolds can be controlled 
through the degree of the crosslinking [283]. Commonly used agents for chitosan 
crosslinking have included glutaraldehyde, genipin, and oligomeric proanthocyanidin 
(OPC) [284-286]. Glutaraldehyde has proven to increase the mechanical integrity of 
chitosan hydrogels, however it has shown to be cytotoxic if not fully consumed during 
crosslinking [287]. Genipin has widely replaced glutaraldehyde as a crosslinker and 
has been shown to have anti-inflammatory and anti-bacterial properties [288, 289]. 
The adhesion and proliferation of fibroblasts has increased on chitosan scaffolds 
crosslinked with genipin [290, 291]. OPC has been a common addition to chitosan 
scaffolds for its natural availability and positive cell response [292-294]. The strong 
hydrogen bonds between chitosan and OPC contribute to the structural integrity of 
these scaffolds while further enhancing the natural antibacterial properties of chitosan 
[295-297]. Additionally, Liu et al. has reported that OPC is 120 times less toxic than 
glutaraldehyde as a crosslinking agent [298]. OPC and genipin are suitable as 
alternative crosslinking agents for chitosan and collagen-like scaffolds to maintain 
mechanical properties [299-302].  
2.5.2. Biodegradability 
 The biodegradability of a biomaterial is another area of consideration for 
scaffold design. The biodegradation of the material must not elicit a foreign body or 
immunological response from the host [4, 303]. Fibres made of PLA, polyglycolic 
acid, and PLGA have shown to be biodegradable without producing cytotoxic residues 
increasing their popularity in tissue engineering research [227]. The products of fibrin 
biodegradation have been shown to promote cell attachment and proliferation and 
stimulate angiogenesis [216].  
 The biodegradability poses a risk to the mechanical strength of the scaffold as 
the rate of degradation must not exceed the rate of matrix deposition and cellular 
ingrowth [17, 130]. There is a fine balance in maintaining the required strength of the 
scaffold while promoting cellular ingrowth and biodegradation. The biodegradation of 
polyglycolic acid based scaffolds leading to loss of structural integrity has been seen 
in as little as 2 weeks of immersion in cell culture medium [304, 305]. The 
biocompatibility and biodegradability of silk scaffolds has increased interest in their 
use, as Wu et al. have reported an 8% weight loss after incubation for 60 days for a 
degummed silk fibroin scaffold [306]. The degradation profiles of biomaterials in cell 





scaffold, however cell culture on these biomaterials is required to gain a true 
understanding of the material’s suitability as a scaffold for tissue engineering 
applications. 
 An ideal scaffold for ligament repair would allow tissue formation that 
advances its proportion of mechanical contribution as the scaffold degrades and 
decreases in mechanical contribution, as depicted in Figure 2.11 [208]. Therefore, 
understanding of the cellular response and tissue generation during degradation of a 
scaffold is required. In an in vivo study using braided collagen fibres as ACL grafts in 
goats, researchers found that the distinction between graft and tissue was difficult to 
interpret with approximately 50% resorption of the scaffold after 6 months [307]. Chen 
et al. have shown evidence of tissue formation and full degradation of a poly(lactic-
co-glycolic acid)-collagen mesh after 12 weeks, however the mechanical integrity of 
the scaffold was not measured [308]. Surrao et al. found an increase in tensile strength 
and ECM similar to a natural ACL on crimped poly(lactide) fibrous scaffolds seeded 
with bovine fibroblasts after 8 weeks of culture and less than 10% mass loss after 4 
weeks [309]. A study investigating braided poly(L-lactide) scaffolds with 
hydroxyapatite enriched bony regions, found sufficient tissue integration across the 
scaffold after 6 weeks in vivo in a rabbit model, however the mechanical integrity was 
not tested post-operatively [310]. Despite the increased studies of tissue deposition on 
biodegradable scaffolds for ligament repair, there is little information regarding the 
combined scaffold resorption, tissue generation, and the subsequent mechanical 
strength of the scaffold over time. 
 
Figure 2.11: Diagram of the mechanical contribution of a scaffold and new host tissue, or tissue 
generation on a scaffold, over time. The mechanical contribution of the new tissue should overtake 







 The popularity of hydrogels has surged recently because of their exceptionally 
tuneable structural, chemical, and mechanical properties and tissue-like water content 
[217, 311]. Hydrogels are formed of a 3D network of hydrophilic polymers that have 
the capacity to swell and retain a large volume of water [312]. Hydrogels can provide 
a more similar environment for cell growth while allowing the diffusion of nutrients 
and waste [313]. A unique characteristic of hydrogels is their injectability and variable 
rheology [314]. 
 In order to more accurately replicate the native environment, hydrogels can be 
synthesized from a variety of materials, from natural to synthetic polymers [315]. The 
synthesis of hydrogels is highly adaptable and tuneable to the specific application due 
to the high diversity of available biomaterials and bioadditives, Figure 2.12 [316]. The 
synthesis of hydrogels is largely based on the desired tissue engineered product.  
 The mechanical strength of hydrogels is typically low due to its high water 
content. This is suitable for soft tissues that do not experience high levels of force in 
situ. However, for tissues that require a higher level of structural integrity, studies have 
explored the addition of PLLA fibres, polycaprolactone and silk fibroin fibres, and 
titanium springs into hydrogels [317-319]. The flexibility of hydrogel composition has 
led to the research and implementation of hydrogels in an increasing number of 
biomedical applications.  
 
Figure 2.12: Two examples of hydrogel synthesis. A) Formation of ionic hydrogels either through 
the use of a multivalent cation or a polycation. Examples include alginic acid and polylysine 
complex and chitosan complexes B) Formation of crosslinked hydrogels using reactant groups. 
Examples include reactions with collagens, polysaccharides, and poly(ethylene glycol). Image 
adapted from Hoffman [316]. 
2.6.1. Hydrogels in Ligament Regeneration 
 Due to the low mechanical strength of hydrogels, ligament engineering 
researchers have begun to implement strategies that have shown success in other 





electrospun meshes in cartilaginous and vascular studies Thayer et al. incorporated 
cylindrical electrospun meshes into poly(ethylene glycol) hydrogel networks and 
found that they provided an adequate mechanical scaffold for ligament engineering 
but were unable to support cellular growth [322]. Freeman et al. have found that a 
hydrogel-fibre composite created a scaffold with similar tensile properties to the native 
ACL and supported fibroblast growth [318]. Paxton et al. have shown that hydrogels 
can support the addition of hydroxyapatite, or other minerals, for an enhanced enthesis 
scaffold [184].  
 Growing numbers of researchers have implemented collagen, gelatin, and 
chitosan into hydrogels for their natural biocompatible properties, high abundance, 
low cost, and the increased cellular response leading to an organised ECM. Murray et 
al. found that collagen-GAG scaffolds supported the migration and complex ECM 
production of ACL derived cells, however the mechanical integrity was not reported 
[154, 155]. Several studies have incorporated a collagen-based hydrogel coating onto 
electrospun fibres of poly(caprolactone), that provide mechanical reinforcement with 
the collagen hydrogel offering a suitable environment for cellular growth [323, 324]. 
The hydrogel was found to increase the cytocompatibility, protein adsorption, and 
fibroblast alignment without alteration of the tensile strength of the fibres. Another 
study created a novel multi-layered composite hydrogel scaffold of gelatin and 
poly(caprolactone) fibres that successfully directed human adipose stem cells towards 
a tenocyte phenotype [265]. 
 Murray et al. have utilized collagen-based hydrogels as a supplement to ACL 
regeneration that released key proteins and platelets to aid in healing [325]. The 
hydrogel supplement resulted in improvements in the tensile loading of the porcine 
ACL. However, this study was performed with a short time point and the longevity of 
the repair method needs further investigating.  
 Fibrin has also been a key component of hydrogel scaffolds for ligament tissue 
engineering based on its function in wound healing [217, 218, 221, 326]. These studies 
have reported successful contraction and migration of cells within the scaffold. 
Breidenbach et al. reported the superior mechanical, structural, and biological 
properties of fibrin hydrogels compared to collagen hydrogels [220]. However, 
Vavken and colleagues found a negative correlation between the fibrin concentration 





that high concentrations of fibrin, such as in medical glue to close wounds, should be 
used with caution [151].  
 The water retention of hydrogels has played a large role in their use for tissue 
engineering applications [323]. Several studies have created hydrogel fibres that 
maintain the swelling capacity of the hydrogel to better mimic the viscoelasticity of 
ligaments [318, 327]. However, Bach et al. have shown that the swelling of poly(vinyl 
alcohol) hydrogel fibres may lead to the release of fibre orientation which can limit 
the tensile stiffness of the scaffold [328]. The swelling capacity and water retention of 
hydrogels is a hugely important factor in their use in tissue engineering, however these 
properties require more investigation as hydrogels become increasingly popular in 
ligament tissue engineering applications.  
 These studies highlight the necessity of tailoring hydrogel composition and 
synthesis to create a scaffold that mimics the natural environment of the ligament or 
tendon. Hydrogels are becoming an increasingly popular material for ligament tissue 
engineering. However, the low mechanical strength of hydrogels is a limiting factor 
to their implementation and translation beyond in vitro use.  
2.7. Bioreactors in Ligament and Tendon Tissue Engineering 
 Bioreactors regulate specific environmental factors during cell culture in a 
reproducible and controllable fashion [140]. In this way, a bioreactor can more 
accurately simulate the physiological environment of the native tissue and has become 
an indispensable aspect of ligament tissue engineering. A bioreactor for ligament 
engineering applications is composed of four key components: the culture chamber, 
mechanical actuating system, environmental control system, and the medium 
circulation system, Figure 2.13 [8]. Often, bioreactors will be uniquely created and 
modified for individual studies. Bioreactors can reduce the manual handling and 
variation and decrease risk of contamination while increasing scalability and 
production [329, 330]. The use of bioreactors in combination with engineered 
scaffolds affords great control over cell behaviour and interactions. 
 A deeper understanding of the mechanical stimuli requirements for tissue 
regeneration has made bioreactors an important staple in ligament and tendon tissue 
engineering. It has been shown that mechanical stimulation is necessary to regulate 





bearing tissue [331, 332]. Bioreactors for ligament and tendon tissue engineering are 
predominantly essential for precise application of mechanical stimulation. 
 
 
Figure 2.13: The components of a bioreactor for ligament and tendon tissue engineering. The basic 
components include the actuating system for mechanical stimulus, the culture chamber, the 
environmental control, and medium circulation. These components can be modified in a number 
of ways to induce specific cellular responses. Image adapted from Wang et al. [8]. 
 It has been widely reported that fibroblasts require mechanical stimulation 
during culture to produce an ECM that resembles the native ligament ECM [333-335]. 
The current drive in ligament and tendon tissue engineering is generating the optimal 
mechanical stimulation to induce production of a suitable ECM. Bioreactors have 
become increasingly common within ligament tissue engineering research to replicate 
the physiological loading of a natural ligament [19, 215, 255, 336, 337]. Due to the 
necessity of physiological loading during cell culture, the most common bioreactor 
design for ligament and tendon engineering consists of a cell culture chamber with 
two points of attachment for the scaffold to the actuating system. One, or both, of these 
attachments allows the transmission of the physiological loading onto the scaffold and 
seeded cells. In using this design, the attachments of the scaffold to the actuating 






 Cyclic tensile strain has been shown to increase scaffold strength by increasing 
total collagen synthesis and cell alignment, Figure 2.14 [65, 149, 338, 339]. However, 
the application of tensile strain to scaffolds is under debate concerning the rest period, 
frequency, and strain rate [8, 340, 341]. This has led to a range of strain rates, such as 
2% and up to 10%, highlighting the range of physiological strain during movement of 
the native ACL [62, 149, 215]. The time of applied mechanical strain also ranges from 
1hr/day to 8hr/per day [19, 342-344]. Further optimization of the strain regime has 
concluded that an ample rest period is conducive to cell proliferation and to allow 
adequate ECM protein synthesis [344, 345]. Several studies utilizing a bioreactor for 
ligament tissue engineering are outlined in Table 2.6 describing the mechanical 
parameters, scaffold and cell type, and the overall outcome. 
 
Figure 2.14: A simple schematic of a hydrogel scaffold (yellow) with anchors (grey) at either end 
seeded with cells (pink) undergoing tensile strain within a bioreactor. The hydrogel scaffold is 
housed in the bioreactor (middle diagram) in the grey plane below the white planes that control the 
movement of the anchors. Before the application of strain, the collagen fibres (orange) are 
unorganised and sparse in number. After the tensile strain, the collagen fibres are more numerous 
and organised.  
 Reproducing the natural environment remains a challenge as investigators 
attempt to create in vitro studies that more similarly replicate mechanical behaviours 
that would occur in vivo. This has led to studies creating bioreactors that can apply 
multi-dimensional strain that more accurately mimics the functional units of the 
ligament, such as the AM and PL bundles of the ACL [136, 346]. Goodhart et al. 





find significant differences upon the scaffold, potentially due to the shared medium 
[347].  
 Due to the factors described, bioreactors have become an indispensable 
component of ligament and tendon engineering. Bioreactors offer a controlled and 
reproducible environment with the potential for upscaling that is not typically seen 
within cell culture. The mechanical stimulation that bioreactors can provide is an 
important factor in creating a tissue engineered ligament. However, there are many 
elements to consider when implementing a bioreactor resulting in numerous custom 




























































































































































































































































































































































































































































































































































































































































































































































































































































2.8. Biological Characterisation of a Tissue Engineered Ligament 
 Within ligament tissue engineering, there are several biological markers that 
are used to characterize the scaffold during and after cell growth, including cell 
morphology, ECM composition, and gene expression. These biological markers are 
indicative of accurate cell growth, proliferation, migration, and ECM production [348, 
349]. Surveying these markers during the process of regeneration in tissue engineering 
is an important and valuable tool.  
2.8.1. Cell Organisation and Morphology 
 The cell organisation and morphology within a scaffold for ligament tissue 
engineering are useful measures of cell growth on a scaffold. As discussed previously, 
the cellular organisation and morphology varies throughout the regions within a 
ligament, such as the ligamentous region compared to the entheses. Near the middle 
ligamentous region, the fibroblast morphology is elongated and sparse, whereas near 
the entheses, the fibrochondrocytes become more rounded and are found in pairs 
[163]. The cell number also depends on the healing stage of the ligament where mature 
ligaments have sparse cell numbers and healing ligaments have a dense cell population 
[96, 350]. 
 Monitoring the cell morphology on a scaffold can help to identify signals of 
positive regrowth. Additionally, undesirable cell responses can be mitigated early by 
observing the cell morphology and organisation.  
2.8.2. ECM Components 
 The composition of the ECM determines the structure of the tissue and aids in 
its function [208]. One of the most important components of the ECM of ligaments is 
the collagen content and organisation, specifically collagen types I and III [351]. It has 
been shown that the crosslinking between fibrils and length of collagen fibrils along 
the longitudinal axis of the ligament increases with maturity of the tissue [20, 352]. 
The organisation of collagen fibrils is important as they regulate the mechanical forces 
within the ligament and transmit these forces to the adjacent bone, though the 
organisation and localisation of collagen fibrils and accompanying proteoglycans in a 
healing ligament is unknown [352, 353]. The collagen content can be measured 
through immunoassays while the organisation of the fibrils can be visualised through 
fluorescent staining. 
 Decorin, elastin, and tenascin-C are vital proteoglycans within the ECM of 





components are indicative of matrix deposition and remodelling that is essential for 
ligament repair [350]. Tenascin-C has been used as a ligament-specific biological 
marker due to its high concentration in ligaments and tendons and its upregulation 
from mechanical loading [348]. These biomarkers are typically measured with a 
terminal assay through a range of fluorescent markers and immunoassays to determine 
concentration and organisation.  
 Additionally, there are several genetic markers that indicate growth of cells on 
a scaffold that is similar to a native ligament or tendon [354-356]. These markers 
include gene expression of collagen I, GAG, and scleraxis [357, 358]. There are also 
genetic markers that may predispose ligaments and tendons to injury [22]. Genetic 
analysis has proved to be a useful means to examine cellular growth on a scaffold for 
a ligament tissue engineering application [354, 357].  
2.9. Conclusion 
 In this literature review, the anatomical and biochemical structure of the ACL 
was discussed along with its healing capacities and current strategies for 
reconstruction, as an example of ligament injury and repair. Because of the similarity 
of ligaments and tendons, tendons have also been discussed in this review. Due to the 
limited restoration of natural function of the current available grafts for ACL 
reconstruction, tissue engineering research has begun to develop biomimetic scaffolds 
as alternative repair options. The selection of scaffold material, cell source, and 
mechanical stimulation has relied on the underlying knowledge of the ligament 
healing process and the biomechanical loading of the native intact ligament. Although 
the ideal tissue engineered ligament has not yet been created, there have been great 
advancements as new methods and technologies are established.  
 As ligament tissue engineering progresses, a deeper understanding of the cell 
phenotypes found in the ligament midsubstance and enthesis region will lead to a more 
educated cell source choice for grafts. There is no consensus on the most suitable 
material for ACL scaffolds as there are many factors to consider when developing the 
scaffold, such as the biodegradability, the architecture, and the response to mechanical 
stimulation and the cell response to the scaffold. The enthesis has challenged ligament 
engineering research due to its complex regions of graded mineralization and 
associated cell phenotypes that create a biomechanically strong interface, resulting in 
the implementation of calcium phosphate salts to increase the mineralization potential 





research incorporating the ligament midsubstance and the enthesis to create a complete 
bone-ligament-bone scaffold, or sinew, for ligament engineering to examine the tissue 
formation potential and mechanical strength.  
 This research aims to add to the understanding of scaffold materials, through 
the use of cost-effective and sustainable materials (chitosan, gelatin, and OPC) that 
have not previously been used in the methods described here as a scaffold for ligament 
tissue engineering. Further, this chitosan-gelatin hydrogel will be developed to contain 
two bony attachments, representing a sinew structure, that will be implemented within 
a tensile bioreactor to better understand the effect of cyclic strain on a primary 
fibroblast culture. The tensile bioreactor used in this study was designed to focus on 
the effect tensile loading has on the hydrogel scaffold and attached cells. In its design, 







2.10. Aims of Research Project 
 This literature review discussed ligament and tendon injury and repair using 
ACL injury and its reconstruction as a clinical example. Current tissue engineering 
approaches to ligament repair were discussed with detail on the demand to develop 
approaches to better create an engineered prosthesis for ACL repair. While the current 
autograft and allograft options provide a suitable return of function, there are certain 
drawbacks such as donor site morbidity, graft failure, and immunogenic responses that 
have motivated research to find a more suitable alternative. Within tissue engineering 
there are distinct challenges in creating a scaffold that is biologically and 
biomechanically similar to the native ligament and produces a successful, permanent 
enthesis. 
 This research aims to create a hydrogel scaffold from sustainable biomaterials, 
chitosan, gelatin and OPC, that can withstand similar mechanical forces to the ACL 
without permanent deformation through the use of a tensile bioreactor. Modification 
of the hydrogel to influence an osteogenic response at the enthesis region will be 
investigated by incorporating calcium phosphate salts into the hydrogel. The cellular 
response of two different cell cultures will be recorded on the hydrogel midsubstance 
and enthesis regions. 
 In the development of the hydrogel scaffold, a novel method of creating a 
detached hydrogel scaffold will be assessed. The detached hydrogel scaffold will be 
analysed for its cytocompatibility, surface chemistry, and mechanical properties. This 
project will conclude with the use of a custom tensile loading bioreactor that 
incorporates the hydrogel scaffold with calcium phosphate rich enthesis regions to 






3. General Methodology 
3.1. Introduction 
 This chapter describes the general methodology that is repeated throughout the 
workflows. In each workflow, the methodology will be referenced to this chapter and 
any modification to the protocol will be noted within the chapter.  
3.2. Cell Culture 
 Cell culture protocol was followed as written and adapted by Lesley Cyster, 
Louise France, Jonathan Ratcliffe, Matthew Moles, and Kayla Kret for the 
Bioengineering Research Group Cell Culture Laboratory at the University of 
Nottingham [359].  
3.2.1. Cell Culture Maintenance 
 The cell culture medium consists of Dulbecco’s Modified Eagle’s Medium 
(Sigma Aldrich, UK) supplemented with 10% Foetal Bovine Serum (FBS) (Fisher 
Scientific, UK), 2% antibiotics-antimycotics, 2% HEPES buffer, 1% non-essential 
amino acids, 1% L-Glutamine (cell culture supplements from Gibco Invitrogen, UK), 
and 0.25mg/ml of ascorbic acid (Fisher Scientific, UK). Cell culture medium and 
reagents were warmed to 37ºC in a water bath prior to use.  
 Live cell cultures were kept in a humidified 37ºC, 5% CO2 incubator. A 
deionized water reservoir was kept in the incubator at all times with the addition of 
copper sulphate (Sigma Aldrich, UK) to eliminate microbial growth. 
 The NIH-3T3 (3T3) cell line was used for cell culture at passage 7-20 (3T3 
Swiss Albino, ECACC, 85022108). A primary cell culture was created from ovine 
fibroblasts, which is described in further detail in section 3.2.5. Both cell cultures 
received the same cell culture medium and cell culture treatments.  
Cells were kept in cell culture flasks before use on samples. While in flasks, 
the cell culture medium was changed every two days by aspirating the depleted 
medium, washing the cells with warm phosphate buffered saline (PBS) (Sigma 
Aldrich, UK), and then replacing with fresh medium.  
3.2.2. Bringing Cells to Culture from Cryopreservation 
 When cells were not in use, they were stored at -80ºC in a liquid nitrogen tank. 
Cells were brought up from frozen by leaving the microtubule at room temperature for 
1 minute then carefully held in the water bath until 90% defrosted, without letting the 




a T75 cell culture flask and 10 ml of medium was added. The medium was changed 
after 24 hours to remove any unattached, dead cells.  
3.2.3. Passaging Cells 
 The cells were passaged after they reached 80% confluence, as observed 
through phase contrast microscopy, if they were not being used. This was done by 
aspirating the cell culture medium from the flask, washing with 5 ml of PBS, and 
adding 1 ml of 0.05% trypsin in disodium ethylenediaminetetraacetic acid (EDTA) 
(Sigma Aldrich, UK). The flask was then incubated for 3-5 minutes. After incubation, 
the flask was gently tapped to fully dislodge all of the cells. Cell culture medium was 
added to the flask in two phases of 6 ml and 3 ml and the cell suspension was added 
to a Falcon tube. The suspension was centrifuged at 4500 rpm for 4 minutes at 37ºC. 
The supernatant was removed, and the pellet was then resuspended in n ml of medium, 
with n corresponding to the desired number of flasks to be split between, typically 2 
or 3. The suspension was then aliquoted between the flasks with 9 ml of warm medium 
in each to bring the total volume of cell culture medium and cell suspension to 10 ml.  
3.2.4. Cryopreservation 
 When cells reached confluency and were not going to be used, they were 
frozen down. The cells received the same trypsin treatment as in passaging cells until 
the resuspension step. After centrifuging and removing the supernatant, the pellet was 
resuspended in 1 ml of 10% dimethyl sulfoxide (Sigma Aldrich, UK) in FBS. The cell 
suspension was then transferred into an ampoule and placed into the vapour box of the 
liquid nitrogen tank. After 24 hours in the vapour box, the ampoule was moved into a 
storage box. 
3.2.5. Primary Ovine Fibroblast Culture 
 In order to evaluate the scaffolds further, a primary cell culture was utilized. 
The ovine cranial cruciate ligament and caudal cruciate ligament of the stifle joint 
were chosen because they are comparable to the human anterior cruciate ligament and 
posterior cruciate ligament, respectively, Figure 3.1 [360].  
3.2.5.1. Specimen Harvesting 
 Female English Mule Sheep, of biological age 2-4 years old, were culled by 
trained technicians at the University of Nottingham Sutton Bonington campus. The 
sheep were killed by either an overdose of phenobarbital or by electric shock and 
exsanguination. The ovine ligaments of the stifle joint were exposed by creating a 




and fascia were cut away to reveal the femur, the menisci, and patella. The patellar 
tendon was cut distally to allow the free movement of the joint revealing the cruciate 
ligaments. The joint was then put into full flexion and the cruciate ligaments cut as 
close to the bone as possible. The tissue was collected and stored in Hanks Buffered 
Saline Solution (HBSS) (Sigma Aldrich, UK) on ice until digestion could take place, 
roughly 1.5 hours.  
 
Figure 3.1: Anatomical drawing of the proximal region of the tibia of the stifle joint to show the 
cranial and caudal cruciate ligaments, a and b respectively. Image taken from Allen et. al [361]. 
3.2.5.2. Tissue Digestion 
 Prior to digestion, all tissue was thoroughly washed with PBS and any 
remaining synovial membrane tissue and bony tissue was removed. After washing, the 
tissue was finely minced into portions approximately 2mm2. The minced tissue was 
then digested using collagenase [150, 345].  
 The tissue was immersed in a collagenase type I (Sigma Aldrich, UK) solution 
containing 0.05% collagenase in cell culture medium in 6-well plates. There were 
three concentrations of collagenase in cell culture medium in the well plates; 2:1, 1:2, 
and 1:1 with a total volume of 6 ml. The collagenase concentrations completely 
covered the tissue. The well plates were left to incubate for 24 hours. After incubation, 
each digestion was added to 9 ml of medium, centrifuged to form a pellet, the 
supernatant removed, and the pellet resuspended in 1 ml of medium and cultured into 




 All three concentrations produced viable cells, as judged by phase contrast 
microscopy, and all flasks were considered available for future experiments. From this 
point, the ovine ACL and PCL cells from the concentrations were collectively called 
PFib due to the limited numbers of cells and their morphological similarities [24].  
3.2.6. Cell Seeding 
 When cells reached 80% confluency and ready for use, the cells were seeded 
onto samples. The same trypsin treatment as passaging was used until the resuspension 
step where the pellet was resuspended in 1 ml of cell culture medium. The cells were 
counted using Trypan Blue dye (Sigma Aldrich, UK) and a haemocytometer. To count 
the cells, 50 µl of cell suspension was mixed with 50 µl Trypan Blue dye and left for 
60 seconds to allow the dye to fully incorporate into the cells. The dyed cell solution 
was then inserted into the haemocytometer and the live cells counted under a phase 
contrast microscope. The required cell density was calculated, and additional cell 
culture medium added to the cell suspension as necessary. The cells were then pipetted 
onto the samples, with an ample amount of cell culture medium added to each well 
after attachment.  
3.2.7. PFib Culture 
 The PFib cells received the same cell culture medium and treatment that the 
3T3 cells received, with the modification that the cells were first cultured in T25 flasks 
after cryopreservation and then transferred to T75 flasks upon confluency to aid 
growth. The PFib cells were kept at ultra-low passages, between passages 0-2, before 
use [362]. The volume of liquids in all processes were scaled down for the T25 flasks. 
3.3. Cell Area Measurement 
 The area of the cells was calculated using Fiji software from photographs taken 
under a phase contrast microscope throughout culture periods. Photographs from the 
phase contrast microscope were scaled using a graticule.  
 A minimum of 45 cells were measured in each photograph, avoiding areas 
were the cell-cell contact made it difficult to differentiate between cells when possible. 
3.4. Cell Culture Assays 
Assays were used at different time points throughout cell culture to measure 
the cell growth, differentiation, and ECM productions of the cells. The metabolic 
activity assay is an indicator of the viability of the cells and was used at several 




acid (DNA), alkaline phosphatase (ALP), and glycosaminoglycan (GAG) assays are 
all terminal assays and could only be used at the final time point.  
3.4.1. AlamarBlue 
 The alamarBlue assay (Bio-Rad, UK) is a colorimetric reading of the 
metabolism by viable cells of non-fluorescent resazurin reduced to fluorescent 
resorufin, as seen in Figure 3.2. 
 
Figure 3.2: Resazurin reduced to fluorescent resorufin by the metabolic activity of viable cells. 
Image taken from the Bioengineering Research Group Cell Culture Protocol [359]. 
 At the selected time point, alamarBlue solution was made up in a 1:10 ratio of 
alamarBlue to HBSS and kept warm in the water bath protected from light. The 
medium was removed from the samples and the cells were washed with warm PBS. 
The cells were washed with warm PBS twice more, with the PBS left in the wells for 
5 minutes. After the PBS washes, a sufficient amount of the alamarBlue solution was 
aliquoted into the wells. For example, in a 24-well plate, 1 ml of alamarBlue solution 
was used and for a 12 well plate, 1.5 ml of alamarBlue solution was used.  
 The well plate was replaced in the incubator for 80 minutes. After incubation, 
the plates were wrapped with aluminium foil and placed on the plate shaker at 250 
rpm for 5 minutes to thoroughly mix the reacted dye within the solution. Aliquots of 
100 µl of each sample and 3 blanks were read in triplicate in a 96-well plate using a 
fluorescence plate reader (FLX-800, Bio-Tek Instruments, Inc, USA) at excitation 560 
nm and emission 590 nm wavelengths.  
 Because alamarBlue is not a terminal treatment to the cells, the samples were 
able to continue culture after the assay. If further culture took place, the remaining 
alamarBlue solution was aspirated from the wells and each sample was washed twice 
with warmed PBS for 5 minutes. After the PBS washes, additional cell culture medium 
was added, and the well plates replaced into the incubator. 
3.4.2. Cell Lysing 
 Prior to further assays, the cells were lysed by undergoing a freeze thaw cycle. 
This was carried out by washing the samples twice with PBS and then adding 1 ml of 




tape and subjected to snap freezing using liquid nitrogen. The plates were placed in a 
Styrofoam box and liquid nitrogen was added to create a shallow layer. The lid was 
replaced and left for 5 minutes. Once frozen, the plates were transferred into the 
incubator and allowed to thaw. The well plates were frozen and thawed twice more. 
The cell lysate was then transferred to microtubules.  
3.4.3. DNA Assay 
 To quantify the DNA content in each sample, the PicoGreen DNA kit 
(ThermoFisher Scientific, UK) was used following the manufacturer’s suggested 
protocol. A TE buffer was created by adding the concentrated TE stock supplied to 
room temperature SDW. The reagent was made using the supplied concentrated 
reagent in TE buffer and protected from light using aluminium foil. The buffer and 
reagent were made on the day of the assay, as close to the reading as possible. 
 A standard reference curve, such as the one below in Figure 3.3, was created 
using the Lambda DNA standard that was supplied with the kit. The DNA standards 
were created in increasing concentrations from 0-1 µg/ml in the TE buffer. The DNA 
standards were read by aliquoting 100 µl of each in triplicate into a 96-well plate and 
then adding 100 µl of the reagent. The plates were covered in foil and placed on a plate 
shaker at 250 rpm for 3 minutes at room temperature. The plates were then read on a 
fluorescence plate reader (FLX-800, Bio-Tek Instruments, Inc, USA) at excitation 480 
nm and emission 520 nm wavelength. A trendline was created ensuring R2>0.95. A 
standard curve was created each time the PicoGreen assay was carried out. 
 
 
Figure 3.3: A typical standard curve used for DNA quantification with the PicoGreen kit.  

























 Each sample was thawed, vortexed, and then aliquoted in triplicate 100 µl into 
96-well plates. Then 100 µl of the reagent was added and the plates covered with foil 
and left on the plate shaker for 3 minutes at room temperature. The plates were then 
read using the fluorescent plate reader. The DNA content of each sample was then 
calculated using the standard curve.  
3.4.4.  Alkaline Phosphatase Activity 
 Alkaline phosphatase (ALP) is an early marker for osteogenesis of osteoblast-
like cells [363]. ALP is a colorimetric absorbance assay to quantify the amount of ALP 
present in a sample. A slight colour change to yellow occurs if ALP is present. 
ALP activity was measured using the ALP kit (Randox Laboratories, UK) 
following the manufacturer’s protocol. Reagent AB was created by adding 10 ml of 
Reagent B to Reagent A and mixing thoroughly. The cell lysate was thawed to room 
temperature and vortexed prior to use. 50 µl of the lysate was aliquoted in triplicate 
into a 96-well plate followed by 50 µl of Reagent AB. The plate was loosely covered 
with aluminium foil and left on the plate shaker at 250 rpm for 30 minutes at room 
temperature. The plate was read using an absorbance plate reader (ELX-800, Bio-Tek 
Instruments, Inc, USA) at 405 nm wavelength. The ALP activity was normalized 
against the DNA content of each sample.  
3.4.5. Papain Digestion 
 After lysing, a papain digestion was used to solubilize the ECM to allow for 
evaluation of sulphated glycosaminoglycans (GAG).  
 Papain is a proteolytic enzyme that dissociates the ECM once activated [364]. 
The papain solution consisted of papain buffer (sodium phosphate 0.1M, cysteine 
hydrochloride 0.005M, EDTA 0.005M, and dH2O) and 0.1% w/v papain (Sigma 
Aldrich, UK). The pH of the papain solution was adjusted to 6.5 with 1M hydrochloric 
acid (HCl) or 1M sodium hydroxide (NaOH), as appropriate. The papain was added 
to the papain buffer on the same day that the digestion was to take place. The papain 
solution was added to the lysate samples in a well plate at a 1:1 ratio and left overnight, 
18 hours, in a 60ºC oven. The papain digestion was then allowed to come to room 
temperature prior to use. If the samples were not immediately used after papain 
digestion, they were stored at 4ºC until use.  
3.4.6. Glycosaminoglycan Assay 
 The 1,9-dimethylmethylene blue (DMMB) assay is commonly used for 




sulphated groups of the GAG causing a concentration dependent chromatic change 
from blue to violet [364-366]. The potential for interference from DNA and the serum 
in the cell culture medium was accepted [365, 366].  
 
Figure 3.4: The chemical structure of chondroitin sulfate, where the yellow arrows indicate 
sulfation sites [367]. 
 The DMMB dye was made according to the protocol from Coulson-Thomas 
and Gesteira [366]. The dye contained 8mg DMMB, 1.52g glycine, 0.8g NaCl, 10% 
acetic acid made up to 500 ml and pH adjusted to 3.0 with HCl or NaOH, as 
appropriate. The prepared dye was stored for up to 3 months at room temperature, 
protected from light. 
 A standard reference curve was created using chondroitin-4-sulfate (Sigma 
Aldrich, UK) stock in concentrations ranging from 0 to 100 µg/ml. 20 µl of each of 
the standards was aliquoted into the 96-well plate in triplicate followed by 200 µl of 
the DMMB dye and the absorbance read using an absorbance plate reader (ELX-800, 
Bio-Tek Instruments, UK) at 540nm wavelength. The solution is not stable after 
adding DMMB and, therefore, was read immediately. The standard curve was 
calculated ensuring that R2>0.95. 
 Following papain digestion, 20 µl of the sample digestion was aliquoted into a 
96-well plate in triplicate. Then 200 µl of dye was added to the wells. The plates were 
read immediately using the absorbance plate reader. The GAG content was calculated 
using the standard curve. 
3.4.7. Environmental Scanning Electron Microscopy  
3.4.7.1. Fixation  
 Prior to environmental scanning election microscope (ESEM) imaging, the 
cells need to be fixed to reduce any time-dependant damage. A 4% glutaraldehyde 
solution was added to each sample to completely cover the surface for 45 minutes. 




times. If the samples were going to be imaged immediately, they were additionally 
washed three times with SDW. If the samples were imaged at a later date, the samples 
were stored in the 4ºC refrigerator with an excess of PBS. Before imaging, the PBS 
was removed from the samples and washed three times with SDW. On the day of 
imaging, the samples were kept with a thin layer of SDW and in a chilled box to reduce 
any dehydration prior to image capture.  
3.4.7.2. ESEM Imaging 
 The samples were imaged with a FEI Quanta 650 ESEM. The samples were 
imaged at a decreasing temperature range of 3-0ºC, a decreasing humidity range of 
100-85%, and decreasing pressure at 5.5-2.5 torr with a Peltier stage to control the 
temperature of the sample. At these parameters, the samples were able to be imaged 
for approximately 30 minutes before damage to the sample occurred.  
3.5. Hydrogel Scaffold  
3.5.1. Hydrogel Preparation 
 A solution of 3% w/v chitosan, (85% deacetylated, Sigma Aldrich, UK) and 
2% v/v acetic acid (Sigma Aldrich, UK) in dH2O was left on a heated stirring plate at 
37ºC overnight. Concurrently, a solution of 3% w/v gelatin from porcine skin (Fluka 
Biochemika, Germany) in PBS was left on a heated stirring plate at 50ºC for a 
minimum of 2 hours, or until fully dissolved. The chitosan and gelatin solutions were 
then mixed fully at 37ºC with the addition of NaOH to raise the pH to 5.0. Finally, a 
2% w/w proanthocyanidin (OPC) (Mushroom Supplies, UK) solution, based on the 
chitosan-gelatin content, in distilled water was gradually added to the chitosan-gelatin 
mixture and left to fully mix at 37ºC. The OPC solution was made immediately prior 
to adding to the chitosan-gelatin mix.  
3.5.2. Hydrogel Casting 
 Prior to casting, the hydrogel was ensured to be at 37 ºC and pH 5.0. The 
hydrogel was cast into the well and allowed to gel at room temperature, where the 
volume cast was dependent on application and is specified in each results chapter. 
Once fully gelled, a 10% NaOH solution was added into the wells to completely cover 
the hydrogel surface and left at room temperature for 2 hours. The NaOH solution 
neutralizes the excess acetic acid on the surface and raises the surface pH of the 
hydrogel and allows for further crosslinking to occur [368]. After 2 hours, the NaOH 





3.5.3. Hydrogel Sterilization 
 To sterilize the hydrogels, the well plates were transferred to a cell culture hood 
to maintain the sterility. The hydrogels were washed three times with SDW. The 
surface of the hydrogel was then sprayed with IMS and left to evaporate. Any 
remaining IMS was then washed off with excess SDW. The hydrogels were then 
subjected to ultraviolet (UV) radiation for 2 hours. After UV radiation, cell culture 
medium was added to each well covering the hydrogels and allowed to incubate 
overnight to condition the hydrogel surface. The conditioning medium was removed 
before any further cell culture took place.  
3.5.4. Cell Culture and Assays on Hydrogel Scaffolds 
 Cell seeding and culture on the hydrogels followed the same protocol as stated 
above in section 3.2 (page 42). The cell culture assays on the hydrogels followed the 
same protocols as stated in section 3.4 (page 45), adding a blank of hydrogel without 
cells as appropriate. The cell culture assays did not have a negative effect on the 
hydrogel integrity. The hydrogel remained intact within the wells throughout cell 
culture and the following assays.  
3.5.5. ESEM 
 The hydrogel samples were imaged using ESEM as described previously. The 
hydrogel samples were prepared with the addition of a glass coverslip in the well plate 
before casting to allow removal. Samples for ESEM were not used for the DNA, ALP, 
or GAG assays.  
3.6. Statistical Significance 
 The statistical significance at the 95% confidence interval was determined 
using mixed effects analysis or one-way/two-way ANOVA analysis with Tukey post 
hoc comparison using GraphPad Prism™ 8 software (version 8.0.1, GraphPad 
Software, San Diego, CA, USA, www.graphpad.com). The differences between 
means were considered to be significant when p <0.05. The mean values with standard 
error of mean were calculated using GraphPad Prism.  
 The biological and technical replicates, with repeats, are stated within each 
experiment, section 4.2.2 (page 53), section 5.2.10 (page 75), section 6.2.2 (page 96), 





4. Optimization of Chitosan-Gelatin Hydrogel Thickness to 
Assess Fibroblast Response 
4.1. Introduction 
 Chitosan and gelatin have become popular biomaterials within tissue 
engineering for their biocompatibility, availability, and tuneable mechanical 
properties [369-371]. The structural properties of chitosan and gelatin create a more 
similar microenvironment of native tissues than other synthetic and non-collagen 
derived materials [265, 273]. The versatility of both chitosan and gelatin have allowed 
a wide range of scaffolds to be produced, such as fibres and hydrogels, as well as the 
incorporation of additional materials to modify scaffold properties [278, 279, 293, 
372]. Previous studies using chitosan-gelatin hydrogel have shown the optimization 
of crosslinking of these biomaterials has produced favourable cell adhesion and 
spreading for tissue engineering applications [370, 373].  
 This chapter discusses a sustainable hydrogel created from chitosan and gelatin 
and crosslinked with OPC as a scaffold for tissue engineering. The 3T3 cell line and 
primary ovine fibroblast culture will be used to determine cytocompatibility and 
suitability of the hydrogel thickness. The cellular response on each thickness of 
hydrogel will be measured through metabolic activity, DNA content, GAG content, 
and ALP activity. The metabolic activity assay and DNA assay will give an indication 
of cell proliferation and density. The DMMB assay will determine the GAG 
production within the ECM. Although there is not expected to be high levels of ALP 
activity, the ALP assay will illustrate the differentiation capability of the fibroblasts. 
The cell morphology and mean cell area will also be analysed. These results will 
determine the optimal hydrogel thickness and most suitable cell source for future 
works. 
4.2. Methodology 
4.2.1. Hydrogel Casting 
 The chitosan-gelatin hydrogel was created using the same protocol as stated in 
section 3.5 (page 50). To assess cytocompatibility and optimise the cell response, the 
hydrogel was cast in thickness from 0.5mm to 2.5mm increasing in increments of 





to be cast was calculated using the diameter of the well and the desired thickness. Once 
cast, the hydrogels underwent the same sterilization protocol as outlined previously. 
4.2.2. Cell Culture 
 The 3T3 cell line and the PFib culture were individually seeded onto the 
hydrogel of increasing thickness. Both cell types underwent the same protocol for cell 
seeding as outlined in section 3.2.6 (page 45) with a seeding density of 10,000 
cells/cm2 at a volume of 500 µl. The wells were topped up with 1 ml of cell culture 
medium after 1 hour allowing the cells to adhere to the hydrogel. The cell culture 
medium was replaced after 48 hours and then every 2-3 days. There was one biological 
replicate and 12 technical replicates, repeated twice.  
 The cell culture was carried out to 28 days. Images using phase contrast 
microscopy were taken throughout the culture period to monitor the growth and 
morphology of the cells. The mean area of the cells was measured at each time point.  
 At Day 3, 7, 14, 21, and 28 an alamarBlue assay was carried out following the 
protocol in section 3.4 (page 45). The PBS washes were done with extreme care to 
prevent disrupting the cells. Samples were read in triplicate and blanked against 
alamarBlue dye. The cell culture medium from each sample was collected at Day 28 
and stored at -20°C for further analysis. The collected cell culture medium included 
the final 3 days of culture.  
 After the final alamarBlue assay, all samples underwent the freeze/thaw 
process. The cell lysate was used for the DNA and ALP assays and was then digested 
in papain for the DMMB assay. The collected cell culture medium was similarly 
prepared and assayed following the DMMB protocol. These assays were carried out 
according to the protocol outlined previously.  
 The mean ALP activity results from the MG63 cell line (human osteosarcoma, 
ECACC, 86051601) and a primary osteoblast culture from neonatal mouse calvaria 
were used as a reference for osteoblastic levels of ALP activity. The MG63 and 
primary osteoblasts were cultured on TCP at a similar initial cell density to the same 
timepoint. These osteoblast cultures were not used for any other assays.  
4.2.3. ESEM  
 The hydrogel was cast into the well plates with an added glass coverslip 
allowing the removal of the hydrogel after cell culture. The hydrogel was similarly 





days of culture, the hydrogel samples were fixed as described previously and removed 
from the well plate for imaging. 
4.3. Results 
4.3.1. Morphology of Hydrogel 
 The hydrogels were homogenous within the cell culture plate across all 
thicknesses. It was observed that the edges of the hydrogel formed a meniscus against 
the wall of the well due to the surface tension of the hydrogel. This did not appear to 
affect the bulk thickness of the hydrogel near the centre of the well. However, this 
could not be experimentally quantified as the hydrogel could not be removed from the 
well.  
4.3.2. Mean Area of Cells During Culture 
The measured mean area of the 3T3 cells remained under 2.0 µm2 at all time 
points across all sample thicknesses, as seen in Figure 4.1. The 0.5mm sample had the 
largest mean cell area of 1.9348 µm2 at Day 3 and then decreased to below 0.7 µm2 
beyond Day 7. The smallest mean area of 3T3 was seen at Day 7 on the 0.5mm sample 
at 0.12909 µm2. The mean area of the 3T3 cells on the 2.5mm sample could not be 
recorded beyond Day 21 due to the opacity of the hydrogel. 
The 3T3 mean cell area on the 0.5mm sample experienced a significant 
decrease at Day 7 followed by a significant increase at Day 21. The 1.0mm exhibited 
a similar trend with a significant decrease at Day 7 followed by significant increases 
at the subsequent timepoints until Day 24. The 1.5mm sample showed a more variable 
trend with significant decreases in the mean cell area at each timepoint until Day 14, 
followed by a brief increase at Day 21, a decrease at Day 24, and a further increase at 
Day 28. The 2.0mm sample demonstrated a significant decrease in mean area at each 
timepoint until Day 21. The 2.5mm sample displayed a significant decrease in mean 
area at Day 21. The TCP sample had a significant decrease of mean area at Day 7, a 
significant increase at Day 14, and another significant increase at Day 24.  
 The PFib cells are a larger cell type than the 3T3s, visibly seen through phase 
contrast microscopy. The mean area of the PFib cells experienced a more variable 
change throughout the culture period, as seen in Figure 4.1. Images were unable to be 
taken after Day 21 for the 2.0mm sample and beyond Day 7 for the 2.5mm sample. 
The largest mean cell area was seen on the TCP sample at Day 24 with 2.307 µm2. 
The smallest mean area was seen on the 2.0mm and 2.5mm samples at Day 3 with 





The PFib cell area on the 0.5mm sample displayed a significant decrease in 
mean area at Day 7, a significant increase at Day 24, followed by a significant decrease 
at Day 28. The 1.0mm sample experienced a significant decrease in mean area at Day 
7 followed by a significant increase at Day 17. The 1.5mm sample experienced a 
significant increase in mean area between Day 7 to Day 14, a significant decrease to 
Day 21, a significant increase at Day 24, followed by a significant decrease at Day 28. 
The TCP sample showed significant increases in mean cell area at Day 7 and Day 24. 






























































































































































































































































4.3.3. ESEM Imaging  
 The 3T3 cells were found to be numerous and created a confluent cell layer, or 
monolayer, on all sample thicknesses as observed through phase contrast microscopy. 
The monolayer was visible on several samples using ESEM imaging, as seen in Figure 
4.2. However, a layer of water obscured the visibility of cells on several samples. 
Where a water layer obscured visibility, such as on the 2.0mm sample, some features 
of the cells could be seen above the water layer but the morphology could not be 
identified. While in a monolayer, the morphology of individual 3T3 cells was difficult 
to identify using ESEM.  
 
Figure 4.2: ESEM images of 3T3 cells grown on 1.0mm (left), 1.5mm (middle), 2.0mm (right) 
thickness chitosan-gelatin hydrogel after 28 days of culture. A complete monolayer can be seen on 
the 1.0mm and 1.5mm sample. There appears to be some damage to the monolayer of the 1.5mm 
sample, potentially from fixation or the imaging process. A water layer restricts the visibility of 
the cells on the 2.0mm sample, however some features of the cells can be seen above the water 
layer. The blue line indicates 50 µm. 
 The PFib cells did not create a monolayer on any of the hydrogel thicknesses, 
as seen through phase contrast microscopy and ESEM. As a result, individual cells 
with a spread morphology could be identified on the samples, as seen in Figure 4.3. A 
water layer was visible on all samples during ESEM imaging, restricting the visibility 
of cells. On the thinner hydrogel samples, the PFib cells showed a spread morphology 
with many extensions. The PFib cells displayed a more elongated morphology on the 
thicker hydrogel samples rather than a spread morphology as seen on the thinner 
hydrogel samples. A water layer can be seen on the 2.0mm sample, however the 
morphology of the PFib cells was still visible.   
 
Figure 4.3: ESEM images of PFib cells grown on 1.0mm (left), 1.5mm (middle), and 2.0mm (right) 
thickness chitosan-gelatin hydrogel after 28 days of culture. The 2.0mm image was taken 
immediately prior to the freezing of the sample and the water layer seems to be semi-frozen around 





4.3.4. Metabolic Quantification 
 The metabolic activity of cells is a reliable indicator of proliferation of the cells 
and cytocompatibility of the substrate. In combination with the cell area and 
morphology, the metabolic activity can illustrate the cycle of proliferation and growth 
of the cell.  
4.3.4.1. Metabolic Analysis of 3T3 Cells 
 The 3T3 cells on the 0.5mm sample showed a significant decrease in metabolic 
activity at Day 7, as seen in Figure 4.4. There was a similar decline in metabolic 
activity at the subsequent timepoints beyond Day 7. The metabolic activity on the 
0.5mm sample did not significantly recover from the decline. The 3T3 cells on the 
TCP control exhibited a similar trend, however there was a significant increase in 
metabolic activity at Day 28 when compared to Day 14, the lowest metabolic activity. 
 The 1.0mm sample showed a significant decrease in metabolic activity at Day 
14 when compared to Day 3 however, this sample showed a significant resurgence of 
proliferation and metabolic activity at Day 28 when compared to Day 14. The 1.5mm 
sample experienced a similar trend, with a significant decline in metabolic activity at 
Day 14 and a significant increase at Day 21. The metabolic activity on the 2.0mm and 
2.5mm samples did not display significant declines at any timepoint. There was a 
significant increase in metabolic activity on these thicknesses at Day 28.  
4.3.4.2. Metabolic Analysis of PFib Cells 
 The metabolic activity of the PFib cells did not experience significant declines 
in activity at any point across all sample types, as seen in Figure 4.5. There was a 
steady positive trend in metabolic activity across all samples from Day 3 to Day 28. 
There was a significant increase in the metabolic activity on all hydrogel samples at 
Day 14, TCP excluded. Overall, the metabolic activity of the PFib cells at Day 28 was 
significantly higher than the activity recorded at Day 3 and 7 for all hydrogel samples.  
 There were significant differences in metabolic activity between the 3T3 and 
PFib cells across sample thicknesses and timepoints. The 3T3 metabolic activity was 
significantly higher than the PFib metabolic activity at Day 3 on the 0.5mm, 1.0mm, 
and 1.5mm samples. Between Day 7 and Day 21, the PFib metabolic activity was 
significantly higher than the 3T3 metabolic activity across the samples. However, at 
Day 28 the only significant difference between the two cell types was found on the 






























































































































































































































































































































































































































4.3.5. DNA Quantification 
The DNA content in each of the 3T3 samples varied more than the PFib DNA 
content, as seen through the larger error bars in Figure 4.6. The 3T3 cells exhibited the 
highest mean DNA content on the 1.0mm thick sample at 0.03916 µg/ml. The PFib 
cells showed the highest DNA content on TCP at 0.04561 µg/ml. Of the hydrogel 
samples, the PFib cells resulted in the highest DNA content on the 2.0mm sample with 
0.02556 µg/ml. 
 The 3T3 cells on the 1.0mm sample had significantly more DNA content than 
all other 3T3 samples, except the 2.0mm sample. Of the PFib samples, only the TCP 
sample was significantly different than all other samples.   
 There were several significant differences between the DNA content of the 
3T3 and PFib cells across the hydrogel thicknesses. The 3T3 DNA content was 
significantly higher than the PFib DNA content on the 1.0mm, 1.5mm, and 2.0mm 
sample. However, the PFib DNA content was significantly higher than the 3T3 DNA 
content on the TCP sample. There was no significant difference found between the 
DNA content of the 3T3 and PFib cells at the 0.5mm and 2.5mm samples.  
 
Figure 4.6: DNA quantification of 3T3 and PFib cell lysate after 28 days of cell culture on chitosan-
gelatin hydrogel of increasing thickness, using the PicoGreen DNA kit. The error bars represent 
the standard error of mean. Where * p <0.0332, ** p <0.0021, *** p <0.0002, and **** p <0.0001 
and n=12 with 2 repeats. 
4.3.6. GAG Content  
 There was a bimodal trend seen in the GAG content from both the 3T3 and 
PFib lysate across the hydrogel samples where both the thinnest and thickest hydrogel 
samples had the highest content, as seen in Figure 4.7. The highest GAG content of 
the 3T3 cells was recorded from the lysate of the 2.5mm sample at 6.239µg/ml, and 































the lysate from the TCP sample at 10.043µg/ml. The highest GAG content of the PFib 
cells was recorded from the lysate of the 2.5mm sample at 5.514µg/ml. There was no 
GAG content detected in the lysate of the 1.5mm sample with 3T3 cells.  
 The 3T3 TCP lysate had a significantly higher GAG content than the lysate of 
the 3T3 hydrogel samples. There was no significant difference found in the GAG 
content between the PFib lysate of the hydrogel and TCP samples. There was no 
significant difference in the GAG content found between the lysate of the 3T3 and 
PFib cells across the hydrogel samples, TCP excluded.  
 The GAG content of the collected medium exhibited a similar bimodal trend 
for both the 3T3 and PFib cells. The collected medium of the 3T3 cells on the 1.5mm 
sample showed GAG content, in contrast to the related cell lysate. The collected 
medium of both cell types showed a decreased amount of GAG content across the 
samples compared to the related cell lysate, except in the 0.5mm sample with 3T3 
cells. The highest GAG content from the collected medium was found on the 0.5mm 
sample with 3T3 cells at 5.754µg/ml. The lysate of the 2.5mm sample of both cell 
types showed significantly higher GAG content than the related collected medium. 
The lysate of the 3T3 TCP sample showed significantly higher GAG content than the 
related collected medium.  
 
Figure 4.7: GAG content of the lysate and collected cell culture medium of the 3T3 and PFib cells 
after 28 days of growth on increasing thicknesses of chitosan-gelatin hydrogel, using a DMMB 
assay. The 3T3 lysate from the 1.5mm hydrogel sample did not show any GAG content, despite 
the related medium detecting GAG content. Error bars represent standard error of mean. Where * 
























































 The GAG/DNA ratio displayed a bimodal trend for the lysate of the 3T3 
hydrogel samples and a slight positive trend for the lysate of the PFib hydrogel 
samples, as seen in Figure 4.8. The lysate from the 2.5mm hydrogel samples for both 
the 3T3 and PFib cells showed the highest GAG/DNA ratio, excluding TCP. The 
GAG/DNA ratio of the 3T3 cells on TCP showed a significantly higher ratio in the 
lysate than the related collected medium. 
 
Figure 4.8: GAG/DNA ratio of the lysate and collected cell culture medium from the 3T3 and PFib 
cells on increasing thicknesses of chitosan-gelatin hydrogel after 28 days of cell culture. The error 
bars represent standard error of mean. Where * p <0.0332, ** p <0.0021, *** p <0.0002, and **** 
p <0.0001 and n=12 with 2 repeats.   
4.3.7. ALP Activity 
As alkaline phosphatase is an early marker for osteogenic differentiation, high 
levels of ALP activity were not expected from either fibroblast culture on this 
chitosan-gelatin hydrogel. Though some ALP activity from the 3T3 cells was seen on 
the 0.5mm and TCP samples. The PFib cells showed ALP activity on the 0.5mm, 
1.5mm, 2.5mm, and TCP samples, Figure 4.9. However, only one sample from the 
PFib 1.5mm and 2.5mm samples showed ALP activity resulting in the lack of error 
bars. 
There was no significant difference found between the 3T3 ALP activity on 
the 0.5mm and TCP samples. Similarly, there was no significant difference between 

























































The MG63 cell line and primary osteoblast culture were used as reference to 
show the ALP activity of osteogenic cells, the dotted and dashed line in Figure 4.9 
respectively. Both osteoblasts showed significantly higher ALP activity than the 3T3 
and PFib cells on the 0.5mm and TCP samples.  
 
Figure 4.9: Normalized ALP activity of 3T3 lysate and PFib lysate on chitosan-gelatin hydrogel 
of increasing thickness after 28 days of culture, using the ALP Randox Kit. The dotted line 
represents a mean ALP activity of the MG63 cell line and the dashed line represents a mean ALP 
activity of a primary mouse osteoblast culture as reference of ALP activity of osteoblast cultures. 
The error bars represent standard error of mean. Where n=12 with 2 repeats.  
4.4. Discussion 
4.4.1. Chitosan-Gelatin Hydrogel Cytocompatibility 
 The scaffold is a central element in tissue engineering as it must provide 
structural support without inhibiting cellular ingrowth and ECM production [17, 210]. 
Research has turned towards hydrogels for soft tissue applications for their extensive 
composition possibilities, malleability, adaptable mechanical properties, and their 
cytocompatibility [314, 315]. The chitosan-gelatin hydrogel used in this study was 
demonstrated to be cytocompatible in line with previous research using similar 
hydrogel assemblies [277, 293, 370]. All hydrogel samples showed 3T3 and PFib 
fibroblast growth and some degree of ECM production over the 28-day period of cell 
culture. 
 The 3T3 cell line has been a model cell line used extensively across many 
applications and is known to reach confluency in a relatively short period, followed 
by cell death and a period of latency, resulting in a regrowth of cells [374]. The stages 
of cell death and regrowth can be identified in the cell metabolic graphic, Figure 4.4, 
by the sharp declines and surges at the sequential timepoints. This uncontrolled 
proliferation can be attributed to the lack of cell contact inhibition of proliferation of 





























the 3T3 cells [375, 376]. The change in mean area of the cells was also an indicator of 
the proliferation, death, and regrowth cycle of the 3T3 cells, Figure 4.1. The increase 
in metabolic activity was attributed to cell confluency and a decrease of the mean cell 
area. Immediately following the sharp decline in metabolic activity signifying cell 
death, the mean cell area was seen to increase as more space was available to allow 
proliferation and spreading of the 3T3 cells.  
 In contrast, the PFib cells exhibited a slower proliferation rate and did not 
experience significant periods of cell death compared to the 3T3 cell line. As a primary 
culture, the PFib cells possess cell contact inhibition characteristics and therefore did 
not display signs of overcrowding leading to cell death [376]. Additionally, the change 
in mean cell area of the PFib cells was more variable and potentially indicated periods 
where there was some degree of cell death to allow for continued proliferation. 
4.4.2. The Effect of Hydrogel Thickness on Cell Proliferation, ECM 
Production, and Differentiation 
 The stiffness of a material is a key property of a scaffold in tissue engineering, 
as the cell behaviour can be directly influenced by the substrate stiffness [377-381]. 
The stiffness of the material has shown to have a direct influence on the ECM 
organisation as the cell exerts large forces onto the substrate for focal adhesions and 
stress fibre organisation [382, 383]. Stiff substrates are able to reciprocate these 
cellular forces whereas a soft substrate is unable to do so leading to lesser developed 
focal adhesions and fewer stress fibres [384].  
 A study by Encerrado et al. investigating the mechanical properties of a similar 
chitosan-gelatin hydrogel confirmed that the tensile modulus of the hydrogel does not 
change by altering its thickness but rather by modifying the OPC and crosslinking 
concentration [373]. Additionally, they concluded that the differing morphology of 
cells found on the varying thicknesses of hydrogel was a result of how the cell 
perceived the stiffness of the substrate. In this research, it can be presumed that the 
sample thickness is inversely correlated to its perceived stiffness, as hydrogels are an 
innately soft material [311, 385]. As such, the perceived stiffness of the hydrogel 
decreases as the thickness increases. There may have been some contribution to the 
perceived stiffness of the thinner hydrogels from the underlying TCP as the hydrogel 
was tightly adhered to the well plate, contributing to the similar results seen on the 





on the metabolic activity of the cells, and thus, the proliferation, spread, and GAG 
production of the cells.  
 It is well known that most adherent cells, such as fibroblasts and osteoblasts, 
proliferate and spread more on stiff substrates, especially glass and TCP, leading to 
the increase in research of hydrogels with varying stiffness [311, 381, 385, 386]. 
Following this trend, both the 3T3 cells and PFib cells showed highest metabolic 
activity on the 0.5mm and 1.0mm hydrogel samples, as well as TCP. The metabolic 
activity was lower on the increasing thicknesses of samples, suggesting that the 
proliferation was slower. These trends support the reasoning that the cells perceived 
the 0.5mm and 1.0mm samples as stiffer than the 1.5mm, 2.0mm, and 2.5mm samples.  
 The mean area of both cell types on the sample thicknesses further supports 
the trend of fibroblasts spreading on perceived stiffer substrates, based on the 
understanding that fibroblasts spread when the substrate can reciprocate the 
cytoskeletal forces leading to reorganisation of the cytoskeleton [378, 379]. In this 
way, the perceived stiffness of the substrate has an effect on the internal structure of 
the cell, which governs the morphology and composition of the cell [377, 379]. The 
PFib mean cell area, in Figure 4.1, demonstrates this as the cells spread to the largest 
mean area on TCP.  
 With this in mind, it is interesting to see the lack of significant difference in 
metabolic activity across sample thicknesses at Day 28 for both the 3T3 and PFib cells. 
This may indicate that although both cell types initially perceived the thicker samples 
as softer, the cells became acclimatized to the substrate and the proliferation rate 
increased [387]. The DNA content displayed a similar result as there was no 
significant difference in DNA concentration found at Day 28. This is accepted as the 
metabolic activity and DNA content are indicators of cells numbers.  
 Fibroblasts, mesenchymal in derivation, have a wide, scoping role in wound 
healing and therefore the fate and function of the fibroblast is based largely on its 
environment [388]. The perceived stiffness of the substrate has the potential to govern 
the outcome of the maturation, or production of ECM, of the fibroblast [335, 389].  
 Previous studies have shown an increase in the GAG/DNA ratio of ligament 
and tendon scaffolds at the enthesis region [157, 390, 391]. The close relation of GAG 
at the entheses of ligaments and tendons and to the stiffness of articular cartilage 
within joints led to the hypothesis that the GAG content would be highest on the 





content results of the 3T3 cells on TCP compared to the hydrogel samples. The PFib 
GAG content results did not support this as there was no significant difference across 
the hydrogel and TCP samples. The lysate of the PFib cells had an overall higher mean 
GAG/DNA ratio across the hydrogel thicknesses, except 0.5mm, than the 3T3 cell 
lysate, however this difference was not significant. Of the hydrogel samples, the lysate 
from the 2.5mm samples of both cell types showed the highest GAG/DNA ratio, 
further disproving that the perceived stiffest samples would prompt the highest GAG 
production. The GAG/DNA ratio of the 3T3 and PFib cells suggest that environmental 
cues for differentiation into a fibrochrondrogenic phenotype were present [377]. 
 The medium was also collected for quantification of GAG content. The 
collected medium indicates that the thinnest samples had a higher release rate of GAG 
[393]. The kinetics of GAG release were not evaluated in this research, although there 
may be a correlation between the cell proliferation and the released GAG [393]. The 
released GAG in the collected medium may serve as an additional tool to measure the 
production of GAG on the increasing thicknesses of hydrogel, however this would 
require further investigation.  
 ALP activity was not expected from either of these fibroblasts on this chitosan-
gelatin hydrogel; however, it was interesting to see some levels of ALP activity on the 
0.5mm and TCP samples for both the 3T3 and PFib cells. These results suggest an 
osteoblastic differentiation due to the environmental signals [388]. As stated 
previously, the metabolic activity of both cell types suggests that the 0.5mm hydrogel 
sample and the TCP sample are perceived as the stiffest. The modulus of the 
polystyrene plastic is roughly 106 kPa most closely resembling bone at 206 kPa, 
whereas cartilage and muscle are in the range of 42 kPa and 12 kPa, respectively [394, 
395]. The ALP activity of the 3T3 and PFib cells suggest the perceived stiffness of the 
0.5mm and TCP samples resembles an osteogenic environment. Although some 
1.5mm and 2.5mm samples showed some ALP activity from PFib cells this was not 
observed in the majority of samples and was therefore discounted [396]. 
4.4.3. Modelling with a Cell Line vs. a Primary Culture 
 There are many benefits to using a cell line in an early tissue engineering study, 
such as the ease and speed of use, immortality, cost, and preapproved ethics [376, 397, 
398]. However, cell lines do not always give an accurate representation of how true 





biochemical content and biomechanical structure that is similar to that of the native 
tissue and a cell line may not always be a representative model of tissue growth.  
 Many studies have recorded the DNA, GAG, and total collagen content from 
ovine and rabbit cruciate ligaments, patellar tendon, and Achilles’ tendon [66, 390]. 
The fibroblasts from cruciate ligaments are highly differentiated and specialized to 
form such a biomechanically and anatomically unique ligament [66, 133]. The 
intrinsic properties show that the DNA and GAG content is much higher in the cruciate 
ligaments compared to the patellar and Achilles’ tendon, while the collagen content is 
roughly similar, Table 4.1 [66, 390]. It is worth noting that the biochemical 
concentrations found in Table 4.1 are calculated from native tissue that has been 
dehydrated prior to analysis. In this research, the cell monolayer was unable to be 
dissociated, dried, and then weighed and can be assumed to be ~1µg per sample 
solubilized in 1 ml of liquid, either papain solution or SDW.  
 The DNA and GAG content of the 3T3 and PFib cells was lower than those 
listed from previous studies in Table 4.1 [24, 66, 390]. The 3T3 cell line has a higher 
metabolic activity across the samples but its lack of contact inhibition may have 
hindered the production of ECM components, such as GAG. The PFib cells showed a 
higher GAG content than the 3T3 cells, despite lower metabolic activity results and 
DNA content. Based on the GAG content, signifying the production of ligament-like 
ECM components, the PFib cells may be a more accurate representation for ligament 
engineering research [66, 150, 158].  
 
Table 4.1: Concentrations of DNA, GAG, and collagen found in the cruciate ligaments, patellar 
tendon, and Achilles' tendon. Adapted from Amiel et al. and Rumian et al. [66, 390]. 
 DNA Content 





Cruciate Ligaments 2.73 ± 0.05 7.4 ± 1.3  802.6 ± 9.8 
Patellar Tendon 1.40 ± 0.05 2.3 ± 0.3 867.2 ± 8.9 
Achilles’ Tendon 1.74 ± 0.04 2.75 ± 0.2 868.2 ± 10.2 
 
 Additionally, the intrinsic qualities of the PFib cells may decrease the 
ligamentization period that has been seen in tenocytes of tendon autografts used for 
ACL reconstruction [69, 94, 103, 133]. However, it is noted that the highly 
differentiated cells from a cruciate ligament proliferate and produce an ECM at a much 





 Further, the ALP activity results prove that the PFib culture has retained the 
inherent ability of fibroblasts to differentiate into osteoblast like cells [156]. However, 
these results are inconsistent due to the large error bars and few samples with recorded 
activity. A more comprehensive analysis is needed to conclusively prove if the PFib 
cells maintain the ability to differentiate into an osteoblastic lineage. Additionally, 
further analysis of the surface chemistry of the chitosan-gelatin hydrogel may reveal 
if the PFib cells respond to the chitosan-gelatin hydrogel better than the 3T3 cells.  
4.5. Conclusion 
 The chitosan-gelatin hydrogel is a suitable biomaterial for cell culture. The 
variation in thickness of the hydrogel showed a similar trend in response from both 
the 3T3 and PFib cells in terms of metabolic activity, DNA concentration, and GAG 
production.  
 Of the five thicknesses, the 1.0mm thickness showed a realistic and repeatable 
response from both cell types. Additionally, the 1.0mm thickness was consistent in 
production. Therefore, the 1.0mm thickness will be the preferred sample thickness 
moving forward.  
The GAG content and ALP activity results show that the PFib cells began to 
produce ECM components and appear to differentiate into an osteoblastic lineage 
upon reaching confluency, whereas the 3T3 cell line did not respond to such 
environmental cues and continued to proliferate. The PFib culture does not lack 
contact inhibition and will begin the sequence of maturation once the cell monolayer 
has reached confluency. The lack of significant difference of metabolic activity at Day 
28 may be due to the PFib cells having a longer adjustment period on perceived softer 
substrates. Additionally, the PFib cells showed some ECM production across all 
sample types, with similar GAG/DNA ratios.  
The PFib cell culture is the preferred cell model on this chitosan-gelatin 
hydrogel scaffold but the 3T3 cell line proves an invaluable preliminary model to test 
cytotoxicity before the rigors of producing a primary cell culture are undertaken. The 
fast proliferating 3T3 cell line is a quick marker to determine if the substrate can 
proceed to further tests and to understand the potential behaviour of cells. As with 
other cell lines, a precaution is taken in understanding the modifications to the cells 





5. Production of Detached Hydrogel using an Intermediate 
Layer 
5.1. Introduction 
This chapter discusses the development of an intermediate layer to create a 
chitosan-gelatin hydrogel that does not adhere to the TCP of the well plate or 
bioreactor chamber. As chitosan-gelatin hydrogel is adherent to TCP, a method to 
produce a detached scaffold is necessary to assemble the hydrogel scaffold within the 
tensile loading bioreactor and to enable the stress dispersion through the scaffold 
[399]. Additionally, a detached scaffold is required to replicate the contraction seen in 
previous tissue engineered ligament studies [218, 400, 401]. The intermediate layer 
must not compromise the cytocompatibility of the hydrogel through the addition of 
further material to the cell culture system.  
There has been success fabricating freestanding hydrogel membranes using 
layer-by-layer and surface-initiated polymerization technologies, however these 
methods typically are more suited to films and membranes in the nano-meter scale of 
thickness, employ multiple components, and often use toxic crosslinkers such as 
glutaraldehyde [402-405]. A similar layer method has been utilized in studies that have 
cast fibrin hydrogel onto SYLGARD coated plates with cell culture medium to 
‘release’ the fibrin sinew scaffold producing a scaffold of appropriate thickness 
without the addition of toxic crosslinkers [218, 401, 406, 407].  
The advancement of the fibrin hydrogels was adapted in this research by 
developing several methods to act as a releasing agent of the chitosan-gelatin hydrogel 
from the TCP. This involved the production and use of a polyurethane (PU) coating, 
a polytetrafluorethylene (PTFE) membrane, and an intermediate layer of either cell 
culture medium or PBS. The intermediate layer method had the added benefit of 
maintaining the cost-effective philosophy of this tissue engineered ligament system. 
The resultant novel detached chitosan-gelatin hydrogel was assessed for 
cytocompatibility using the alamarBlue assay and characterized using X-ray 
photoelectron spectroscopy (XPS), near ambient X-ray photoelectron spectroscopy 
(NAP-XPS), and ESEM. The physical properties of the detached hydrogel were also 





contraction of detached fibrin hydrogels has been recorded, the detached chitosan-
gelatin hydrogels were also monitored for contraction [218, 401, 407]. 
5.2. Methodology 
5.2.1. Polyurethane Coating 
 The PU coating was created by dissolving PU pellets (Chonoflex AL 80A, 
Advansource, CA) in tetrahydrofuran (THF) on a magnetic stirrer at 50°C. The beaker 
was kept covered to reduce evaporation of the THF during mixing. Once the pellets 
were fully dissolved, the PU solution was quickly poured into the wells of a 6-well 
plate to create a coating within the well. The coated well plates were left to air-dry in 
the fume cupboard with a loose covering of aluminium foil for a minimum of 48 hours. 
The wells were washed with IMS and detergent before use. 
 Chitosan-gelatin hydrogel was made with the same protocol as given in section 
3.5 (page 50). After washing the PU coated well plates, the hydrogel was cast into the 
wells at 1mm thickness and allowed to gel. The hydrogel was then sterilized as 
described previously.  
5.2.2. Polytetrafluoroethylene Membrane 
 A premade PTFE membrane from Goodfellow (Cambridge, UK) was 
purchased to place into the wells. The membrane came in two thicknesses, 0.5mm and 
1.0mm, in sheets of approximately 15cm x 15cm. The membranes were cut to size for 
placement in 6-well plates. The membrane pieces were thoroughly washed with 
detergent and IMS before use.  
 The hydrogel was made and cast onto the PTFE membrane discs within the 
well plate at 1mm thickness. The hydrogel was sterilized as described previously.  
5.2.3. Intermediate Layer 
 Cell culture medium and PBS were investigated to create the intermediate 
layer as these materials are regularly used in cell culture. To create the intermediate 
layer, cell culture medium or PBS was frozen into a 2mm thick layer in a 6-well cell 
culture plate. Chitosan-gelatin hydrogel was then made using the protocol described 
previously. Once the intermediate layer was frozen, the hydrogel was swiftly cast into 
the wells to create a circular shape of 1mm thickness. The hydrogel was also cast into 
well plates without an intermediate layer.  
 The frozen cell culture medium or PBS was allowed to melt at room 
temperature as gelation of the hydrogel occurred. Complete gelation occurred within 





behind a detached hydrogel disc. The thawed liquid covered the surface of the 
hydrogel discs. Hydrogels cast onto the cell culture medium were coded sample ‘MH.’ 
Hydrogels cast onto the PBS were coded sample ‘PH.’ Hydrogels cast into the well 
plate without an intermediate layer were coded ‘NH.’  
 The MH and PH detached hydrogel discs and NH were then sterilized as 
outlined previously. The 10% NaOH solution was gently pipetted into the wells to 
cover the entire detached hydrogel sample.  
5.2.4. Cross-Section Detached Hydrogel Measurement 
 To ensure that the casting of the detached hydrogel produced the desired 
thickness, the MH and PH samples were cut in a cross section and measured. The 
detached hydrogel was removed from the well plate using a spatula and gently placed 
on a dry paper towel. The detached hydrogel was then cut through the midline using 
the spatula. The cut piece of hydrogel was then measured against a ruler.  
5.2.5. Density Measurement 
 The density of the hydrogel was calculated to determine whether the hydrogel 
discs, MH and PH, would remain fully submerged in the cell culture medium during 
cell culture. Density was calculated by measuring the mass of 500 µl of hydrogel in 5 
replicates using the equation: d=m/v. Where d is the density, m is the mass, and v is 
the volume. The density of the cell culture medium and PBS was calculated in the 
same manner.  
5.2.6. Hydrogel Swelling and Degradation 
 The swelling of MH and PH was monitored using a protocol similar to Bryant 
and Anseth and the ASTM F2900-11 standard [408, 409]. MH and PH were created 
and sterilized. After sterilization, the samples were incubated in PBS for 24 hours and 
then the wet mass was measured. The samples were then dried in an oven at 50ºC for 
2 hours and then the dry mass was measured.  
 The swelling ratio, Q, of the hydrogel was calculated using Equation 1, where 
Ds is the mass of the swollen hydrogel and Dw is the mass of the dried hydrogel [408]. 
 









 The degradation of MH and PH was measured by creating and sterilizing the 
samples and then incubating the samples in either cell culture medium, PBS, or SDW. 
Each sample was kept in triplicate in each treatment and kept completely submerged 
in the designated liquid during incubation. Fresh medium, PBS, and SDW was 
replaced every 7 days. The wet mass of the hydrogel was measured prior to casting, 
Day 0, and then the wet mass of each sample was measured after sterilization, Day 1, 
and then after 21 days.  
5.2.7. MicroTensile Testing 
 A stress/strain curve was calculated using a Deben in-situ MicroTest tensile-
compression stage MTEST200VT unit for FEI Quanta 650 ESEM with a Peltier 
Cooling Stage. The Peltier Cooling stage was used to stabilize the mid-section of the 
hydrogel, the temperature control function was not utilized.  
In order to calculate a stress/strain curve for the hydrogel, adaptations to the 
casting method were needed to suit the testing unit. The dimensions of the detached 
hydrogel were required to be a minimum of 10mm x 50mm. To account for this, the 
hydrogel was cast in a large glass petri dish with a 2mm thick intermediate layer of 
either the cell culture medium or PBS. An outline of 10mm x 85mm was drawn on the 
bottom of the petri dish to guide casting, with the excess length allowing for easier 
mounting into the testing unit. These samples were sterilized followed the same 
methods described previously. It was recommended that the hydrogel samples be cast 
in a ‘dumbbell’ shape to reduce breakage at the clamps but this shape could not be cast 
and uniform strips were used [409]. 
 The detached hydrogel samples were transferred into the testing unit using 
forceps and a spatula. To secure the ends of the hydrogel within the clamps, two pieces 
of painter’s tape were attached to the top and bottom of the inside of the metal clamp. 
The pieces of tape were replaced once the adhesive became oversaturated and 
detached from the metal. The detached hydrogel strip was loaded at the stationary 
clamp first. At the mobile end, the hydrogel was held as taught as possible to reduce 
any sag while the clamp was secured. The complete set-up of the MicroTest unit and 






Figure 5.1: (Top) A schematic of the MicroTest unit with direction of movement. The schematic 
shows the mobile and fixed clamps of the rig with the hydrogel sample attached to both. The Peltier 
Cooling stage can be seen underneath the middle portion of the hydrogel sample. (Middle) An 
oblique view of the testing unit using a MH sample without a Peltier Cooling Stage at mid 
extension. The stationary clamp can be seen on the right and the mobile clamp on the left, with 
excess hydrogel protruding out. A piece of tape covers the rotating motor rod to reduce any 
remnant liquid from the sample dripping onto the rod. Data from tests without the Peltier Cooling 
stage was not used. (Bottom) A superior view of the MicroTest unit using a MH sample with a 
Peltier Cooling stage at the resting position. The stationary clamp is on the right and the mobile 
clamp on the left, again with excess hydrogel protruding. The Peltier stage reduces sagging of 






 The surface chemistry of the hydrogels was analysed using XPS. In order to 
analyse the samples, the hydrogel had to be fully dehydrated. The MH, PH, and NH 
samples were cast and sterilized as described previously at 1mm thickness. After 
sterilizing, excess liquid was removed and all samples placed into a drying oven at 
45°C for 24 hours, all in 6 well plates. After complete drying, all three samples 
resembled a brown film and were removed from the well plates in 5mm sections. There 
were no structural deformities, such as a tear or rupture, in any of the samples. As the 
dehydrated hydrogels had adhered to the culture plastic, the hydrogels were scraped 
off of the culture plastic and both the lower surface (plate side) and surface exposed 
to air during hydrogel casting were analysed. The surfaces of the samples were 
analysed using a LiPPS, Kratos Axis Ultra Instrument (Kratos Analytical, Kyoto, 
Japan). The charge was corrected so the peak of C 1s was read at 285 eV. Samples 
were secured using double sided tape. Three areas per sample were used for wide scans 
and high-resolution spectra. CasaXPS software was used to analyse the data.  
5.2.9. NAP-XPS 
 The surface chemistry of the hydrogels was also examined with NAP-XPS 
using a SPECS Devi-sim NAP-XPS instrument with a Peltier stage (SPECS, Berlin, 
Germany). The MH and PH samples were cast at 1mm thickness, sterilized, and stored 
in a well plate with excess medium until reading. Excess cell culture medium was 
allowed to run off before loading the sample onto the stage. The surface of the 
detached hydrogel exposed to air during casting was analysed. However, as the 
intermediate layer thawed, the liquid encapsulated the hydrogel disc and both surfaces 
of the hydrogel disc were expected to be similar. The NAP-XPS was cooled to 5ºC, 
kept at 100% relative humidity, and the pressure at 8 mbar. SpecsLab Prodigy software 
version 4.12 was used to analyse the data. 
5.2.10. Cell Culture 
MH, PH, and NH were cast and sterilized at 1mm thickness. NH was cast in a 
12-well plate. After sterilization, the conditioning medium was removed and the MH 
and PH hydrogel discs were transferred to 12-well plates that were coated with poly(2-
hydroxyethyl methacrylate) (poly-HEMA) (Sigma, UK) to reduce cell adhesion to the 
well plate. 3T3 cells were then seeded at a density of 80,000 cells/cm2 at a volume of 





well plate, the cell solution was pipetted dropwise onto the disc, ensuring the cell 
solution covered the entire hydrogel disc. The cells were incubated for 1 hour before 
additional medium was added. During medium changes, extra care was taken to not 
disturb the hydrogel disc. There was one biological replicate and 6 technical replicates, 
repeated three times. 
 An alamarBlue metabolic assay was carried out at Day 3 and Day 7 as 
described in section 3.4.1 (page 46). As before, there was care taken during the 
washing steps to not disturb the hydrogel disc. 
 Following alamarBlue, the samples chosen for ESEM were fixed following the 
same protocol as described previously in section 3.5.5 (page 51), with care during 
fixation and PBS washes.  
 An additional NH sample was cast with a glass coverslip underneath and 
sterilized for ESEM. This sample was seeded with 3T3 cells at a density of 5,000 
cells/cm2 at a volume of 500 µl and cultured for 5 days before imaging to analyse the 
morphology of the 3T3 cells.  
5.3. Results 
5.3.1. PU Coating and PTFE Membrane 
There was concern regarding the emission of toxic particles from the PU and 
THF but these two materials have been proven to be non-cytotoxic [255, 410]. 
Similarly, leaching from the PTFE was questioned for future use within cell culture. 
However, the hydrogel adhesion to the PU coating and PTFE membrane was similar 
to that of the TCP in well plates. No further investigation took place using either of 
these methods. 
5.3.2. Intermediate Layer 
 The hydrogel of the MH samples remained detached from the well plate and 
intact throughout sterilization, cell culture, assays, and imaging. The PH samples were 
inconsistent in production where not all samples remained intact during sterilization. 
The PH samples that disintegrated during sterilization were not used and further 
samples were created. This led to no more than three PH samples cast at the same time 
to better monitor the quality of the samples. Additionally, it was observed that upon 
removal of the liquid of the intermediate layers, the volume of liquid had decreased 
from the initial volume used, indicating the potential uptake of the intermediate layer 





 The development of the cell culture medium and PBS intermediate layers 
produced a convex lens-like hydrogel scaffold that could be repositioned or transferred 
to a separate container, as seen in Figure 5.2. Due to the convexity, the centre of the 
hydrogel discs remained 1mm in thickness as the edges became thinner. 
 
Figure 5.2: An image of two MH samples after sterilization in a 6-well plate. Note the size of the 
scaffolds are significantly smaller than the well itself. 
 The cross-section of the detached hydrogel confirmed that the casting method 
produced the desired thickness, Figure 5.3. The cross-section also confirmed that the 
detached hydrogel samples had a convex shape, similar to a convex lens, as the centre 
of the sample remained 1mm in thickness and the edges became thinner. The 1mm PH 
samples, Figure 5.4, appeared to have a lesser degree of convexity than the MH 
samples.  
 
Figure 5.3: The cross-section of a MH sample of 1mm thickness. Left) The portion of the MH 
sample held against the paper towel to observe the slice. Right) The portion of the MH held against 






Figure 5.4: The cross-section of a PH sample of 1mm thickness. Left) The portion of the PH sample 
held against the paper towel to observe the slice. Right) The portion of the PH sample held against 
a ruler to measure the thickness. 
5.3.3. Characterisation of the Detached Hydrogel 
5.3.3.1. Density 
The density of the hydrogel was 0.8 g/cm3. The density of the cell culture 
medium was 0.949 g/cm3 and PBS was 0.977 g/cm3. Despite the hydrogel being less 
dense than the cell culture medium, the hydrogel discs remained submerged in the cell 
culture medium during incubation and cell culture.  
5.3.3.2. Swelling Ratio 
 The degree of swelling for MH was calculated to be 17.68 while the degree of 
swelling for PH was 10.78. This resulted in the MH sample having a 61% higher 
swelling ratio. The frozen cell culture medium appeared to undergo some phase 
separation during freezing and had a concentrated layer of medium constituents on the 
surface that may have affected the water uptake of the cast hydrogel. The frozen PBS 
did not appear to have this same concentrated layer. The decreased protein and salt 
content of the PBS may have increased the amount of water available for hydrogel 
absorption during casting. As the phase separation of the cell culture medium appeared 
to occur after prolonged storage in the freezer, effort was taken to reduce storage time 
to minimize this effect.  
5.3.3.3. Degradation 
 The degradation profile of the MH sample can be seen in Figure 5.5. The 
decrease in wet mass at Day 1 was not significant after incubation in any of the three 
liquids. The decrease in wet mass was significant at Day 21 after incubation in the 





mass than in PBS and SDW. Similarly, the MH incubated in PBS had a significantly 
higher wet mass than in SDW at Day 21.  
 
Figure 5.5: The degradation profile of MH in medium, PBS, and SDW after 21 days of incubation 
expressed as % initial weight. Day 0 indicates the hydrogel before casting. Day 1 indicates the day 
the hydrogel discs have been sterilized. The error bars represent standard error of mean. Where 
n=3. 
 The degradation profile of the PH sample can be seen in Figure 5.6. The 
decrease in wet mass at Day 1 and at Day 21, compared to Day 0, was significant after 
incubation in the three liquids. At Day 21, the wet mass of PH incubated in medium 
was significantly higher than in SDW. At Day 21, the difference of wet mass between 
PH incubated in medium and incubated in PBS was not significant, as well as between 
PBS and SDW.  
 
Figure 5.6: The degradation profile of PH in medium, PBS, and SDW after 21 days of incubation 
expressed as % initial weight. Day 0 indicates the hydrogel before casting. Day 1 indicates the day 
the hydrogel discs have been sterilized. The error bars represent standard error of mean. Where 
n=3. 
 The wet mass of MH was significantly higher than PH after sterilization across 
incubation in all three liquids. The difference in mass between MH and PH was not 
significant at Day 21 across all three liquids. Overall, the MH samples experienced a 
less significant change in mass loss after sterilization compared to PH. The PH sample 









































incubated in cell culture medium showed an increase in wet mass at Day 21 from Day 
1, however this was not significant.  
5.3.3.4. XPS 
 The XPS results showed a significantly higher weight percentage for Na and 
Cl in the MH and PH samples compared to NH, listed in Table 5.1. Both MH and PH 
had similar weight percentage results of all elements found on the surface and no 
significant difference was found between the two sample surfaces. Additionally, the 
weight percentage of C and O was significantly higher on the NH surface than the MH 
and PH. 
 The wide scan, Figure 5.7, revealed a small peak at Na 1s for NH. The O 1s 
peaks for MH and PH were shifted to the Auger feature of Na KLL. This could be due 
to the increased amount of Na present in these samples. The C 1s peaks for all three 
samples occurred at 284 eV, indicating C-N, C-O, and C-Cl bonds. The N 1s peak for 
all three samples occurred at 400 eV. The O 1s peak occurred at 532 eV for the NH 
sample indicating the presence of hydroxides and phosphates. The Na 1s peak for all 
three samples occurred at 1072 eV indicating presence of NaCl and sodium 
phosphates, however the peak for NH had a much lower intensity. The peak for Cl 2p 
occurred at 198 eV for NH and 199 eV for MH and PH indicating the presence of 
alkali chlorides. 
Table 5.1: Weight percentage values of the MH, PH, and NH samples estimated from the wide 
scan of XPS. Si was not detected in either MH or PH samples, resulting in a ‘0’ weight percentage. 
The total of each row is equal to 100.  
 C 1s (%) Cl 2p (%) N 1s (%) Na 1s (%) O 1s (%) Si 2p (%) 
MH 35.64 40.07 1.89 16.27 6.13 0 
PH 34.81 44.31 1.48 15.12 4.28 0 







Figure 5.7: The wide survey scan of MH (Sample 1), PH (Sample 2), and NH (Sample 3). Note 
the much smaller peak for Na 1s from NH (Sample 3). The O 1s peak for Sample 1 and 2 sits on 
the Auger feature produced by Na KLL. Graph courtesy of Mrs. Emily Smith.  
5.3.3.5. NAP-XPS 
 The NAP-XPS results revealed no residue of salt deposits from the 
intermediate layer of cell culture medium or PBS. The survey scan detected N, O, C, 
and Na but Cl could not be detected, as seen in Figure 5.8. The detailed spectra showed 
peaks for N 1s, O 1s, and C 1s that were similar for both MH and PH. As Na was not 
detected in the survey scan, a peak for Na was absent for both MH and PH in the 
detailed spectra. The peak for N 1s occurred around 400.00eV for both MH and PH, 
representing NH2 stretching. The peak for O 1s occurred around 532.00eV for both 
MH and PH, representing O-H or N-O stretching. The peak for C 1s occurred around 
285.00eV for both MH and PH, representing C-C, C-N, or C-O-C stretching. The 
varying intensity was due to the change in proximity of the detector to the sample, as 
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Figure 5.8: NAP-XPS survey (A) and detailed (B-E) spectra of MH, blue, and PH, red. In the 
detailed spectra, (B) shows the area where the peak for Na would be seen, (C) where the peak for 
O is seen, (D) where the peak for N is seen, and (E) where the peak for C can be seen. Note that 
there are no peaks found for Na. The peaks seen in C, D, and E for both MH and PH are similar. 
The difference in intensity is due to the distance the sample is from the detector.  
5.3.3.6. Surface Imagery 
The ESEM images of MH, PH, and NH prior to cell culture showed similar 
surface textures, as seen in Figure 5.9. All three samples appeared to have a smooth 
surface with no outstanding micro-features. The MH and PH samples showed 
undulations throughout the sample, which were considered to be due to the sample 
loading as there was no underlying constraint such as the glass coverslip of NH.  
After prolonged imaging, some specks were visible on the MH and PH 





sample was dehydrated from the decreasing temperature and pressure. These specks 
were homogenous and not believed to be salt depositions as a result from the 
intermediate layer.  
 
Figure 5.9: ESEM images of MH (A), PH (B), and NH (C) prior to cell culture. All samples were 
sterilized before imaging. The smooth surfaces of all three samples can be seen while several 
undulations are visible on the MH and PH sample. The NH sample does not have any visible 
significant surface features. The blue arrows indicate specks that became visible on the surface of 
the MH and PH samples. The blue bar indicates 100 µm. 
5.3.3.7. Microtensile Testing 
 MH and PH were tested with 100% rupture rate. The ruptures occurred near or 
at the mobile clamp. The results are reported as mean with standard error of mean, as 
seen in Figure 5.10. The elongation at failure for MH and PH was 32.3% ± 0.006 and 
29.3% ± 0.031, respectively, resulting in no significant difference between the two 
samples.  
 There was no visible slippage at the clamps. As tension was applied, both MH 
and PH adopted a slight ‘dog bone’ shape and became thinner in width between the 
clamps and the Peltier Stage while maintaining the original width near the clamps. 
MH was stiffer in tension with a tensile modulus of 3757.4 Pa while PH had a modulus 






Figure 5.10: Stress/strain curve based on the data from the MicroTest unit. MH is indicated by the 
blue line and PH by the red line. The outer, thinner lines represent the standard error of mean. n=4 
for both samples. 
5.3.4. Cytocompatibility  
5.3.4.1. Metabolic Quantification 
 The alamarBlue results confirmed that the intermediate layer does not affect 
the cytocompatibility of the hydrogel, as seen in Figure 5.11. The TCP, as expected, 
had significantly higher metabolic activity than all three hydrogel samples at both time 
points. However, there was no significant difference between the MH and PH samples 
and NH at either timepoint. An interesting result of the metabolic activity from this 
short experiment, is the decrease in significant difference between the TCP and 
hydrogel samples from Day 3 to Day 7. At Day 7, the level of significance between 
MH and TCP decreases from p <0.0002 to p <0.0021. The level of significance 
between PH and TCP decreases in a similar fashion from p <0.0001 to p <0.0002. 
There is no change in level of significance between the NH sample and TCP at Day 7. 





















Figure 5.11: Metabolic activity of 3T3 cells at Day 3 and Day 7 using alamarBlue on MH, PH, 
NH, and TCP. Where * p <0.0332, ** p <0.0021, *** p <0.0002, **** p <0.0001. The error bars 
represent standard error of mean and n=6 with 3 repeats.  
5.3.4.2. Cell Morphology 
After 7 days of cell culture, the cell morphology varied between the sample 
types and appeared to be dependent upon the location within one sample type, Figure 
5.12. 
At the centre of the MH and PH samples, the 3T3 cells had a rounded 
morphology. At 250 µm from the edge of MH and PH, there were several cells that 
had an elongated morphology and there were clusters of cells growing near and on top 
of each other. The PH sample showed a higher number of cells that had an elongated 
morphology at this area. At the very edge of the MH and PH sample, roughly 50-100 
µm from the edge, there were large clusters of elongated cells that appeared to be 
growing on top of other cells. Within these clusters, there were still a large number of 
spherical cells seen however, the majority of the cells were elongated.  
The cells formed a complete monolayer on the NH sample which could be seen 
in the central and edge images. The morphology of individual cells could not be seen. 
To view the morphology of individual cells on the NH sample, 3T3 cells were seeded 
at a low seeding density of 5,000 cells/cm2 and imaged at Day 5. While there were 
still some rounded cells seen, a majority of these cells showed an elongated 







































Figure 5.12: ESEM imagery of 3T3 fibroblasts after 7 days of culture on MH, PH, and NH. Images 
were taken at the centre of the sample, approximately 250 µm from the sample edge, and 
approximately 50-100 µm from the sample edge. The image with the red border indicates the centre 
of NH after 5 days of culture using a low seeding density of 5,000 cells/cm2 to highlight the 
elongated morphology of the cells. The blue bar indicates 100 µm. 
5.3.4.3. Contraction 
 At the beginning of this experiment, the contraction of the hydrogel to form a 
sinew structure was investigated as fibroblasts possess a unique contractile 
characteristic necessary for wound healing [401, 411]. The contraction of the hydrogel 
was deemed necessary to create the desired sinew shape of the tissue engineered 
ligament [218]. In order to facilitate the contraction, detached hydrogel scaffolds were 
needed as the adhesion of the hydrogel to the TCP of well plates would restrict this 
movement. However, it was found that the detached chitosan-gelatin hydrogel did not 
contract in this study.  
5.4. Discussion  
5.4.1. Physical Properties of the Detached Hydrogel 
 The translation of in vitro studies to in vivo studies and then into further clinical 
practice has been difficult within tissue engineering. The challenge arises in creating 
a 2-dimensional in vitro study and translating it into a 3-dimensional in vivo 
environment of the natural tissue [412]. To further understand and model the in vivo 





investigated extensively at an in vitro level [125]. In response to this process, the in 
vitro model of ligament tissue engineering has been considerably adapted to better 
replicate the ligament in vivo [125, 130, 227].  
 The final objective of this research is to utilize a tensile bioreactor to more 
accurately apply mechanical stimulation in an attempt to replicate an in vivo 
environment. In order to use the chitosan-gelatin hydrogel in the bioreactor, a method 
to release the adherent hydrogel from the well plate was needed. The intermediate 
layer resulted in a functional detached hydrogel scaffold that was able to be handled 
and transferred, producing a representative biomaterial for in vitro studies. The 
detached hydrogel scaffolds maintained their structural integrity throughout all cell 
culture assays and characterisation tests. Despite the difference in densities, the 
hydrogel discs remained fully submerged in cell culture medium at all times. This is 
necessary to preserve a homogenous hydrated state throughout the hydrogel and to 
maintain cell viability as the cells must be kept in cell culture medium.  
 The biodegradation of the scaffold and ingrowth of cells is crucial in recreating 
a ligament or tendon with characteristics similar to native tissue [130, 315]. The 
biodegradation of the scaffold causes chemical and mechanical changes to occur that 
may affect the cell response [413]. Typically, the degradation of a hydrogel leads to 
the loss of its mechanical strength, unless the ingrowth of cells is adequate enough to 
replace the waning hydrogel [315, 413, 414]. The balance of degradation to cell 
ingrowth is imperative to the tissue development.  
 As there were no available enzymes present within this experiment that are 
able to degrade the chitosan-gelatin hydrogel, namely lysozyme, it became apparent 
that of the degradation mechanisms seen in hydrogels, this chitosan-gelatin hydrogel 
degrades by a combination of dissolution and hydrolysis rather than enzymatic 
cleavage [293, 315, 370, 399, 415, 416]. The high degree of deacetylation and 
crystallinity of the chitosan contribute to the rate of degradation of the hydrogel as it 
is shown that the higher degree of deacetylation causes higher crystallinity which 
decreases the degradation rate of chitosan [415, 417]. As the constituents of this 
chitosan-gelatin hydrogel are all cytocompatible, it is presumed that this hydrogel 
would experience a similar degradation rate in vivo as lysozyme is not typically found 
within the joint capsule or synovial fluid of the knee unless there is an inflammatory 





 Although the degradation profile of the chitosan-gelatin detached hydrogels 
was performed without cells or mechanical stimulation, degradation is affected by the 
composition of the scaffold rather than the environment [315]. Therefore, it is 
expected that the hydrogel discs would be able to sustain cell culture and mechanical 
stimulation without accelerated dissolution.  
 During the swelling studies, it was shown that the period in which the hydrogel 
was fully swollen was prior to sterilization. The bulk of mass loss occurred during 
sterilization, most likely from the UV process as the swelling behaviour decreases with 
increased absorbed energy, such as through UV radiation [420]. The chitosan-gelatin 
hydrogel exhibited a high swelling degree that is comparable to previous studies using 
a similar hydrogel composition, which is necessary to maintain the high water content 
of the hydrogel [293, 372, 421]. Additionally, a high swelling degree proves 
advantageous for homogenous GAG perfusion throughout the scaffold [408]. The 
study by Han et al. has shown that the degree of swelling of a chitosan-gelatin hydrogel 
is directly proportional to the level of crosslinking [421]. Further, the stable swelling 
and degradation of the chitosan-gelatin hydrogel can be attributed to the compatible 
crosslinking interaction of gelatin and chitosan [293, 399, 422]. The swelling degree 
results of this research has shown that the crosslinking of the chitosan-gelatin hydrogel 
is beneficial to maintain the high water content of the hydrogel.  
 The XPS results revealed an increased concentration of Cl and Na on the 
surface of MH and PH, indicating that the intermediate layers deposited salt residue 
on the hydrogel surface. The weight percentage of C and N were similar to a chitosan-
gelatin hydrogel membrane produced by Mao et al. [423]. Increased salt 
concentrations have may have an unwanted effect on the cell-material interaction, such 
as hyperosmolarity or a change in the ECM production [424, 425]. It has also been 
shown that an increase in NaCl has a negative effect on the modulus of the hydrogel 
substrate [414]. However, the dehydration of the hydrogel samples for XPS caused the 
surface to become dissimilar to the surface environment that cells would experience. 
This leads to the conclusion that the XPS data may not give a true surface composition 
analysis of the detached hydrogels in accordance with cell interactions.  
 The NAP-XPS gave a more realistic representation of the surface chemistry 
based on the hydrated environment the cells would experience both in vitro and in 
vivo. The NAP-XPS results did not show Cl or Na residue on the surface of either MH 





to be available at the surface of the chitosan-gelatin hydrogel due to its constituents. 
It is possible that when the hydrogel is in a hydrated state, these underlying 
components are masked and do not affect the cell-material interaction and response. 
The NAP-XPS results reported here match previous studies of the surface chemistry 
of chitosan-gelatin hydrogel crosslinked with OPC [293, 422]. The decreased liquid 
volume of the intermediate layer immediately after hydrogel casting suggested trace 
amounts of fluid uptake by the hydrogel but the NAP-XPS results did not show salt 
residues from the cell culture medium or PBS.  
 A previous study by Nagahama et al. reports the elasticity and flexibility of 
chitosan-gelatin hydrogels are best when the ratio of gelatin to chitosan is 0.50, as it 
is in this experiment [399]. Previous studies have also confirmed the addition of OPC 
further strengthens chitosan-gelatin hydrogel [293, 373]. The microtensile results 
showed that MH and PH can withstand small forces performed in a relatively slow 
manner. Although difficult to image, MH and PH appeared to act similarly to 
ligamentous tissue in that the tensile strain was transmitted radially and formed a ‘dog 
bone’ shape between the grip and Peltier stage [426].  
 The elongation before failure of the MH and PH samples was similar to that of 
a natural ACL, near 33%, and higher than that of several commercially available 
synthetic grafts such as Gore-Tex and Dacron, 9% and 18.7% respectively [7, 135]. 
However, MH and PH had significantly lower ultimate tensile strengths than the 
natural ACL and synthetic grafts. The tensile moduli of MH and PH were significantly 
lower than previous studies investigating braided PLGA (100-400 MPa) and PLLA 
scaffolds (55.0 MPa), collagen fibres (359.6 MPa), and chitosan/hyaluronan fibres 
217.6 MPa) [213, 225, 227, 228]. The tensile moduli of the MH scaffolds was most 
similar to stromal tissue, with a modulus around 3000 Pa, while the PH scaffolds were 
most similar to breast tissue, with a modulus around 900 Pa [427]. Additionally, the 
tensile modulus of both MH and PH were significantly lower than the modulus of a 
2% OPC chitosan-gelatin hydrogel (127.4 kPa) calculated from compressive testing 
in a study by Encerrado et al., indicating that the intermediate layer may have a 
negative effect on the strength of the scaffold [373]. This may be due to water uptake 
during casting or a potential phase separation of the hydrogel once it is cast on the 
frozen layer. The large difference between the modulus of MH and PH suggested that 
the PBS intermediate layer may have a more significant effect on the structural 





can be reasoned that the chitosan-gelatin hydrogel mixed at 37°C experienced a large 
decrease in temperature upon casting on a frozen substrate, potentially producing some 
phase separation, although this was not visible. In a study by Goycoolea et al., a 
correlation between the temperature and shear and storage modulus of a chitosan 
hydrogel was reported, with a significant decrease in both moduli at ~21°C [428]. This 
further suggests that the structure of the hydrogel was altered due to casting on the 
frozen intermediate layer.  
 Chitosan-gelatin hydrogel is typically adherent to TCP and has a smooth 
surface [399]. The NH sample was relatively featureless as the hydrogel was 
constrained through its complete adhesion to the well plate. In contrast, randomly 
oriented undulations were seen in MH and PH. It is presumed that the undulations 
were a result of the lack of an underlying constraint and loose mounting for ESEM 
imaging. As these hydrogels have been created with intention of use in a tensile 
bioreactor, it is expected that undulations would not be present while mounted in the 
bioreactor and the surface of MH and PH would become similar to NH.  
The contraction of the hydrogel scaffold was assumed to be a natural 
occurrence once seeded with cells, as outlined previously. However, it was noted that 
contraction was seen on scaffolds composed of only collagen or had the addition of 
fibrin [218, 400, 429, 430]. Fibrin is a known protein associated with wound 
contraction and healing, which has accelerated its use in tissue engineering research 
[217]. As collagen and fibrin are the main hydrogel components in the previous 
studies, the lack of contraction seen in this research may be a result of the composition 
or crosslinking of the chitosan-gelatin hydrogel. 
5.4.2. Cell Response to Detached Hydrogels 
The metabolic activity of the 3T3 cells demonstrated that the intermediate 
layer did not negatively affect the cytocompatibility of the chitosan-gelatin hydrogel. 
Both MH and PH had similar metabolic activity as NH by Day 7, suggesting that the 
adhesion and acclimation period of the fibroblasts may be longer on the detached 
hydrogels than the constrained NH hydrogels, potentially due to the perceived stiffness 
of the substrate. Hadjipanayi has reported a similar lag period when using fibroblasts 
to investigate substrates with gradient stiffness [387]. A lag period of fibroblast 
proliferation has also been recorded during contraction of collagen-GAG scaffolds 
[431, 432]. There is potential that increasing the cell seeding density on MH and PH 





rates to NH at earlier timepoints. The decreased significance at Day 7 between TCP 
and hydrogel samples may be due to a combination of proliferation on the hydrogel 
samples and a declined 3T3 cell population due to overcrowding on the TCP sample.  
 The surface topography and roughness are important factors in the cell 
interaction with the scaffold. Some studies report that a smooth surface topography is 
ideal for fibroblast attachment, proliferation, and spreading [433, 434], whereas there 
is also evidence that fibroblasts may prefer a rougher surface [435]. Several studies 
have reported the spread and organised actin filament network of fibroblasts on 
smooth surfaces [399, 433]. In this study, a smooth topography with extensive 
fibroblast proliferation and spreading is evident in the ESEM images of NH, further 
confirming that the chitosan-gelatin hydrogel is a satisfactory biomaterial for 
fibroblast growth. 
The surface chemistry of a substrate also plays an important role in cell 
adhesion as the functional groups available on the surface dictate the type of 
attachment from cells through the adsorbed protein layer and selective integrin binding 
[143, 436, 437]. As the adsorbed protein layer on biomaterials forms quicker than cell 
adhesion, this protein layer plays a large role on the type of cell adhesion that occurs 
[434]. The NAP-XPS results indicated the presence of amine and COOH functional 
groups on the surface of the detached hydrogels which are beneficial for adsorption of 
adhesive proteins leading to increased fibroblast attachment, proliferation, spreading, 
and enhanced ECM formation [434, 438]. Despite NH not analysed using NAP-XPS, 
it is reasonable to believe that the surface chemistry of NH has similar functional 
groups available as there was no indication that the intermediate layer caused surface 
modification. 
The correlation between cell morphology and location on the MH and PH 
sample suggests that the perceived stiffness of the hydrogel plays a large role in 
fibroblast proliferation and spreading. As discussed in Chapter 4, the perceived 
stiffness of a material can affect the growth, spread, organisation, ECM production, 
and differentiation of fibroblasts [377, 379, 389]. The ESEM results indicate that the 
fibroblasts perceived the thinning edges of the MH and PH samples stiffer than the 
centre of the discs through the increased cell numbers and some elongation of cells.  
 Still, if the 1mm constrained NH samples are compared to the 1mm centre of 
MH and PH, the cell morphology is considerably different. At all timepoints on NH, 





and PH, the fibroblasts remained rounded and sparse in number at Day 7. This suggests 
that the internal rigidity of MH and PH affected the cell morphology, and therefore 
the cell proliferation.  
The internal rigidity, or pliability and compliance, of a substrate has an impact 
on the cell-cell and cell-substrate interactions [394, 439]. Several studies have shown 
that focal adhesions and cytoskeletal structure are directly affected by the rigidity of a 
sample, such as depicted in Figure 5.13 [125, 378, 379, 440]. A compliant substrate is 
unable to reciprocate the cell mediated forces and can lead to a decrease in cell 
proliferation, ECM production, and differentiation [441]. Without the reciprocal 
forces, cell migration is also limited by the rigidity of a substrate [356]. In this way, 
the low internal rigidity of the MH and PH samples influenced the adhesion, 
morphology, and proliferation of the 3T3 cells. Hadjipanayi et al. have shown that the 
internal rigidity of a substrate can be increased by being ‘anchored’, such as the 
adherence of the NH sample to the well plate in this research [387]. The higher internal 
rigidity of the NH sample led to a higher proportion of elongated cells as seen through 
the ESEM images.  
It is shown that soft, compliant substrates with low internal rigidity can trigger 
fibroblasts into a quiescent state [440]. This quiescent state arrests the cells in the G0 
phase, causing a slowed rate of proliferation, growth, and maturation [442]. While in 
the quiescent state, fibroblasts stop any DNA production and direct their metabolic 
activity towards self-preservation [443]. The rounded fibroblasts at the centre of MH 
and PH may have entered a quiescent state as the low internal rigidity was 
unfavourable for growth and spreading [444]. As this detached hydrogel is being 
developed for use in a tensile bioreactor, it is expected that the implementation in the 
bioreactor would increase the internal rigidity of the hydrogel and decrease the 
likeliness of the fibroblasts entering a quiescent state.  
Additionally, the internal rigidity of the hydrogel may also influence its 
contraction as Freyman et al. have shown that total stiffness of the substrate does not 
affect the contractile ability of fibroblasts and is rather force-limited, Figure 5.14 
[431]. Therefore, a substrate that is unable to compensate and reciprocate the cell 
mediated forces required for cell spreading, ECM production, and remodelling is less 
likely to show contraction. The limiting factor to the contraction of the detached MH 
and PH samples may be the lack of strong focal adhesions of the 3T3 cells and lack of 





hydrogel and the low internal rigidity of the detached samples may influence the 
exerted cell forces and therefore limit the contraction. This further suggests that the 
crosslinking percentage and interaction between chitosan, gelatin, and OPC do not 
prohibit contraction of the hydrogel, as previously hypothesised. 
 
Figure 5.13: A graphical description of how the stiffness and rigidity, or compliance, of a substrate 
can affect the cell morphology. In this depiction, the cell is spread and has developed organised 
actin fibres on the stiff substrate. While the cell on the soft, compliant substrate maintains a more 
rounded morphology and has not been triggered to develop actin fibres. Image adapted from 
Underhill et al. [125]. 
 
Figure 5.14: A depiction of the force mediated contraction of a cell on a substrate. At (a) the cell 
has formed adhesion sites along the leading edge (1). At (b) new adhesion sites are beginning to 
form (2) as the cell continues to elongate and a slight buckling of the substrate is seen. At (c) 
further adhesion sites are formed (3) and a noticeable strut, or substrate contraction, has formed. 
This motion is dependent upon the force exerted by the cell. Image adapted from Freyman et al. 
[431].  
5.5. Conclusion 
The intermediate layer allowed the progression of a hydrogel biomaterial that 
is dependent upon the vessel it is cast in to a versatile and functional scaffold. The 





it can be reproduced in a tissue engineering setting or worked with clinically. This 
fabrication method has shown to allow the adaptability of casting dimensions, as seen 
in the MicroTest casting.  
By removing the anchorage of the hydrogel to the well plate, the internal 
rigidity of MH and PH was decreased resulting in a rounded morphology of the 3T3 
cells due to the weaker focal adhesions of the cells to the hydrogel. The lack of 
contraction seen in the MH and PH samples was more likely a result of the weak focal 
adhesions of the cells to the substrate rather than the physicochemical interactions 
between chitosan, gelatin, and OPC.  
The cell metabolic activity was comparable for the MH and PH samples, 
suggesting that neither intermediate layer had a detrimental effect on the 
cytocompatibility which was confirmed by the alamarBlue results. The detached 
hydrogel scaffolds had a similar elongation at failure and tensile modulus, indicating 
that the cell culture medium and PBS had a similar structural effect on the detached 
hydrogel. The NAP-XPS results confirmed that there was no salt residue on the surface 
of the hydrogel scaffolds as a result of the intermediate layers. However, the 
consistency in creating the MH samples was preferred in comparison to PH. For 
further experiments requiring detached hydrogel, the cell culture medium intermediate 
layer will be used for its slightly higher metabolic activity, resultant modulus of the 





6. Modified Chitosan-Gelatin Hydrogel to Promote an 
Osteogenic Response 
6.1. Introduction 
 The bony anchors are an essential design element of a tissue engineered 
ligament that can increase the likelihood of enthesis success [445]. Failure at the 
enthesis has been a common occurrence in ACL tendon grafts due to several factors 
such as lack of tissue integration and mismatched biomechanical behaviours [446, 
447]. The development of the enthesis is a critical challenge in ligament tissue 
engineering due to the complex biomechanical loading of the region and the intricate 
graded mineralization from soft ligament midsubstance to hard bony tissue.  
 Recently, several studies have investigated the decellularization of the bony 
insertion of an animal tendon to maintain the optimal biomechanics of the enthesis 
region [173, 448, 449]. These decellularized scaffolds showed success in maintaining 
their biomechanical strength and infiltration of cells into the scaffold. However, this 
research is in its early stages and requires further investigation into the 
implementation, such as the attachment of decellularized midsubstance to native 
tendon or transformation into a ligament prosthesis requiring an additional enthesis 
region.  
 Previous methods of developing an artificial enthesis for tissue engineering 
have involved the creation of bony insertions using hydroxyapatite or brushite [184, 
401]. The manufacture of the enthesis from hydroxyapatite and brushite increases the 
availability of calcium phosphates and influences an osteoblastic response to this 
region of the scaffold [171, 192]. The crystallinity of these calcium phosphates also 
helps to regulate the degradation rate of the biomaterial [450]. While hydroxyapatite 
and brushite have shown an increase in biomaterial strength of the enthesis scaffold 
and an osteogenic cell response, further development is required to replicate the 
functional, biological attachment of the enthesis of a ligament or tendon.  
 This chapter aims to build on the recent success in enthesis biomaterials 
through the addition of calcium carbonate and calcium phosphate to the chitosan-
gelatin hydrogel, creating a composite hydrogel. The response of 3T3 cells and PFib 
cells to increasing thicknesses of this composite hydrogel will be analysed through 





 As the main goal of this research is to develop a tissue engineered ligament in 
a tensile bioreactor system, anchorage points are required to secure the detached 
hydrogel scaffold (discussed in Chapter 5) to the bioreactor and to transmit tensile 
strain to the hydrogel scaffold. Several designs of anchors will be assessed for 
suitability within the bioreactor, including a design made entirely of the composite 
hydrogel and a design using an acetal rod as a reinforcing core with a coating of the 
composite hydrogel. These designs aim to incorporate the composite hydrogel as an 
enthesis biomaterial while providing the functionality of the anchor within the 
bioreactor. The anchor designs will be characterized through degradation studies, 
ESEM, and compressive analysis.  
6.2. Methodology 
6.2.1. Composite Hydrogel Synthesis 
 Chitosan-gelatin hydrogel was created as outlined previously in section 3.5 
(page 50). A combination of calcium carbonate (CaCO3) and dibasic calcium 
phosphate (CaHPO4) was then added to the chitosan-gelatin hydrogel to create a 30% 
w/w composite hydrogel. The amounts of CaCO3 and CaHPO4 were calculated to 
maintain a theoretical Ca:P molar ratio of 1.5, similar to previous protocols [16, 401]. 
This ratio is representative of ß-tricalcium phosphate [191]. The CaCO3 and CaHPO4 
were used to increase the availability of calcium and phosphate without introducing 
the brittle nature of brushite and hydroxyapatite [192, 194]. Alternative dry weight 
percentages (10%, 20%, 40% w/w) of the CaCO3 and CaHPO4 in the chitosan-gelatin 
hydrogel were also explored.  
 The CaCO3 and CaHPO4 was mixed into the hydrogel directly before casting. 
A small spatula was used to gently stir the composite hydrogel mixture to avoid 
creating air bubbles. Once fully mixed, the beaker of composite hydrogel was tapped 
against the work surface to bring any air bubbles to the surface.  
6.2.2. Cell Culture on Composite Hydrogel 
 The composite hydrogel was cast into well plates with increasing thickness 
from 0.5mm to 2.5mm in 0.5mm increments and sterilized using the same protocol as 
outlined previously. Separately, the 3T3 and PFib cells were seeded onto the 
composite hydrogel in a volume of 500 µl at a density of 10,000 cells/cm2 with an 
alamarBlue assay carried out at Day 3, 7, 14, 21, and 28. The cell culture medium was 





which included the medium from the final 3 days of culture. There was one biological 
replicate and 12 technical replicates, repeated twice. 
 After the final alamarBlue assay, the samples were lysed by the freeze/thaw 
method and prepared for DNA, GAG, and ALP activity assays. These assays were 
carried out as described previously in section 3.5.4 (page 51). The collected medium 
was prepared in a similar manner for GAG quantification. In all assays, a composite 
hydrogel sample without cells was used as a blank to normalize the results. 
 The composite hydrogel was also cast at increasing thicknesses into a well 
plate with glass coverslips, allowing for fixation and removal for ESEM imaging. 
Separately, the 3T3 and PFib cells were seeded onto the composite hydrogel at 10,000 
cells/cm2 at a volume of 500 µl. At Day 28, the composite hydrogels were fixed for 
ESEM. These samples were not used for any further assays.  
 The mean ALP activity results from the MG63 cell line and a primary 
osteoblast culture from neonatal mouse calvaria were used as a reference for 
osteoblastic levels of ALP activity. The MG63 and primary osteoblasts were cultured 
on TCP at a similar initial cell density to the same timepoint. These osteoblast cultures 
were not used for any other assays. 
6.2.3. Degradation of the Composite Hydrogel  
 To measure the degradation of the composite hydrogel, detached composite 
hydrogel discs were made to the same protocol as outlined in section 5.2.3 (page 71) 
creating a composite MH and composite PH. The detached composite hydrogel discs 
were sterilized and then incubated in an excess of cell culture medium. The wet mass 
was measured before casting at Day 0, after sterilization at Day 1, at Day 7, and at Day 
14. The cell culture medium was replaced after Day 7.  
6.2.4. Anchor Design 
 Two designs for anchors were assessed: 
1) Anchors made entirely of the composite hydrogel. These anchors were dried 
at 4°C (MA4C) or freeze-dried (MAFD). 
2) Anchors with a reinforced acetal core coated with composite hydrogel (CA). 
These anchors were dried at room temperature. 
 Acetal (Plastics Direct, UK) was used to create the moulding for the MA4C 
and MAFD anchors and as the reinforced core of the CA anchors. Acetal was chosen 






6.2.4.1. Entirely Composite Hydrogel Anchor Model 
 The first design consisted of an anchor made entirely of the composite 
hydrogel. This was done by creating a three-piece acetal mould that produced anchors 
12mm in length with a tapered diameter from 5mm to 4mm using the SolidWorks 
software package (Dassault Systèmes, France), as seen in Figure 6.1 [453]. The 
tapered design was fashioned for the attachment of the anchors to the bioreactor. 
Acetal moulds of 12mm and 22mm length and 4mm diameter that attached directly to 
the bioreactor plates were modelled and machined. The composite hydrogel anchor 
would be inserted into the moulds and the taper of the design would cause it to be 
lodged within the mould. 
 Six bolts held the two acetal mould pieces together firmly while spring-loaded 
clips secured an additional piece of acetal to the bottom of the mould, as seen in Figure 
6.2. The composite hydrogel was injected into each well and gently tapped to remove 
any air bubbles. The surface of the mould was not covered during drying time. The 
composite hydrogel anchors were dried at 4°C for 16 hours (MA4C) or freeze dried 
for 48 hours (MAFD). 
 
Figure 6.1: The SolidWorks design of one half of the composite hydrogel anchor mould. The top 







Figure 6.2: The complete framework of the acetal mould for composite hydrogel anchors, MA4C 
and MAFD, with spring-loaded clamps securing the acetal base. The composite hydrogel has been 
injected into each well. 
6.2.4.2. Reinforced Anchor Model 
 A second design was based on an acetal rod that would act as the core of the 
anchor with a coating of composite hydrogel (CA). The acetal rod had a diameter of 
8mm ± 0.1mm and was cut into lengths of 18mm ± 0.5mm and 28mm ± 0.5mm. As 
these rods will eventually be fastened to the bioreactor, a hole for a screw was 
fashioned at the superior end of the acetal rods for attachment to the bioreactor plates.  
 The acetal rods were sandblasted using a Formula 1200 Sand Blaster with 
white saftigrit alumina (Guyson International Ltd, UK) to increase the surface 
roughness and allow for better adhesion of the composite hydrogel to the acetal. The 
rods were sandblasted for approximately 60 seconds with constant rotation. The rods 
were then cleaned by sonication followed by detergent and IMS.   
 After cleaning, the inferior ends of the rods were then coated with the 
composite hydrogel that was made up directly before coating. The coating was allowed 
to gel for approximately 5 minutes before a second coating was applied. The coated 
acetal anchors were allowed to dry at room temperature before further testing.  
6.2.5. Compression Testing of Anchors 
 Compression testing was performed on the anchors from both manufacturing 
methods. The MAFD and CA anchors were tested alongside uncoated acetal rods. An 
Instron Dual Column Universal Testing system was used at a crosshead speed of 






6.2.6. Degradation of Anchors 
 The mass of the composite hydrogel anchors was measured directly after 
production. After 24 hours of incubation in cell culture medium, the mass was 
measured again.  
6.3. Results 
6.3.1. Composite Hydrogel 
 The addition of the CaCO3 and CaHPO4 created a homogenous composite 
chitosan-gelatin hydrogel. The homogeneity of the composite hydrogel can be seen in 
Figure 6.11. The consistency of the composite hydrogel was incompatible with 
pipettes and a syringe was more appropriate for casting. The composite hydrogel 
gelled in a similar time as the chitosan-gelatin hydrogel, indicating that the addition 
of the CaCO3 and CaHPO4 did not affect the gelling time. Some separation was seen 
when the composite hydrogel was left on low heat (35°C) without agitation for a 
period longer than three hours, therefore the composite hydrogel was made up 
immediately prior to use. 
 The ratio and mixture of both compounds in hydrogel has been seen in previous 
literature without a negative effect during the gelation stage [16, 401]. However, the 
solubility of both the CaCO3 and CaHPO4 in the chitosan-gelatin hydrogel was not 
investigated in this study. 
6.3.1. Adjustment of Calcium Salts to Composite Hydrogel  
 The viscosity of the composite hydrogel was altered by adjusting the dry 
weight percentage of the CaCO3 and CaHPO4. The 10% and 20% w/w composite 
hydrogels had a thin consistency and were not stable during sterilization. The 40% 
w/w composite hydrogel resembled a paste and was unable to be consistently cast into 
well plates.  
6.3.2. Cell Assays on Composite Hydrogel  
6.3.2.1. Metabolic Activity  
 The 3T3 metabolic activity showed an inverse correlation to the thickness of 
the composite hydrogel; as the thickness increased, the metabolic activity decreased, 
as seen in Figure 6.3. All samples experienced a significant decline in metabolic 
activity; however, this decline was seen at later timepoints for the thicker samples. 
The cycle of proliferation, overpopulation, death, and regrowth of the 3T3 cells was 
seen on the composite hydrogels where the metabolic activity exhibited significant 





regrowth. The pattern of continued proliferation leading to cell death and regrowth of 
the 3T3 cells was most prominent in the 0.5mm, 1.0mm, and TCP samples.  
 The metabolic activity of the PFib cells on the composite hydrogel showed a 
steady increase in activity from Day 3 to Day 28 across all sample types, as seen in 
Figure 6.4. There were no significant declines in metabolic activity on any sample, 
though a decrease in activity on the 0.5mm and 1.0mm samples was visible. A plateau 
was seen on the 1.5mm, 2.0mm, and 2.5mm samples at Day 28 as there was no 
significant increase of metabolic activity beyond Day 21. The PFib cells did not show 
as strong an inverse correlation of metabolic activity to hydrogel thickness as the 3T3 
cells did. At Day 28, there was no significant difference of metabolic activity values 




























































































































































































































































































































































































































































6.3.2.2. DNA Quantification 
 Interestingly, the 3T3 and PFib DNA concentration appeared to increase with 
increasing thickness of composite hydrogel, as seen in Figure 6.5. This differs from 
the metabolic activity results, as the thickest samples showed the lowest metabolic 
activity from both the 3T3 and PFib cells.  
 The highest mean concentration of DNA in the composite hydrogel samples 
was on the 2.5mm sample for both the 3T3 and PFib cells, 0.02579 µg/ml and 0.02764 
µg/ml respectively. The lowest mean concentration of DNA was on the 1.0mm sample 
for the 3T3 cells, 0.01827 µg/ml, and on the 0.5mm sample for the PFib cells, 0.01951 
µg/ml. The TCP sample had the highest mean concentration of DNA for both the 3T3 
and PFib cells across all samples. 
 The 3T3 cells had significantly different DNA content across several samples. 
The TCP sample had significantly higher DNA content than the 1.0mm and 1.5mm 
samples. The 1.0mm sample had significantly lower DNA content than all other 
samples. The 2.0mm sample had significantly higher content than the 1.5 sample. The 
2.5mm sample had significantly higher DNA content than the 1.5mm, and 2.0mm 
samples.  
 Of the PFib samples, the TCP sample had a significantly higher DNA content 
than all of the composite hydrogel samples. The 0.5mm sample had significantly lower 
DNA content than all other hydrogel samples except the 1.0mm samples. The 2.5mm 
sample had significantly higher DNA content than the composite hydrogels of 
decreasing thickness. The DNA content of the 2.0mm sample followed a similar trend 
as the 2.5mm sample.  
 The 3T3 cells showed significantly higher DNA content on the 0.5mm sample 
compared to the PFib cells. The PFib cells had significantly higher DNA content on 
the 1.0mm, 2.0mm, 2.5mm, and TCP samples compared to the 3T3 cells. There was 
no significant difference in DNA content between the 3T3 and PFib cell cultures on 






Figure 6.5: DNA concentration of 3T3 and PFib cells on composite hydrogel of increasing 
thickness after 28 days of cell culture, using the PicoGreen DNA kit. The error bars represent 
standard error of mean. All composite hydrogel samples were blanked against composite hydrogel 
without cells. * p <0.0332, ** p <0.0021, *** p <0.0002, and **** p <0.0001 and n=12, with 2 
repeats. 
6.3.2.3. GAG Content 
 The 3T3 cells demonstrated sporadic GAG content on the composite hydrogel, 
as seen in Figure 6.6. The 0.5mm and 1.0mm lysate samples were significantly higher 
than the 2.0mm lysate sample. Although GAG content was undetected in the 1.5mm 
and 2.5mm sample lysate, it was detected in the related cell culture medium. The GAG 
content was lower in the collected medium than the digested lysate samples, however 
this difference was significant only in the 1.0mm related sample. There was no 
significant difference found in the GAG content between the collected medium from 
the increasing thickness of composite hydrogel samples. 
 The GAG content of the PFib TCP lysate was significantly higher than the 
lysate from the composite hydrogel samples, except the 1.5mm sample. There was no 
significant difference of the GAG content between the lysate of the composite 
hydrogel samples. The collected medium from the PFib TCP sample had significantly 
lower GAG content than the collected medium from the composite hydrogel samples 
and the related TCP lysate. The PFib cell lysate had higher GAG content than the 3T3 
cell lysate on the 1.5mm, 2.0mm, 2.5mm, and TCP samples, however this difference 
was not significant.  
 The GAG/DNA ratio showed a similar trend as the GAG content, Figure 6.7. 
The PFib cells exhibited higher GAG/DNA ratios than the 3T3 cells, except the 1.0mm 
lysate, however this difference was not significant. The only significant difference in 










































the GAG:DNA ratio arose from the 3T3 lysate of the 1.0mm sample compared to the 
collected medium from the 1.0mm sample.  
 
Figure 6.6: GAG content measured through the DMMB assay of the 3T3 and PFib fibroblasts on 
composite hydrogel samples of increasing thickness, including the medium collected from these 
samples. The error bars represent the standard error of mean. All samples were blanked against 
composite hydrogel without cells. The collected medium was blanked against the medium 
collected from the blank composite hydrogel. * p <0.0332, ** p <0.0021, *** p <0.0002, and **** 
p <0.0001 and n=12. 
 
Figure 6.7: GAG/DNA ratio of 3T3 and PFib fibroblasts on composite hydrogel samples of 
increasing thickness after 28 days of cell culture. The collected medium was collected after the 28 





















































































































6.3.2.4. ALP Activity 
 ALP activity is an early marker for osteogenesis and, therefore, high levels of 
activity were not expected from either fibroblast cell type. The 3T3 cells showed low 
levels of ALP activity on the 0.5mm and 1.5mm samples, as seen in Figure 6.8. As 
only one 1.5mm replicate showed ALP activity, this can be disregarded as an outlier. 
The 3T3 ALP activity exhibited higher results on the composite hydrogel compared 
to the chitosan-gelatin hydrogel of Chapter 4 in section 4.3.7 (page 63). 
 The PFib fibroblasts showed significantly higher ALP activity on TCP than all 
composite hydrogel samples. No significant difference was found between the 
composite hydrogel samples. The PFibs on the composite hydrogel showed more 
consistent ALP activity when compared to the chitosan-gelatin hydrogel. 
 The mean ALP activity of the MG63 cell line and a primary osteoblast culture 
were used as reference to show the ALP activity of osteogenic cells, the dotted and 
dashed line in Figure 6.8 respectively. Both osteoblasts had ALP activity results that 
were significantly higher than the 3T3 and PFib results across samples, as expected.  
 
Figure 6.8: Normalized ALP activity against DNA content of lysate of the 3T3 and PFib cells on 
composite hydrogel of increasing thickness after 28 days of cell culture, using the ALP Randox 
kit. The dotted line represents an osteoblastic MG63 cell line and the dashed line represents a 
primary mouse osteoblast culture. Error bars represent standard error of mean. Where there are no 
error bars, there was not enough data to accurately represent a standard error of mean and this 
result should be disregarded as a chance happening. All samples were blanked against composite 
hydrogel without cells. * p <0.0332, ** p <0.0021, *** p <0.0002, and **** p <0.0001 and n=12 
with 2 repeats. 
6.3.2.5. ESEM Images 
 The composite hydrogel was difficult to image during ESEM compared to the 
chitosan-gelatin hydrogel due to the reduced amount of time before the composite 
hydrogel began to dehydrate and fracture. There was no issue of a residual water layer 
































on the surface, as seen during the ESEM imaging of the chitosan-gelatin hydrogel. In 
all images of the composite hydrogel, large mineral crystals could be seen which often 
obscured the identification of cells.  
 The 3T3 cells grew on the entirety of the composite hydrogel surface of the 
1.0mm thickness sample, as seen in Figure 6.9. The 3T3 cells were numerous across 
the sample, with a rounded morphology and some extensions. The cells did not appear 
to adhere or grow directly on the large mineral crystals found throughout the sample. 
Minimal amounts of 3T3 cells had remained intact while spanning a fissure, a 
consequence of the dehydration and fracturing.  
 The PFib cells were seen across the sample but appeared to be less numerous 
and larger than the 3T3 cells. The individual cells had a mostly rounded morphology 
with some extensions. Similar large mineral crystals could be seen in the sample, 
especially where the sample had fractured. Similar to the 3T3s, the PFibs did not 
appear to adhere to the mineral crystals. Where there were fractures caused by the 
dehydration, a handful of PFib cells remained intact traversing the fissures, as seen in 
the bottom right corner of Figure 6.9. 
 The 1.0mm thickness was representative for the morphology of the 3T3 and 
PFib cells on the remaining composite hydrogel thicknesses. The morphology of the 
3T3 and PFib cells remained rounded on all sample thicknesses. The number of cells 
and cell extensions appeared to decrease with increasing sample thickness. 
 
Figure 6.9: ESEM image of 3T3 fibroblasts (left) and PFib fibroblasts (right) grown on composite 
chitosan-gelatin hydrogel of 1.0mm thickness after 28 days of culture. Mineral crystals can be seen 
in both images. (Left) The 3T3 cells can be seen across the sample but not growing on the 
composite crystals. A large fracture of the composite hydrogel can be seen towards the left of the 
image. (Right) The PFib cells can be seen across the sample. Individual PFib cells can be clearly 
identified in the image. A fracture can be seen in the bottom right corner of the image with a PFib 








6.3.3. Degradation of the Detached Composite Hydrogel 
 The degradation profile of the detached composite hydrogel can be seen in 
Figure 6.10. The wet mass loss at Day 1 was found to be significant for the composite 
PH and not significant for the composite MH. Both composite PH and composite MH 
experienced significant wet mass loss between Day 1 and Day 7. The wet mass loss at 
Day 14 was not significant for either composite MH or PH compared to Day 7. 
However, the overall mass loss from Day 0 to Day 14 was found to be significant for 
both composite MH and PH. This resulted in a 16.67% mass loss for the composite 
MH and a 24.12% mass loss for the composite PH. 
 In comparison to the detached MH and PH of Chapter 5 section 5.3.3.3 (page 
78), there was a significantly larger mass loss for both composite MH and PH after 
sterilization. The composite MH and PH had a similar weight loss percentage as the 
chitosan-gelatin MH and PH, respectively, when incubated in cell culture medium.  
 
Figure 6.10: Degradation profile of detached composite hydrogel discs MH and PH in cell culture 
medium expressed as % initial weight. Day 0 is the wet mass prior to casting and Day 1 is the wet 
mass after sterilization. Error bars represent standard error of mean. n=3. 
 
6.3.4. Anchor Modelling 
 The MA4C design did not produce consistent anchors. The middle portion of 
the composite hydrogel in the mould did not have a similar drying effect as the exposed 
surface, as seen in Figure 6.11. These samples did not maintain integrity upon 
transferring and often sheared upon removal from the mould. When the MA4C 
anchors were successfully removed from the mould, a rapid disintegration was seen 
upon incubation. Full disintegration was seen in as quickly as 2 hours. For this reason, 






















MA4C anchors were not used in degradation testing, compression testing, or future 
experiments.  
 The freeze-drying technique of the MAFD design produced anchors that had 
uniform size and comparable drying effects throughout the anchor, as seen in Figure 
6.12. The anchors maintained their structural integrity throughout handling and were 
used in the degradation testing and compression testing. 
 The composite hydrogel coating of CA was uniform and was not dislodged or 
damaged during transfer or incubation. A coating of the chitosan-gelatin hydrogel on 
acetal rods can be seen in Figure 6.13. The chitosan-gelatin hydrogel was used for the 
image as the colour of the composite hydrogel was not distinguishable from the acetal 
rod.  
 
Figure 6.11: MA4C anchors after 16 hours of drying at room temperature. In both images, the 
surface exposed to air has a considerably different consistency than the surface covered by the 
acetal base plate. (Left) The separated acetal mould, shearing the MA4C anchors at the zone where 
the different drying effects were evident. (Right) Six MA4C anchors that were successfully 
extracted from the acetal mould but possessed an uneven structure due to the exposure to air at one 
end. In both images, the homogeneity of the composite hydrogel can be seen. There are no areas 






Figure 6.12: The result of freeze-drying the 
composite hydrogel in an acetal mould, 
producing MAFD. The image was taken 
directly after freeze drying. The anchors 
have uniform size and drying effect 
throughout the sample.  
 
Figure 6.13: Acetal rods of varying lengths 
coated in chitosan-gelatin hydrogel to allow 
imaging of the coating. The colour of the 
composite hydrogel was not distinguishable 
from the white of the acetal rod in images. 
These rods were not used in any further tests.
6.3.5. Anchor Compression Testing 
 The compression results for the MAFD anchors and the CA anchors can be 
found in Table 6.1. The testing set-up can be seen in Figure 6.14. The uncoated acetal 
rod and CA anchor withstood a significantly higher load than the MAFD anchors.  
 The MAFD anchors withstood loads of over 24 N, with a mean load of 35.15 
N. The highest maximum load withstood by the MAFD anchors was 43.90 N. The 
compressive strength of the MAFD anchors ranged from 1.55 MPa to 2.76 MPa, with 
a mean of 2.21 MPa.  
 The CA anchors withstood loads between 8611 N to 9406 N, with a mean load 
of 8885.72 N. The compressive strength ranged from 203 MPa to 231 MPa, with a 
mean load of 220.14 MPa. The uncoated acetal rod withstood a higher maximum load 
but had a lower compressive strength than the CA anchor.  
 
Table 6.1: Compressive testing results, showing mean figures, of the MAFD anchors, the CA 
anchors, and the uncoated acetal rod. 
 Maximum Load (N) Compressive Strength (MPa) 
MAFD Anchor 35.15 2.21 
CA Anchor  8663.84 227.61 







Figure 6.14: The compression testing of a MAFD anchor, left, and a CA anchor, right, using an 
Instron Dual Column Universal Testing system. 
6.3.6. Degradation of the Composite Hydrogel Anchors 
 After 24 hours of incubation in cell culture medium, the MA4C anchors had 
entirely disintegrated. The wet mass was unable to be measured after incubation. This 
disintegration was seen from all MA4C samples. 
 The MAFD anchors had an average wet mass of 0.079 g before incubation in 
cell culture medium and had an average wet mass of 0.042 g after 24 hours of 
incubation. This resulted in a 46.84% mass loss. The degradation rate of the MAFD 
anchors was significantly faster than that of the detached composite MH and PH. 
6.4. Discussion 
 In ligament and tendon tissue engineering, the enthesis is of great importance 
due to its interface of two distinctly different tissue types and its biomechanical role 
in stress dispersal [139, 184, 445]. The native enthesis of the ACL is a direct insertion 
of the ligament into the periosteum of the trabecular bone consisting of a ligamentous 
region, an unmineralized fibrocartilaginous region, a mineralized fibrocartilaginous 
region, and a bony region [164, 169, 454]. The intricate graded mineralized tissue 
disperses great stresses during joint movement by reducing the modulus disparity 
between the bone and ligament tissues [18, 176]. After injury, the natural healing of 
the enthesis does not regenerate the organised graded mineral content and often results 
in disorganised fibrovascular scar tissue with weaker mechanical properties than the 
physiological enthesis [164]. Due to the poor healing of this complex interface, 





organisation of the graded mineralized regions leading to a more functional modulus 
match between the soft and hard tissues of the ligament and bone [159, 169, 455]. 
 The cell response to the composite hydrogel is a key factor to understanding if 
this biomaterial is suitable for enthesis engineering. The anchor is a paramount 
component of the bioreactor system as the detached hydrogel scaffold requires a point 
of attachment to the bioreactor for stress dispersal. The design of the anchors must 
provide attachment of the detached hydrogel scaffold (of Chapter 5) to the bioreactor 
and endure the tensile strain and culture environment within the bioreactor.  
6.4.1. The Composite Hydrogel as an Enthesis Biomaterial  
 The enthesis is a complex interface where there are several cell types found 
within the graded mineralized areas such as osteoblasts at the bony region, 
fibrochrondrocytes in the fibrocartilaginous regions, and fibroblasts in the ligament 
region [52, 180]. Regenerating this complex mineralization has proven difficult within 
tissue engineering due to the complex cell responses required in each region.  
 The need for a varying cell response on a scaffold has prompted research into 
composite scaffolds, custom bioreactors, modified cell culture medium by introducing 
growth factors, and co-culturing of multiple cell types to produce the desired cell 
phenotype throughout the scaffold [456, 457]. Previous studies have shown success 
with composite scaffolds to provoke mesenchymal differentiation in osteochondral 
studies investigating the articular cartilage in joints [458, 459]. However, there has 
been little translation of the success of composite scaffolds in osteochondral studies 
into enthesis development. The scaffolds in this research aim to build on the progress 
of osteochondral composite scaffolds by modifying the midsubstance material through 
the addition of CaCO3 and CaHPO4 to produce a composite hydrogel for the enthesis 
region.  
 Although the metabolic activity of the 3T3 and PFib fibroblasts was slightly 
lower on the composite hydrogel compared to the chitosan-gelatin hydrogel of Chapter 
4 (page 59), the metabolic activity results showed that the composite hydrogel is 
cytocompatible [396]. The metabolic activity results of both cell types followed a 
similar trend to that of the chitosan-gelatin hydrogel, with the highest metabolic 
activity seen on the thinnest samples and a decline in metabolic activity as the 
thickness increased. The significant declines of 3T3 cell metabolic activity at several 
timepoints on the composite hydrogel can be attributed to the continued proliferation 





showed a positive trend of increased metabolic activity at each subsequent timepoint 
across all thicknesses of the composite hydrogel with no significant declines in 
metabolic activity. The differences in the 3T3 and PFib metabolic activity between the 
thicknesses of the composite hydrogel became less significant as a function of time, 
consistent with fibroblasts grown on a collagen hydrogel scaffold [430]. The lack of 
significant difference of metabolic activity related to sample thicknesses at Day 28 
may be attributed to the acclimation lag of the PFibs to the substrate [387]. A similar 
delay of cell colonization on a calcium phosphate modified substrate was seen in a 
study by Daculsi et al. investigating an injectable hydrogel with microporous biphasic 
calcium phosphate granules, 40% hydroxyapatite and 60% ß-tricalcium phosphate, as 
a bone filler [460]. 
 The DNA concentration results showed a conflicting response to the hydrogel 
thickness compared to the metabolic activity, with the highest DNA concentration 
found on the thickest hydrogel samples for both the 3T3 and PFib cells. The DNA 
results suggest that there was a higher cell number on the thicker samples, for both the 
3T3 and PFib cells, despite having a lower metabolic activity [461].  
 The morphology of the 3T3 fibroblasts on the composite hydrogel was unlike 
the morphology seen on the chitosan-gelatin hydrogel of section 4.3.3 (page 57). 
Where the 3T3 cells had formed a monolayer and individual cells were difficult to 
identify on the chitosan-gelatin hydrogel, the 3T3 cells were rounded and more 
distinctive individually on the composite hydrogel. The PFib cells on the composite 
hydrogel maintained a rounded morphology with extensions across all sample 
thicknesses, unlike the elongated morphology of the PFib cells on the chitosan-gelatin 
hydrogel. 
 The perceived stiffness of the substrate, discussed previously in section 4.4.2 
(page 65), may also play a role in the 3T3 and PFib cell proliferation, morphology, 
and DNA content on the composite hydrogel [377, 462]. However, where the 
perceived stiffness of the chitosan-gelatin hydrogel of Chapter 4 appeared to decrease 
with the increasing hydrogel thickness, the perceived stiffness of the composite 
hydrogel did not appear to have the same pattern with increasing thickness. This is 
evidenced through the decreased level of significance of metabolic activity between 
the composite hydrogel thicknesses at Day 28, especially from the PFib cells, and the 
similar morphology of the 3T3 and PFib cells across the sample thicknesses. The 





stiffness may even increase with increasing hydrogel thickness. It is possible that the 
calcium phosphate salts increased the perceived stiffness of the composite hydrogel 
by decreasing the contribution to the perceived stiffness from the chitosan-gelatin 
hydrogel. While it has been shown that calcium salts increase the mechanical stiffness 
of a hydrogel substrate, the perceived stiffness of the hydrogel substrate after addition 
of calcium phosphate salts has not been previously reported [184, 463]. 
 It is well known that bone contains a high percentage of inorganic mineral 
content, mainly in the form of hydroxyapatite [464-466]. This has led to the 
investigation of hydroxyapatite as a biomaterial for bone grafts. The osteoconductivity 
and resemblance to bone composition makes hydroxyapatite an attractive biomaterial, 
however it is very brittle, remains in the body for a prolonged period, and has little 
biological and mechanical similarity to bone [465, 467, 468]. These unfavourable 
qualities of hydroxyapatite have directed research towards other calcium phosphate 
salts, such as brushite and ß-tricalcium phosphate [469-471]. Brushite has shown 
success as a biomimetic bone scaffold, however its tendency to hydrolyse to form 
hydroxyapatite result in similar graft instability [16, 192, 472, 473]. ß-tricalcium 
phosphate has gained success as an orthopaedic biomaterial due to its ability to 
produce pyrophosphate ions while preventing hydrolysis into hydroxyapatite [192, 
465]. The pyrophosphate ion is crucial in mediating the biomineralization of new bone 
formation [465]. In the presence of ALP, the pyrophosphatase ions are hydrolysed 
releasing a concentration of phosphate ions resulting in localized mineral deposition 
and bone formation [465, 474]. However, the main constituents required for tissue 
mineralization are a surplus of calcium and phosphate ions, which can be created 
through the addition of calcium phosphate salts [469, 474]. 
 The composite hydrogel of this research intended to mimic the calcium and 
phosphate availability of ß-tricalcium phosphate through the addition of CaCO3 and 
CaHPO4. The ALP activity found in the PFib samples suggests that the composite 
hydrogel increased the availability of calcium and phosphate ions on the surface, 
initiating an osteogenic response. In a study by Zhang et al., an increase of ALP 
activity through the addition of calcium phosphates to a chitosan scaffold was reported 
[473]. Mutsuzaki et al. have also shown success of the incorporation of calcium 
phosphate salts into a tendinous graft that resulted in an osteogenic response and a 
bony interface that resembled a natural direct insertion [171]. A previous study by 





chitosan-gelatin hydrogel created a biomimetic scaffold with similar density and 
porosity to bone that promoted biomineralization by rat osteoblasts after 3 weeks of 
cell culture [368]. It can be reasoned that the addition of calcium phosphate salts to 
the chitosan-gelatin hydrogel increased the availability of calcium and phosphate ions 
and thereby increased the osteogenic potential of the hydrogel.  
 As both fibroblasts and osteoblasts have a similar origin, it is no surprise that 
fibroblasts can differentiate into an osteoblastic phenotype [156, 475]. Both cell types 
have similar gene expression, with the exception that osteoblasts encode for 
production of osteocalcin and fibroblasts do not [476]. Several studies have reported 
that fibroblasts, namely from ligaments, have differentiated into osteoblasts and 
produced ECM similar to bone [477-479]. The differentiation of fibroblasts has been 
shown to be dependent on several factors, such as the type and maturity of fibroblast, 
the chemical signals, the substrate, and the surrounding ECM [156]. It has also been 
shown that tensile stress in bone fractures recruits neighbouring fibroblasts, eventually 
initiating an osteoblastic differentiation [480]. The ALP activity levels from the PFib 
cells reported here indicate that the calcium phosphate-rich environment of this 
hydrogel was favourable for an osteogenic differentiation. 
 GAG, mainly chondroitin sulfate, are found throughout the organic matrix of 
bone, alongside collagen, and play a key role in the mineralization of new bone [481-
485]. The GAG content is inversely correlated to the mineral density of bone, 
therefore, newly ossified bone has a higher GAG content than mature bone of high 
mineral density [481, 486]. The GAG/DNA ratio of the 3T3 and PFib cells across the 
sample thicknesses suggest a chondrogenic response, which may be beneficial for the 
graded fibrocartilaginous regions of the enthesis where fibrochondrocytes are found 
[52, 164, 169, 487].  
 The ALP activity and GAG content results suggest that the composite hydrogel 
elicits an osteogenic and chondrogenic response from the PFib cells indicative of 
enthesis formation. The 3T3 cells indicate some GAG production, however the ALP 
results were not consistent enough to suggest an osteogenic response. These results 
further confirm that the PFib fibroblasts have maintained their innate ability to 
differentiate into an osteoblastic lineage [156, 475]. 
6.4.2. Mechanical Functionality of the Anchors 
 The structure of an enthesis is highly complex due to its role mechanical 





forces during active and passive movement of the joint. An appropriate cellular 
response should also be seen on the bony anchor to generate the fibrocartilage 
digitations into the periosteum [162]. The mechanical properties of the anchor can 
influence the cell response leading to the successful stress management between the 
graded mineralization of the tissues [54, 445]. It has been shown that after injury, the 
healed enthesis has lower mechanical strength than before injury with an increased 
rate of tendon pull-out due to the inadequate regeneration of the fibrocartilaginous 
regions [173]. The mechanical strength and the influenced cell response are critical 
factors to enthesis engineering. 
 The main goal of the anchors within this tissue engineered ligament bioreactor 
system was to provide an attachment for the detached hydrogel scaffold that could 
disperse the tensile forces through to the hydrogel midsubstance while also permitting 
cell proliferation and differentiation. The anchors must be able to withstand shear 
forces while in the bioreactor and not degrade before adequate cell growth. Within this 
experiment, the MAFD and CA anchors were subjected to forces much higher than 
the projected 2.4% strain of the tensile loading bioreactor and fared well. However, 
the degradation rate of the MAFD anchors indicates that their inclusion in a cell culture 
environment over a period of several weeks may be detrimental to the MAFD structure 
and strength. 
 Based on previous papers incorporating calcium phosphate salts into chitosan 
hydrogel, it is expected that the CaCO3 and CaHPO4 weakly interacted with the 
chitosan-gelatin hydrogel, with the potential of some hydrogen bonding [473, 488]. 
This may explain why some settlement was seen when the composite hydrogel was 
not immediately used.  
 A study by Huang et al. has shown that chitosan-gelatin hydrogel does not have 
the required mechanical strength to act as the sole biomaterial for the anchors of a 
tissue engineered ligament [370]. However, several studies have shown that the 
addition of calcium increases the stiffness of chitosan-gelatin hydrogel [385, 463, 472, 
489]. A similar study by Maji et al. incorporated a bioactive glass into a chitosan-
gelatin scaffold through freeze-drying and found sufficient scaffold mechanical 
properties for an osteogenic application [267]. The addition of calcium phosphates to 
chitosan scaffolds has shown to increase the mechanical strength of the chitosan 





the results of previous studies, the addition of CaCO3 and CaHPO4 would enhance the 
mechanical strength of the chitosan-gelatin hydrogel used in this experiment.  
 Compared to the detached MH and PH hydrogel discs of section 5.3.3.3 (page 
78), the wet mass loss after sterilization at Day 1 of the detached composite MH and 
PH was significantly larger, suggesting a decreased swelling behaviour [420]. The 
chitosan-gelatin PH and composite PH detached hydrogel samples showed a 
significant wet mass loss immediately after sterilization. The MH samples of both 
studies, chitosan-gelatin and composite hydrogels, did not show a significant decline 
in wet mass after sterilization. These results suggest that the addition of CaCO3 and 
CaHPO4 had a negative effect on the swelling behaviour of the chitosan-gelatin 
hydrogel. Although the crystallinity of the CaCO3 and CaHPO4 was not investigated, 
it was assumed that the addition of these increased the crystallinity of the chitosan-
gelatin hydrogel, as discussed in section 5.4.1, and therefore decreased the swelling 
capacity and affected the degradation [450, 490, 491]. However, the intermediate layer 
most likely did not affect the swelling behaviour of the composite hydrogel.  
The degradation rate of the MAFD was significantly faster than the detached 
composite hydrogel discs, suggesting that the freeze-drying process altered the 
physicochemical properties of the chitosan-gelatin hydrogel. This led to the rejection 
of MAFD design for the anchors to be used in the bioreactor. Paxton et al. and Zhao 
et al. have shown that anchors of a similar mineral composition were able to withstand 
the culture conditions for up to 3 weeks without significant degradation suggesting 
that the composition used in this research may be sufficient during cell culture [16, 
368]. For a better understanding of the degradation profile of the anchor designs and 
composite hydrogel, further investigation using simulated body fluid is needed [472].  
6.5. Conclusion 
 The composite hydrogel has shown to be a cytocompatible material for the 
proliferation and growth of the PFib and 3T3 cells. The positive ALP activity results 
indicated that the CaCO3 and CaHPO4 content of the composite hydrogel promoted an 
osteogenic response. The significantly higher levels of ALP activity found within the 
PFib samples suggests that this primary fibroblast culture is a more viable cell source 
for a tissue engineered ligament application rather than the 3T3 cell line. In order to 
confirm the suitability of the composite hydrogel as an enthesis material, further 
investigation into the cell response to the composite hydrogel and the availability of 





 It has been shown that the addition of CaCO3 and CaHPO4 are advantageous 
in increasing the mechanical strength of a chitosan-gelatin hydrogel [463, 489]. 
Although the mechanical strength of the composite hydrogel was not analysed, it can 
be expected that the addition of the CaCO3 and CaHPO4 would have a similar effect 
on the mechanical strength of the composite hydrogel as the previous studies. Both of 
the anchor designs, MAFD and CA, showed mechanical strength that indicate they 
would be able to endure the tensile and shear stresses applied by the bioreactor once 
implemented in the system. However, the degradation of the MAFD anchor indicates 





7. Bioreactor Design, Assembly, and Application  
7.1. Introduction 
 Bioreactors have quickly become a staple in ligament and tendon tissue 
engineering research due to their controllable and reproducible changes of 
environmental factors, reduced risk of contamination, upscaling ability, and their 
ability to accurately apply mechanical loads [492, 493]. The necessity of applied 
tension to fibroblast seeded scaffolds to facilitate the organised ECM production 
similar to ligament tissue has driven the use of tensile loading bioreactors within 
ligament and tendon tissue engineering research [400, 494, 495]. There have been a 
range of bioreactors reported in the literature, ranging from commercial models to 
custom designs that have contributed to a deeper understanding of the ligament and 
tendon regeneration process (see Table 2.6) [8, 492, 496].  
 While it is known that mechanical loading of fibroblasts is required for ECM 
production similar to a ligament or tendon, the optimal amount and application of this 
loading is unknown [497, 498]. A number of studies have attempted to replicate the 
physiological loading of the natural ligament, however this has led to a range of strain 
rates from 2-10% [339, 343, 499, 500]. These studies reported an increase in many 
factors that indicate production of ECM similar to that of a ligament, such as collagen 
type I synthesis, cell density, elongated cell morphology with orientation along the 
axis of tension, as well as many genetic markers. The duration of applied stress and 
rest period is also less understood, as studies suggest that cells require some rest time 
to actively synthesize the ECM components—the optimal rest period is yet to be 
reported [345, 347, 498]. Despite the varying rates and duration periods, it has been 
widely accepted that a cyclic strain regime is beneficial for ligament tissue 
development [8, 19, 501]. While the majority of bioreactors for ligament tissue 
engineering apply uniaxial strain, Altman et al. created a biaxial tensile bioreactor to 
more accurately replicate the tensile and torque forces experienced by an ACL during 
movement and found that mesenchymal stem cells showed differentiation into 
ligament like fibroblasts [136]. Since the findings of Altman et al., several studies have 
further investigated a similar multi-dimensional bioreactor [502-505]. Multi-
dimensional bioreactors may be more accurate in mimicking the physiological loading 
of the ACL, however uniaxial tensile systems remain the most common bioreactors 





 This chapter outlines the design, application, and results of a custom tensile 
bioreactor as a model for ligament engineering research. The bioreactor incorporates 
the previously discussed detached hydrogel scaffolds (MH), the composite hydrogel 
coated acetal anchors (CA), and the PFib cells while applying a cyclic strain regime 
to upregulate cell proliferation and the production of ligament ECM components. A 
strain rate of 2.4% was chosen due to its similarity to the physiological loading of an 
ACL and the reported success of an increase in collagen synthesis and scaffold 
stiffness [62, 339, 342-344, 506]. 
 To analyse the effect of the tensile strain on the hydrogel sinew and the PFib 
cell response, a static system was assembled as a control. After 3 weeks of culture 
within the cyclic bioreactor or static control, the hydrogel sinews were prepared for 
imaging and biochemical analysis. The imaging allowed the morphology, orientation, 
and number of cells to be analysed. The biochemical assays allowed for quantification 
of the metabolic activity, DNA content, and GAG production. As the bioreactors were 
fixed within the incubators during culture, NH (at 1mm thickness) and TCP samples 
were used to monitor the cell growth and risk of contamination.  
7.2. Methodology 
7.2.1. Bioreactor Design 
 The custom-made bioreactor design was uniquely tailored for the development 
of tissue engineered ligament constructs. The design allows for an arduous strain 
regime, beyond the strain parameters reported here. The design was based on previous 
bioreactors in elastic cell culture systems [255, 317, 507]. An elastic cell culture 
system employs scaffolds, bioreactors, or a combination of the two to create a more 
biomimetic cell environment [255, 508].   
 Creo software (PTC, MA, USA) was used in the design process to model and 
optimise each of the components and to specify the component dimensions for 
machining. The frame was constructed from an aluminium base plate and two 
aluminium vertical plates that attached firmly to the base plate. The frame housed the 
6-well cell culture plate and the two acetal plates that held the anchors. A Creo 
rendering image and assembly of the bioreactor are shown in Figure 7.1. 
 A non-captive linear actuator with a resolution of 0.03mm/step (size 14) was 
purchased from Hayden-Kirk (CT, USA). The actuator was attached to the taller of 
the vertical plates of the frame. The actuator rod passed through the frame and attached 





shorter vertical plate, at the opposite end of the actuator, was used to secure the cell 
culture plate within the frame.  
 The mobile and static acetal plates were positioned within the frame on top of 
the 6-well plate. The static plate was housed directly atop the cell culture plate and 
held the ‘short’, fixed anchors. The mobile plate was directly atop the static plate and 
held the ‘long’, mobile anchors. Each anchor connection to the acetal plate was 
bevelled and inset to reduce any obstruction of movement by the mobile plate. Acetal 
was chosen for its mechanical strength, ease of machining, and low coefficient of 
friction [451, 509]. 
 The original concept of the bioreactor was described here. There were several 
limitations to this design that were exposed during assembly. These limitations were 







Figure 7.1: Top) A Creo rendering image of the bioreactor model, without a cell culture well plate. 
The yellow pillars represent the fixed anchors attached to the static plate. The white pillars are the 
mobile anchors attached to the mobile plate. The actuator rod is not attached to the stabilizing 
block of the mobile plate. Bottom) The assembled bioreactor with labelled components. The 6-
well culture plate was placed in the bioreactor to display the relationship of the frame, the mobile 
and static plates, and the culture plate. The anchors are not attached to the mobile or static plates.  
7.2.2. Experimental Design and Assembly 
 The assembly of the bioreactor and hydrogel scaffold was sequential and 
required great care at each step. The initial plan of using a poly-HEMA coating in the 
6-well culture plate was unsuccessful due to the potential damage during the assembly 





hydrogel. Therefore, non-treated tissue culture 6-well culture plates (Nunc™, 
ThermoFisher, UK) were used in place.  
The day prior to assembly, the chitosan-gelatin hydrogel was made to the 
specifications outlined in section 3.5.1 (page 50) while cell culture medium was frozen 
into non-treated 6-well culture plates. All metal parts of the bioreactor were autoclaved 
at 121°C at 15psi for 30 minutes and allowed to cool overnight. This included the 
aluminium frame, the screws, the actuator rod, the bolt, and stabilizing block. The 
acetal anchor rods and plates were left overnight in IMS. 
On the day of assembly, all bioreactor materials were placed into a Class II 
laminar flow hood. The actuator was attached to the frame and the rod inserted into 
the actuator but did not pass through into the frame. The anchor legs were attached to 
the mobile and static acetal plates, with caution to not over-tighten. The composite 
hydrogel was then made as described in section 6.2.1 (page 96). The anchors were 
each coated in composite hydrogel twice, creating the CA anchors, and allowed to dry. 
The culture plate with frozen medium was then placed into the frame and secured by 
the bolt. The static and mobile plates were then quickly aligned onto the culture plate 
and the actuator rod pushed through and fastened to the stabilizing block on the mobile 
plate. 
 Once the static and mobile plates were in place, 750 µl of hydrogel was rapidly 
cast around the anchors to create a sinew shape. The culture medium was allowed to 
thaw and was removed. The hydrogel was then sterilized as described previously, 
using great caution to not agitate the hydrogel sinew or the composite hydrogel 
anchors. Modifications were made by increasing the NaOH wash time to 2.5 hours 
and the UV radiation time to 3.0 hours. Because the whole bioreactor system was 
under the UV radiation, the actuator was covered with foil to prevent any damage. The 
sterilized bioreactor was carefully transferred into the incubator. Complete cell culture 
medium was then added to each well in excess to condition the hydrogel overnight. 
 A second set of hydrogel sinews was created using a static control system. In 
this system, identical acetal plates with CA anchors as the mobile bioreactor system 
were aligned atop a non-treated 6-well culture plate with frozen medium and secured 
with sterile tape. Hydrogel was cast and sterilized in the same manner as the mobile 
bioreactor. This static control was transferred to the same incubator as the bioreactor 





 Due to the design of the mobile bioreactor and static control system, both 
systems were open within the incubator. To compensate for this, aluminium foil that 
was sprayed with IMS loosely covered each system when the mechanical stimulation 
was not taking place. This helped to minimize evaporation of cell culture medium and 
the potential spread of contaminants. Alongside the bioreactor and static control, NH 
of 1.0mm thickness in a 6-well plate and TCP of a 24-well plate were used as controls 
to monitor cell growth and ensure no contaminants had entered the incubator and 
spread to the bioreactor well plates. The NH was cast and sterilized as described 
previously. 
7.2.3. Cell Culture 
 After the overnight conditioning, PFib cells at passage 1 were seeded at a 
density of 70,000 cells/cm2 at a volume of 9950 µl in a focal manner directly onto the 
midsubstance of the hydrogel sinews in the bioreactor and static control systems and 
on the NH and TCP samples. Despite the focused seeding, the surface tension of the 
cell suspension caused the majority of the suspension to gravitate to the surface of the 
wells in the bioreactor and static control. The volume of cell suspension was 
subsequently modified to ensure that the hydrogel sinews of both systems were 
covered. After an hour, an excess of cell culture medium was added to the bioreactor 
and static control. The cells were incubated for 72 hours before the medium was 
changed and daily stimulation began. The availability of the PFib cells created a 
biological replicate of 3 and technical replicate of 1 for the bioreactor and static 
system. The biological replicate for the NH and TCP cells was 1 and the technical 
replicate was 6.  
 The cell culture medium in the bioreactor and static control was changed every 
other day taking care to not disturb the hydrogel sinews and anchors. No more than 
half of the medium was removed from each well to ensure the scaffolds remained 
submerged and undisturbed. The medium was replaced to the original volume. The 
cell culture medium in the NH and TCP samples was changed every third day as 
described in section 3.2 (page 42). 
 The PFib cells on the NH and TCP samples were monitored through phase 
contrast microscopy throughout the experiment.  
7.2.4. Mechanical Stimulation 
 A code for 2.4% strain at 0.0167 Hz was created using the programming 





Arduino microcontroller. The code for the mechanical stimulation can be found in the 
Appendix section 10.3 (page 180). 
 The mechanical stimulation of the mobile bioreactor began 72 hours after cell 
culture. The bioreactor was turned on for 1 hour per weekday, with the start time the 
same each day, or as close as possible. The weekends acted as rest days. This resulted 
in 1 hour of stimulation to 23 hours rest, with an additional 48 hours of rest after 5 
days of stimulation. The cell culture medium was changed a minimum of 2 hours prior 
to the start of the stimulation on the days when the medium needed changing. 
 Images of the hydrogel sinews in the mobile bioreactor and static control were 
taken with a camera phone through sterilized clingfilm every day before and after 
mechanical stimulation. These images were used to monitor the shape and integrity of 
the hydrogel sinew.  
7.2.5. Cell Culture Assays 
 After 21 days of culture, the PFib cells were analysed for their morphology, 
orientation, metabolic activity, ALP activity, and DNA and GAG content. The cell 
culture medium at Day 21 was collected to carry out selected assays, containing the 
medium from the final 2 days. The imaging and ALP, DNA, and GAG assays were 
carried out as described in Section 3.4 (page 45).  
 Due to damage of the NH samples, a 1.0mm NH sample seeded with PFib cells 
from a previous study was used for analysis of DNA, ALP, and GAG content, labelled 
NH*. The NH* sample results were normalized to an equivalent seeding density and 
culture period as the bioreactor, static control, and TCP samples of this experiment.  
7.2.5.1. AlamarBlue 
 An alamarBlue assay was run after the 21 days of culture and stimulation. 
Earlier timepoints could not take place due to the bioreactor configuration. The assay 
was modified by increasing the amount of alamarBlue dye in the mobile bioreactor, 
static control, and NH samples from 1 ml to 2 ml and increasing the incubation time 
from 90 to 120 minutes. The TCP samples were in a 24-well plate and could only 
accommodate 1 ml of solution, so this was not changed. As the bioreactor samples 
could not be placed on the plate shaker after incubation, the alamarBlue dye was gently 
pipetted up and down several times to ensure thorough mixing of the dye in the wells 
before plating and reading the fluorescence. All samples were washed with PBS to 







 One sample from the mobile bioreactor and static control were chosen for 
ESEM. Prior to dismantling the bioreactor and static control, the midsubstance of the 
hydrogel scaffolds was cut as close to the anchor as possible in an attempt to reduce 
any damage to the scaffold. The bioreactor and static control were disassembled and 
the samples for ESEM removed for fixation and imaging following the protocol in 
Section 3.4.7 (page 49). The ESEM samples were not used for further assays. 
7.2.5.3. DNA, ALP, and GAG Assays 
 The remaining samples from each bioreactor were then prepared for further 
analysis. During the dismantling process, as much of the sinew was left in the well as 
possible resulting in the removal of the anchors from the scaffold leaving some 
damaged composite hydrogel alongside the hydrogel midsubstance. The cell samples, 
including the NH and TCP samples, were then lysed by 3 cycles of snap freezing & 
thawing in SDW. 
 The DNA content and ALP activity were assayed using the lysate. The 
remaining lysate and collected cell culture medium were digested using papain. The 
DMMB assay was used to calculate the GAG content of the lysate and the collected 
medium. A GAG/DNA ratio was then calculated. These assays followed the protocols 
outlined in section 3.4 (page 45). 
7.3.  Results 
7.3.1. Bioreactor Design 
 As a consequence of several limitations of the bioreactor design that were 
discovered during dry trial assembly runs, such as inadequate room for hydrogel 
casting, inability to attach the stabilizing block and actuator rod to the mobile acetal 
plate, and misalignment of the mobile acetal plate during the mechanical stimulation 
periods, modifications to the bioreactor design were required.  
 The circular openings of the mobile and static acetal plates created an elliptical 
opening into the well plate in which to cast the hydrogel around the anchors within the 
well. This opening would not allow a pipette or syringe to properly cast the hydrogel 
around the anchors to create a sinew shape. To accommodate for the casting, the 
circular openings were widened around the anchor fixation, as seen in Figure 7.2. A 
bevelled edge was also fashioned to allow for increased reach of the pipette.  
 Additionally, it was found that the stabilizing block could not be fastened to 





the sequential assembly process. To allow the attachment of the stabilizing block to 
the acetal plate, the stabilizing block was machined to create a superior 2/3 portion 
which attached to the actuator rod and an inferior 1/3 portion that attached directly to 
the mobile acetal plate with a hole for screw fixation. The inferior portion was attached 
directly to the mobile acetal plate during attachment of the anchors. The actuator rod 
was then attached to the superior portion of the stabilizing block and aligned on top of 
the inferior portion to allow a screw to fasten the two portions of the stabilizing block 
together.  
 Further, upon activation of the mechanical stimulation it was found that the 
mobile acetal plate did not remain aligned on the static acetal plate and moved 
diagonally to the left. To correct for this, two aluminium blocks were fashioned to 
create a guideway to ensure the alignment and movement of the mobile acetal plate. 
The aluminium blocks were fastened to the static acetal plate using Araldite Epoxy 
(Araldite, Switzerland). The epoxy was applied following manufacturer’s instructions. 
Excess epoxy was removed after it was completely dried.  
   
Figure 7.2: (Left) The original design of the acetal plate assembly and stabilizing block within the 
bioreactor. The circular openings of each plate created an elliptical opening into the well plate 
beneath. Anchors are not attached in this image. (Right) The modified openings of the acetal plates. 
The circular openings were widened around the anchor fixation points to allow a larger area with 
which to reach the well plate. The modified stabilizing block and actuator rod are attached in the 
image. The two aluminium guiding blocks can be seen on either side of the mobile acetal plate. 








7.3.2. Hydrogel Sinew 
The chitosan-gelatin hydrogel formed a sinew around the CA anchors and 
endured the tensile strain from the bioreactor throughout the 21 days of culture, as 
seen in Figure 7.3. There was no separation at the midsubstance-anchor interface and 
there were no evident tears in the midsubstance, however, several small splits occurred 
during the dismantling of the bioreactor systems. The samples chosen for ESEM did 
not have any damage from dismantling. The tears would be presumed to not have an 
impact on the biochemical assays as the entire scaffold was lysed then digested.  
 
Figure 7.3: (Left) An image of a hydrogel sinew within the mobile bioreactor taken before 
mechanical stimulation. (Right) An image of a hydrogel sinew within the static control. Each sinew 
is intact and there is no separation between the hydrogel midsubstance and the anchors. 
7.3.3. Metabolic Activity 
 The TCP sample showed significantly higher metabolic activity than the NH, 
mobile bioreactor, and static control samples, as seen in Figure 7.4. The NH sample 
had significantly higher metabolic activity than the mobile bioreactor and static 
samples. There was no significant difference of metabolic activity between the mobile 
bioreactor and static control.  
 The variation in experimental setup justifies the significantly higher metabolic 
activity of the NH and TCP samples than the mobile bioreactor and static control. The 
increased area of the well plates used for the bioreactor, static control, and NH samples 
required additional alamarBlue solution and a longer incubation period. Additionally, 
the gravitation of the cell suspension towards the well plate of the bioreactor and 
control samples may have reduced the initial cell density, as the entire cell suspension 






Figure 7.4: Metabolic activity of the PFib cells after 21 days of cell culture within the mobile 
bioreactor, static control, on NH, and on TCP, using an alamarBlue assay. Error bars represent 
standard error of mean. Where * p <0.0332, ** p <0.0021, *** p <0.0002, and **** p <0.0001 
and n=3. 
7.3.4. Cell Morphology 
 The PFib cells on the NH and TCP samples were able to be observed during 
culture through phase contrast microscopy. The cells on TCP were elongated and 
showed areas of high confluence. The NH samples showed elongated PFib cells in 
fewer numbers compared to the TCP samples. The PFib cells maintained an elongated 
morphology throughout the 21-day culture period on the NH and TCP samples.  
 The bioreactor and static control samples were imaged using ESEM to 
examine the cell morphology. Despite the low metabolic activity results, cells were 
visible on the bioreactor and static control samples. The PFib cells were sparse and 
rounded in morphology across the mobile bioreactor sample, as seen in Figure 7.5. 
There appeared to be some alignment of the PFib cells towards the axis of tension in 
the midsection of the hydrogel and near the mobile anchor. Cell debris was seen in the 
midsubstance of the sample. A higher number of cells were seen near the anchor 
interfaces than the midsubstance. Near the junction of the mobile anchor, grooves and 
patterning could be seen on the hydrogel. The hydrogel at the fixed anchor showed 










































Figure 7.5: ESEM images of the PFib cells after 21 days of culture in the mobile bioreactor at the 
midsection, left, and near the mobile anchor junction, right. The green arrow indicates the direction 
of tension. Some alignment of the cells can be seen towards the axis of tension. Cell debris was 
present in the midsection of the scaffold. The hydrogel near the mobile anchor interface showed 
some patterning, a possible result of the tension. In both images, cells can be seen with rounded 
morphology and soft edges. The blue bar indicates 100 µm. 
The PFib cells on the static control sample possessed a similar rounded 
morphology across the sample, as seen in Figure 7.6. The cells appeared randomly 
oriented and no evidence of patterning in the hydrogel was found. The cells were more 
numerous and grew in clusters near the anchor convergence, while the cells were more 
isolated in the midsection. Significantly more cell debris could be seen throughout the 
static control sample than the mobile bioreactor sample.  
 
Figure 7.6: ESEM images of the PFib cells after 21 days of culture in the static control at the 
midsection, left, and near the anchor junction, right. The PFib cells possessed a rounded 
morphology at the midsection and near the anchor. Cell debris was present throughout the scaffold. 
Clusters of cells could be seen near the anchor, whereas the cells were more isolated in the 






7.3.5. Cell Lysing and Digestion 
The NH samples experienced significant damage during the lysing process and 
were unable to be used for further cell analysis. To compensate for this, the PFib 
results on 1.0mm NH samples from a previous study were normalized to the 
corresponding initial cell density and culture period used in this study (NH*). 
7.3.6. DNA Content 
There was no significant difference of DNA content found between the mobile 
bioreactor and static control, Figure 7.7. The NH* and TCP samples had significantly 
higher DNA content than both the mobile bioreactor and static control. The DNA 
content of the TCP sample was significantly higher than the NH* samples. These 
results were expected following the alamarBlue results. 
The variation in experimental setup justifies the difference in results of the 
bioreactor and static system compared to the TCP samples, similar to the alamarBlue 
results.  
 
Figure 7.7: DNA content (µg/ml) of the PFib cells from the mobile bioreactor, static control, and 
TCP samples, using the PicoGreen DNA kit. As NH was significantly damaged during lysing, the 
included NH* was normalized from a previous PFib culture on 1.0mm NH in accordance to the 
seeding density and culture period. Where * p <0.0332, ** p <0.0021, *** p <0.0002, and **** p 
<0.0001 and n=2. 
7.3.7. ALP Activity 
ALP activity was not detected in either of the mobile bioreactor or static 
control systems. It was hypothesized that the ALP activity would be concentrated 







































measurement of the separate midsubstance and anchor areas was not feasible. The 
scaffold was unable to be separated prior to lysing leading to the entire scaffold 
subjected to the same lysing treatment. This resulted in a single cell lysate from the 
midsubstance and at the anchor regions of the sinew.  
7.3.8. GAG Production 
 There was no significant difference of GAG content found between the mobile 
bioreactor and static control, for the lysate and the collected medium, as seen in Figure 
7.8. The lysate of NH* had significantly higher GAG content than the lysate of the 
mobile bioreactor and static control samples. There was no significant difference of 
GAG content between the lysate of TCP and the mobile bioreactor and static control. 
There was no significant difference found for the collected medium between all 
samples. 
 The collected medium of the mobile bioreactor had significantly higher GAG 
content than the cell lysate from the mobile bioreactor. The collected medium of the 
static control followed this trend. There was no significant difference of GAG content 
between the lysate and collected medium for both NH* and TCP.  
 
Figure 7.8: GAG content (µg/ml) of the cell lysate and collected medium of the PFib cells on the 
mobile bioreactor, static control, NH*, and TCP samples, using a DMMB assay. The error bars 
represent standard error of mean. Where * p <0.0332, ** p <0.0021, *** p <0.0002, and **** p 
<0.0001 and n=2 for cell lysate, n=3 for medium. 
 There was no significant difference of GAG/DNA ratio from the cell lysate 
across the bioreactor, control, NH*, and TCP, as seen in Figure 7.9. However, the 
GAG/DNA ratio of the collected medium of the mobile bioreactor was significantly 
higher than the ratio of NH* and TCP. The collected medium from the static control 




























Figure 7.9: GAG/DNA ratio of the lysate and collected medium of the PFib cells on the mobile 
bioreactor, static control, NH*, and TCP. The error bars represent standard error of mean. Where 
* p <0.0332, ** p <0.0021, *** p <0.0002, and **** p <0.0001 and n=2 for cell lysate, n=3 for 
medium. 
7.4. Discussion 
 Tissue engineering research typically begins with the study of cell response on 
a biomaterial surface for ease of experimentation and fast production of results. This 
simple model is then expanded to include additional variables that may impact the cell 
response. Eventually, a 3D environment that resembles the physiological environment 
is produced that includes the mechanical, chemical, and other environmental signals 
required for successful tissue regeneration [510].  
 In order to recreate a natural environment, bioreactors have been utilized 
within ligament tissue engineering to mechanically stimulate cells in a more realistic 
and controlled manner [140]. Bioreactors may also control other environmental 
aspects, such as chambers for co-culture of cells or perfusion of cell culture medium 
[8, 329].  
 In this research, a custom bioreactor was developed as a model for ligament 
and tendon tissue engineering. The bioreactor was designed to allow a wide range of 
strain rates, from 0.01-10%, however a 2.4% strain rate was used in this study to 
replicate the physiological loading of the ACL [62, 511]. The combination of the 
detached hydrogel scaffold and the composite hydrogel coated anchors produced a 
novel chitosan-gelatin hydrogel sinew that could be implemented in a tensile loading 
bioreactor and evaluated for application within ligament tissue engineering research. 
The incorporation of the PFib fibroblasts onto the hydrogel scaffold allowed for the 
evaluation of the cell morphology and orientation and the biochemical content after 
































7.4.1. Bioreactor Design and Application 
 The design of this bioreactor was a preliminary model for ligament and tendon 
tissue engineering research. As each component of the bioreactor was assembled, there 
were ideas of improvement to better facilitate the assembly and transmission of tension 
to the hydrogel scaffold. Fundamentally, the development and use of bioreactors is 
iterative in nature and continually improving as technology and information advances 
and expands [140].  
 Previous studies on bioreactors for tissue engineered ligament applications 
have identified four key components of a bioreactor: the cell culture medium 
circulation, the culture compartment, the environmental control system, and 
mechanical stimulation system [8, 135, 329, 330]. The desired outcome of the tissue 
engineered scaffold commands control on each of the above factors [512]. Within this 
bioreactor design, the focus was on the durability of the hydrogel scaffold and the 
response of the attached PFib cells while cultured with cyclic tensile strain, therefore 
the three other factors were kept as simple as possible. 
 The chitosan-gelatin hydrogel sinew remained intact during assembly and 
throughout the culture period with mechanical stimulation. There was no separation at 
the interface between the chitosan-gelatin hydrogel of the midsubstance and the 
composite hydrogel of the CA anchor. This suggests that the chitosan-gelatin hydrogel 
and composite hydrogel successfully integrated. Additionally, there was no separation 
of the composite hydrogel from the acetal rod further indicating that this anchor design 
was satisfactory for a ligament engineering model.  
 There was no evidence of contamination found within the samples after 
culture, indicating the design was successful in mitigating risk of contaminants. The 
PFib cells were found across the bioreactor and control samples, despite the low 
numbers, suggesting that the cell seeding method allowed attachment of cells, 
although optimization of this method is required to promote an increased cell density 
on the scaffold.  
7.4.2. Cell Response on the Hydrogel Sinew 
 The chitosan-gelatin hydrogel was successfully cast into a sinew structure 
around the CA anchors that endured tensile strain over a 21-day period of cell culture. 
As discussed previously, there was no contraction seen in the chitosan-gelatin 
hydrogel sinews that has been seen in previous fibrin and collagen scaffolds [218, 317, 





crosslinking within the chitosan-gelatin hydrogel, as there have been no previous signs 
of possible contraction in prior chitosan-gelatin hydrogel studies [372, 515]. There has 
been evidence of contraction in collagen-chitosan hydrogels with fibroblast culture, 
however the chitosan content has shown to increase the hydrogel resistance to 
contraction [251, 516]. Additionally, the force generated by the cells may be a limiting 
factor in the contraction, as discussed in section 5.4.2 (page 90) [431]. Based on these 
previous studies, the lack of contraction of the chitosan-gelatin hydrogel used in this 
research was accepted leading to a sinew shape formed through the casting of the 
hydrogel. Further, there was no indication of deformation of the hydrogel sinew while 
cultured in the mobile bioreactor; any change would have been infinitesimal and 
imperceptible by the methods of monitoring used here. 
Despite the low alamarBlue results from the mobile bioreactor and static 
control, the ESEM images of both of these samples indicated that cells were dispersed 
across the scaffold. As discussed in section 5.4.2 (page 90), the rounded morphology 
of fibroblasts may indicate a period of self-preservation, or a quiescent state, as they 
await more favourable conditions for growth and proliferation [443, 444]. The low 
DNA and GAG results can be attributed to the latent phase that the fibroblasts 
remained in on the hydrogel surface.  
Further, the results of the DNA and GAG content do not align with previous 
studies using fibroblasts in a tensile bioreactor for tendon and ligament repair [215, 
341]. Interestingly, the GAG/DNA ratio from the collected medium of the bioreactor 
and control samples was comparable to the composite hydrogel scaffolds, section 
6.3.2.3 (page 105). This suggests that the cells that had adhered to the hydrogel at the 
midsubstance or anchor regions had begun to mature, despite the rounded 
morphology.  
The lack of detected ALP activity would suggest that the composite hydrogel 
of the anchors did not promote an osteogenic response from the PFib cells that had 
adhered in this area. However, it is possible that any ALP activity from the PFib cells 
near the composite anchors was so diluted during the lysing process that the activity 
fell well under the sensitivity range of the plate reader. It is also possible that there 
was not a substantial amount of composite hydrogel exposed that could influence the 






It was hypothesized that the mechanical stimulation from the bioreactor would 
promote the activation of the rounded PFib cells, however the results suggest that the 
conditions were not favourable for production of ECM components on the 
midsubstance and differentiation near the anchors, despite these cells showing positive 
responses to the chitosan-gelatin hydrogel and composite hydrogel separately. It is 
probable that the small population of adhered cells to the sinew were metabolically 
active, synthesised GAG, and expressed ALP activity but the results were diluted in 
the excess solution of the assay or lysate producing inaccurate results.  
It is possible that a higher initial seeding density may have increased the 
number of adhered PFib cells to the sinew which may have influenced the 
proliferation, GAG production, and differentiation of the cells. Several studies that 
investigated the effect of cell seeding density found an increased initial seeding density 
had a positive effect on the cell adhesion, proliferation and ECM production [83, 133, 
343, 517]. There are reports suggesting that the initial seeding density has no impact 
on the cell density after several days or weeks of culture, dependant on the scaffold, 
however a significant increase in ECM constituents was reported in the samples with 
higher initial cell seeding density [517, 518]. Further, it is possible that during seeding 
the fibroblasts attempted to adhere to the well plate rather than the hydrogel. Holy et 
al. found that only 25% of the seeded cells adhere to a freestanding scaffold within a 
well, suggesting the adherence of the PFib cells to the hydrogel was significantly lower 
than the seeding density used [518]. Measures were taken to prevent this, such as the 
non-treated tissue culture well plate and the directed pipetting of the cell suspension, 
but the fluid nature of the medium may have carried a majority of the cells towards 
the well plate rather than the hydrogel scaffold. Additionally, the PFib cells were 
grown to confluence in culture flasks to maximize seeding numbers and could not 
fulfil a higher seeding density than used here.  
 It is well known that connective tissues, including ligaments and tendons, 
require mechanical forces such as tension, compression, shear, and torsion to regulate 
homeostasis [519]. As fibroblasts are the main cell type in many connective tissues, 
there has been extensive research into the fibroblast response to various mechanical 
stimuli [520-522]. Tensile strain causes fibroblasts to produce a more organised ECM 
appropriate for ligament or tendon application, including an increase in cell density 
and collagen content [8, 331, 498].Thus, the application of tensile strain in ligament 





the fibroblast response and suitability for ligament regeneration [136, 345, 523, 524]. 
The mobile bioreactor metabolic activity and biochemical assay results did not show 
a similar increase of cell proliferation and ligament ECM markers as previous studies 
when compared to the control [334, 501]. This potentially indicates that the tensile 
strain was not dispersed throughout the scaffold and did not influence the cell 
response. However, some alignment of the PFib cells on the bioreactor sample was 
seen in the ESEM images suggesting that the tensile strain may have been 
incompletely dispersed to the scaffold, only impacting the mobile anchor and the 
portion of hydrogel midsubstance near it.  
The stiffness and rigidity properties of the hydrogel scaffold that were 
discussed as a result of the method to create a detached hydrogel in section 5.4.2 (page 
90) are also probable causes for the PFib cell response seen on the sinew in the 
bioreactor. From this reasoning, the cells that were able to adhere to the sinew may 
have been influenced by the perceived stiffness of the hydrogel and consequently 
migrated from the softer region of the midsubstance to the edges of the scaffold where 
the substrate would have been perceived as stiffer, similar to the detached hydrogel of 
MH and PH [377, 379, 386]. The rigidity of the midsubstance of the sinews may have 
influenced the cell response within the bioreactor, as a substrate with low rigidity has 
been shown to negatively influence ECM production and organisation compared to a 
substrate with a higher rigidity [378, 379, 439, 440]. It was expected that the low 
rigidity seen in the detached MH and PH hydrogel samples would have increased from 
attachment in the tensile bioreactor due to the anchorage system. Hadjipanayi et al. 
reported the increase in rigidity of a collagen scaffold by its attachment to a well plate 
[387]. Although the detached chitosan-gelatin hydrogel has low perceived stiffness 
and rigidity, these properties were expected to increase by putting the scaffold under 
tension while attached in the bioreactor. The morphological and biochemical results 
did not suggest that these properties were altered once the hydrogel was cast in a sinew 
shape in the bioreactor.   
7.4.3. Scaffold Modification & Reinforcement 
 Although the elongation before failure of the chitosan-gelatin hydrogel was 
similar to the ACL, its tensile strength would not support its use a tissue engineered 
ligament without modification [234]. The application of mechanical loading to the 
PFib seeded hydrogel scaffold was hypothesised to increase the strength of the 





tendon graft seeded with tenocytes after cyclic strain [19]. Several studies have 
reported an increased collagen I content after cyclic strain on various constructs for 
ligament repair [149, 215, 341, 345]. The cyclic loading of the cells promotes the 
production of an ECM similar to a ligament, including organised collagen I synthesis 
which can lead to increased strength of the construct [135]. The chitosan-gelatin 
hydrogel used in this research has shown to promote ECM production of the PFib cells 
through GAG synthesis and it would be reasonable to believe that after optimization 
of cell adherence to the scaffold, the tensile loading of the bioreactor would upregulate 
collagen synthesis which may lead to increased strength of the construct.   
At several points of this research, the addition of a reinforcement into the 
midsubstance of the hydrogel scaffold was deliberated. Wang et al. investigated the 
addition of a titanium spring into a hydrogel scaffold, resulting in a mechanically 
stronger scaffold for ligament repair without adverse cell response [317]. Huguet et 
al. utilized a synthetic fibre prosthesis with a collagen gel coating in ovine models for 
6 months without failure but the histological analysis showed insignificant osseous 
ingrowth at the anchor and an absence of growth between the fibres of the prosthesis 
[525]. Several other studies have researched the development of synthetic fibres 
without a hydrogel or collagen coating with excellent short-term compatibility but the 
long-term results showed failure at the site of implantation [526, 527]. The malleable 
nature of the chitosan-gelatin hydrogel would support a scaffold reinforcement, such 
as a spring, fibres, or mesh, while still possessing the biocompatibility of the chitosan-
gelatin hydrogel. There is potential to improve the mechanical strength, such as the 
tensile modulus, of the chitosan-gelatin hydrogel through the addition of a 
reinforcement.   
7.5. Conclusion 
The bioreactor enabled an environment where tensile strain could be applied 
to the hydrogel sinew while contained within the incubator. The hydrogel sinew 
maintained its structural integrity throughout the mechanical loading during cell 
culture and no evidence of ruptures or tears were found. The anchor interface between 
the composite hydrogel of the CA anchors and the hydrogel midsubstance endured the 
tensile strain with no evidence of separation. Cells were successfully seeded on the 
hydrogel sinews and there were no signs of contamination at the end of the culture 
period. These results suggest that this custom bioreactor design is an adequate model 





bioreactor could accommodate a range of scaffold biomaterials, such as other 
hydrogels or fibre-based constructs. 
At the conclusion of the culture with mechanical stimulation, there was a lack 
of mature PFib cells found at the midsubstance of the sinew and differentiated PFib 
cells at the enthesis regions on both the bioreactor and control samples, as evident 
through the cell morphology, low DNA and GAG content, and ALP activity. The cell 
morphology and biochemical assay results suggest inefficient cell adhesion and 
proliferation on the sinews. However due to the bioreactor design, the adhesion of the 
PFib cells after seeding and their proliferation during the culture period were unable 
to be separately monitored and analysed.  
Although the analysis of cell response did not show a significant increase in 
proliferation of PFib cells and upregulation of GAG production in the bioreactor 
sample compared to the static control, the results indicated that the cells survived the 
culture period with mechanical loading. As this was the first trial of the mobile 
bioreactor, this can be seen as a success that the design allowed intricate casting of the 
hydrogel and seeding of the PFib cells. The design of the bioreactor and hydrogel 
sinew allows for improvements that could increase the synthesis of ligament ECM 
markers. Such improvements could include the acetal plate design to allow for more 
efficient hydrogel casting and cell seeding.  
There is potential for this tensile bioreactor model to become a component for 
regenerative therapy for ligament and tendon repair, such as for ACL reconstruction. 
In order to accomplish this, results indicating a significant upregulation and 
organisation of ligament ECM components would need to be produced. The complete 
and accurate transmission of the tensile strain to the hydrogel scaffold and attached 








8. General Conclusions and Future Work 
 This research has investigated the development of a chitosan-gelatin based 
hydrogel scaffold that could be implemented into a tensile loading bioreactor for a 
tissue engineered ligament application. This required the innovation of an intermediate 
layer that produced a practical detached hydrogel scaffold, an essential element of 
application in the tensile loading bioreactor. Several factors were assessed to ensure 
the adequate cytocompatibility, biodegradability, and mechanical durability of the 
detached hydrogel scaffold. The hydrogel was further modified with the addition of 
CaCO3 and CaHPO4 to investigate the cell response at the enthesis region. The 
suitability of two fibroblast cultures were assessed for use in a ligament engineering 
application. Finally, the detached hydrogel scaffold and composite hydrogel were 
incorporated into a tensile loading bioreactor and seeded with fibroblasts to determine 
the effectiveness of the tissue engineered sinew construct during a tensile loading 
regime. 
8.1. Chitosan-Gelatin Hydrogel Optimization 
The chitosan-gelatin hydrogel was demonstrated to be cytocompatible, 
aligning with previous studies using a similar hydrogel composition [399, 422, 528]. 
The cytocompatibility was maintained across the increasing thicknesses of the cast 
hydrogel, however a decreased rate of proliferation of both the 3T3 and PFib cells was 
seen with increasing thickness.  
The increasing hydrogel thickness of this study has shown the effect of 
perceived stiffness on the cell growth and ECM production. The metabolic activity 
results of the 3T3 cells and PFib cells showed a decline in activity with increasing 
hydrogel thickness. Both cell cultures exhibited spread morphology with elongation 
on the thinner hydrogels, indicating a higher perceived stiffness [378]. The 
morphology of both cell cultures became more rounded with less extensions as the 
hydrogel thickness increased, indicating a lower perceived stiffness. The 3T3 and PFib 
morphology and metabolic activity results on the increasing thickness of hydrogel 
indicated that the perceived stiffness of the hydrogel decreased with increasing 
thickness, as fibroblasts tend to spread and proliferate more on stiffer substrates [382, 
389]. However, the GAG content results suggest that the thinnest hydrogels, 0.5mm, 
were not suitable for deposition of ECM by the 3T3 or PFib cells. This aligns with 




previous studies that have found that fibroblasts prefer substrates with a modulus 
similar to the physiological tissue for production of ECM [394, 439, 529]. 
This study has demonstrated the effect that the hydrogel thickness has on the 
perceived stiffness of the hydrogel by the cells. This is an important factor in 
influencing the cell response to the desired application. The 1.0mm thickness was 
found most suitable for future work due to its consistency in cell response for both cell 
types and accuracy of casting.  
8.2. Detached Hydrogel Disc Produced by an Intermediate Layer 
 The fabrication of a detached hydrogel scaffold was a key factor in 
implementing the hydrogel into the tensile bioreactor. As chitosan-gelatin hydrogel is 
typically adhesive to TCP, a method of detaching the hydrogel from the underlying 
well plate without compromising the cytocompatibility of the hydrogel was necessary 
[399]. Aligning with the cost-effective approach, cell culture medium and PBS were 
investigated as an intermediate layer to release the hydrogel from the well plate.  
 This study proved that the intermediate layer, of either cell culture medium or 
PBS, did not adversely affect the cytocompatibility of the hydrogel. The surface 
chemistry results indicated that there were no excess salt residues on the hydrogel 
surface as a result of the intermediate layer [293]. However, the cell morphology and 
metabolic activity results indicated that the cells perceived the detached hydrogel 
scaffolds as softer than the hydrogel of similar thickness constrained in well plates 
[387]. It was believed that the low rigidity of the detached hydrogel decreased the 
perceived stiffness by the cells [394, 439].  
 The mechanical properties of tissue engineered constructs for ligament repair 
are important in maintaining the strength and stability of the joint once implanted 
[130]. The tensile testing of both detached hydrogel types, MH and PH, resulted in a 
similar elongation at failure as the native ACL [234]. However, the resulting tensile 
strength of the detached chitosan-gelatin hydrogel requires modification to more 
accurately replicate the biomechanical properties of the native ACL [132].  
The cell culture medium intermediate layer produced a more consistent 
detached hydrogel scaffold than the PBS intermediate layer. The PBS intermediate 
layer did not reliably produce hydrogel scaffolds that withstood the handling during 
transfer and sterilization. Therefore, the cell culture medium intermediate layer was 
utilized in further experiments. The method of fabricating detached chitosan-gelatin 




hydrogel scaffolds proves to be an interesting research tool to modify biomaterials that 
are dependent upon an external structure for support.  
8.3. Composite Hydrogel 
 The enthesis has proven to be a challenging area within tissue engineering due 
to the graded mineralization, organisation of collagen, and its role in stress dispersal 
[162, 446, 530]. Previous studies have investigated hydroxyapatite, brushite, and 
calcium phosphate to replicate the bony interface and regenerate the graded 
mineralization [184, 186, 189]. This study demonstrated that the addition of CaCO3 
and CaHPO4 prompted the production of early osteogenic markers by the PFib cells, 
possibly indicating the differentiation towards an osteoblastic lineage. The 
cytocompatibility of the hydrogel was not compromised by the integration of the 
calcium phosphate salts, aligning with previous studies that have incorporated calcium 
phosphate into chitosan and gelatin scaffolds [463, 472].  
 As previously discussed, the substrate stiffness has a profound impact on the 
cell response. To create a more biomimetic environment for osteogenic differentiation, 
several studies have incorporated calcium phosphate salts into chitosan-gelatin 
hydrogel to increase the stiffness [368, 385, 489]. The morphology and metabolic 
activity of the 3T3 and PFib cells indicated that the perceived stiffness of the 
composite hydrogel was less variable with increasing thickness than the chitosan-
gelatin hydrogel. This was believed to be a result of the decreased contribution to the 
perceived stiffness from the chitosan-gelatin hydrogel through the integration of the 
calcium phosphate salts. The results showed a similar rounded morphology of both 
fibroblasts across all composite hydrogel thicknesses and a decrease in significant 
difference of metabolic activity between the sample thicknesses at respective 
timepoints compared to the chitosan-gelatin hydrogel metabolic activity results.  
 The GAG/DNA ratio results reveal a more consistent GAG production by the 
PFib cells than the 3T3 cells. These results may indicate a chondrogenic potential from 
the PFib cells, which is beneficial for the fibrocartilaginous regions of the enthesis. 
These results in combination with the ALP results, provide evidence that the 
composite hydrogel promotes a response from the PFib cells that is indicative of the 
cells found at the enthesis. However, histological analysis and additional assays for 
ECM components should be considered to confirm the production of these matrix 
components.   
 




8.4. Primary Ovine Fibroblast Culture 
 In tissue engineering applications that require a multitude of cell lineages, the 
cell source is a key factor in the appropriate phenotype on the distinct areas of the 
scaffold [4]. The scaffold in this research necessitates two separate cell phenotypes—
a fibroblastic phenotype in the midsubstance of the scaffold and an osteoblastic 
phenotype at the anchors on either end.  
 Upon investigating the growth and GAG production of the 3T3 and PFib cells 
on the chitosan-gelatin hydrogel and composite hydrogel, the PFib cells proved to be 
a more viable option for preliminary models of ligament tissue engineering research. 
The 3T3 cell line is a convenient model for cell culture, in part due to its rapid growth 
rate and accessibility [375]. However, the 3T3 cell line may not always be an accurate 
representation of a fibroblastic response due to the loss of some characteristics, such 
as cell contact inhibition. The experiments in this research have shown that the 3T3 
cell line has a decreased capacity to differentiate into an osteoblastic phenotype.  
 Previous studies have explored the suitability of primary ACL fibroblasts as 
models for ligament engineering research for ACL reconstruction and have found 
upregulated production of ECM components, such as collagen type I & II and decorin 
[148, 150, 215]. The results from these studies demonstrate that the PFib culture is an 
adequate model for ligament engineering applications due to its potential for 
osteoblastic differentiation and innate capability to produce the physiological ECM. 
Collagen synthesis of the PFib cells was not analysed but can be predicted to be similar 
to the primary ACL cultures used in published studies [211, 279]. Further phenotyping 
would be beneficial to confirm the technique of tissue digestion for cell isolation 
resulted in the single fibroblast cell type and did not incorporate cells from the synovial 
sheath or surrounding tissues.  
8.5. Bioreactor Design & Application 
 In order to implement the detached hydrogel into the bioreactor, an anchorage 
system was required that would allow for attachment of the detached hydrogel to the 
bioreactor and would allow for stress dispersal through to the hydrogel and attached 
cells. Of the three designs investigated, the acetal rod with a composite hydrogel 
coating (CA) proved to be the most suitable anchor design for cell culture within the 
bioreactor. The degradation of the MAFD anchors in cell culture medium and the low 
structural integrity of the MA4C anchors during handling rendered these two designs 
inadequate for use within the bioreactor. 




 The design and application of the tensile bioreactor system was the final aspect 
of this research. Several faults of the bioreactor design were identified during early 
assembly trials and modifications to the affected components were completed to 
facilitate assembly. The final configuration of the bioreactor allowed for both the 
complete casting of the chitosan-gelatin hydrogel around the CA anchors, creating the 
hydrogel sinew, and for the seeding of the PFib cells. The hydrogel sinew endured the 
tensile strain and the anchor-midsubstance interface remained intact throughout the 
culture. After the culture period, the PFib cells were found adhered across the sample. 
There was no evidence of contamination throughout the culture period. The successful 
assembly of the bioreactor indicates that the design of this tensile loading bioreactor 
may be a suitable model for ligament tissue engineering research.   
 Based on previous tendon and ligament tissue engineering studies, a significant 
increase in DNA and GAG content was expected after culture within the tensile 
loading bioreactor compared to the static control [8, 19, 345]. There was disparity 
between the initial results from this work and the results observed in previous ligament 
tissue engineering research. However, some cell alignment towards the axis of tension 
was seen in the bioreactor sample indicating the anchors transmitted the strain to the 
hydrogel and adhered cells. Additionally, there was some detection of GAG 
production from the lysate and collected cell culture medium of both the bioreactor 
and static control systems, indicating some production of ligament-like ECM of the 
PFib cells on the sinews. It is difficult to pinpoint the exact cause behind the similarity 
of the metabolic activity, DNA content, and GAG content results of the bioreactor and 
static control samples, thus demanding additional trial runs to confirm results. 
 The results from the application of the tensile loading bioreactor suggest that 
the sequential process of assembly was not detrimental to the hydrogel sinew or the 
PFib cells. However, the cell seeding could be optimised to increase the initial number 
of adhered cells to the sinew. Further, histology and mechanical testing of the sinews 
following culture within the bioreactor should be analysed to understand the effect of 
tensile strain on the spatial relationship of the cells and ECM production and the 
overall strength of the sinew.  
8.6. Future Work 
 This chitosan-gelatin hydrogel has proven to be an exciting biomaterial with 
malleable physicochemical properties to direct the fibroblast response. In this study, 
we have shown the proliferation, GAG production, and differentiation of a primary 




ovine fibroblast culture for use in a ligament tissue engineering application. However, 
to further justify our results the histology and additional ECM components, such as 
collagen and elastin, should be analysed. A total collagen quantification would be a 
useful measure of collagen content, which can be done by a SirCol Assay or a 
hydroxyproline assay. A more detailed account of the types of collagen produced 
would allow a deeper understanding of the newly generated tissue, which would 
require specific ELISA assays or PCR. Further genetic markers of ligamentous ECM 
could also be analysed through PCR, such as tenascin C, decorin, and fibronectin. 
While histological analysis could reveal the spatial relationship of the cells and ECM 
production and the organisation of matrix components, such as collagen fibrils.  
 As the tensile strength of the detached chitosan-gelatin hydrogel scaffolds was 
not similar to the tensile strength of the native ACL, improving the strength of the 
scaffold through increased crosslinking or the addition of a reinforcement should be 
explored. A potential future study of this chitosan-gelatin hydrogel could examine the 
effect of varying the OPC percentage on the tensile modulus of the detached hydrogel. 
Previous work has investigated the incorporation of springs and fibres with success in 
increasing the tensile modulus of the hydrogel construct [226, 317]. The development 
of this hydrogel allows for flexibility in the composition of the scaffold in which a 
central reinforcement, such as a spring or fibres, could be applied.  
 Continued improvements to the osseous anchors would be beneficial in 
creating a more natural enthesis. The anchor was originally designed to be composed 
entirely of composite hydrogel, which was hypothesized to create the graded 
fibrocartilage junction and decrease the risk of delamination between the chitosan-
gelatin hydrogel and composite hydrogel at the interface [52]. Though, the progression 
of this research favoured a reinforced anchor with increased mechanical strength. 
While this research utilized acetal as the material for the osseous anchors, other 
calcium phosphate ceramics and bioglasses, magnesium and its alloys, and titanium 
and its alloys could be investigated due to their use in other orthopaedic applications 
[531, 532]. The anchors composed of only composite hydrogel showed some promise, 
however the fabrication of these anchors would need to be considerably improved 
before further cell culture and bioreactor experiments could take place. Further, the 
interface between the composite hydrogel and chitosan-gelatin hydrogel should be 
investigated before and after mechanical stimulation to better understand the 
mechanical limitations of this tissue engineering construct. 




 In the literature, there are few studies that have developed an entire sinew 
construct, consisting of a ligamentous midsubstance and two entheses. Further, 
investigation of the mechanical properties of the sinew construct prior to and after 
mechanical stimulation is limited. Due to the fabrication of the hydrogel sinews and 
limited PFib numbers, the measurement of the tensile modulus and elongation at 
failure of the hydrogel sinew following mechanical stimulation was unable to be 
measured. The tensile properties of the sinew before and after mechanical stimulation 
should be investigated in further research of this hydrogel sinew. 
 Overall, the chitosan-gelatin hydrogel has proven to be a malleable material 
that has the potential to be used in a wide variety of applications. As a detached 
scaffold, the tensile modulus suggests that it is most suitable for light load bearing 
applications, such as neural, kidney, or endothelial tissue engineering. Further 
modifications and alterations to this hydrogel composition can expand its use. The 
tensile loading bioreactor can be a useful model for ligament tissue engineering and 
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10. Appendix  
10.1. Concentrations for PicoGreen Assay 
Table 10.1: The standard concentrations used for the PicoGreen assay. 
Volume TE 
(µl) 
Volume (µl) of 2 





0 100 100 1 µg/ml 
10 90 100 0.9 µg/ml 
20 80 100 0.8 µg/ml 
50 50 100 0.5 µg/ml 
80 20 100 0.2 µg/ml 
90 10 100 0.1 µg/ml 
99 1 100 0.01 µg/ml 
100 0 100 0 (Blank) 
 
10.2. Concentrations for DMMB Assay 
Table 10.2: The standard concentrations used for the DMMB assay.  
Volume H2O 
(µl) 
Volume (µl) of 500 
µg/ml GAG Stock 




20 0 200 0 (Blank) 
17.8 2.2 200 5 µg/ml 
16.7 3.3 200 7.5 µg/ml 
15.6 4.4 200 10 µg/ml 
13.4 6.6 200 15 µg/ml 
9 11 200 25 µg/ml 
2.4 17.6 200 40 µg/ml 
0 20 200 45.45 µg/ml 
 
10.3. Mean Cell Area Additional Images 
 These are additional images that were used to calculate the mean cell area of 






Figure 10.1: Images used for calculation of mean cell area of 3T3 cells on 0.5mm chitosan-
gelatin hydrogel over a period of 28 days. 
 
Figure 10.2: Images used for calculation of mean cell area of 3T3 cells on 1.0mm chitosan-






Figure 10.3: Images used for calculation of mean cell area of 3T3 cells on 1.5mm chitosan-
gelatin hydrogel over a period of 28 days. 
 
Figure 10.4: Images used for calculation of mean cell area of 3T3 cells on 2.0mm chitosan-






Figure 10.5: Images used for calculation of mean cell area of 3T3 cells on 2.5mm chitosan-
gelatin hydrogel over a period of 28 days. 
 
Figure 10.6: Images used for calculation of mean cell area of 3T3 cells on TCP over a period 






Figure 10.7: Images used for calculation of mean cell area of PFib cells on 0.5mm chitosan-
gelatin hydrogel over a period of 28 days. 
 
Figure 10.8: Images used for calculation of mean cell area of PFib cells on 1.0mm chitosan-






Figure 10.9: Images used for calculation of mean cell area of PFib cells on 1.5mm chitosan-
gelatin hydrogel over a period of 28 days. 
 
Figure 10.10: Images used for calculation of mean cell area of PFib cells on 2.0mm chitosan-






Figure 10.11: Images used for calculation of mean cell area of PFib cells on 2.5mm chitosan-
gelatin hydrogel over a period of 28 days. 
 
Figure 10.12: Images used for calculation of mean cell area of PFib cells on TCP over a period 
of 28 days. 
10.4. Code for Mechanical Stimulation of Bioreactor 
 
// This is setup code for finished Arduino microcontroller 
// Declaration of pins 
#define red_LED 10    // Write this pin HIGH to light RED led 
#define yellow_LED 11 // Write this pin HIGH to light YELLOW led 
#define green_LED 12  // Write this pin HIGH to light GREEN led 
int start = A0; // Use AnalogRead - this is the "automation start pushbutton"  .. 
BROWN 
int back = A1; // Use AnalogRead - this is the "jog backwards" pushbutton, enabled 
when the manual switch is thrown .. ORANGE (button cap red) 
int forward = A2; // Use AnalogRead - this is the "jog forwards" pushbutton, enabled 





int manual = A3; // Use AnalogRead - this is the "auto/manual" switch detection .. 
PURPLE 
int startbuttonstate = 0; // This is the flag to note if the auto program start button has 
been pressed. Default to ZERO so the auto program won't commence uncommanded 
- it will drop straight into manual_operation() function 
int M1inA1 = 1; // YLW - These are the 4 control inputs for motor 1 
int M1inA2 = 0; // GRN - The apparent 0/1 mismatch is due to the numbering of the 
pins on the board. 
int M1inB1 = 2; // BLU - These are the 4 control inputs for motor 1 
int M1inB2 = 3; // PUR - These are the 4 control inputs for motor 1 
int M2inA1 = 4; // BLK - These are the 4 control inputs for motor 2 
int M2inA2 = 5; // WHT - These are the 4 control inputs for motor 2 
int M2inB1 = 6; // RED - These are the 4 control inputs for motor 2 
int M2inB2 = 7; // ORG - These are the 4 control inputs for motor 2 
 
int M1_enable = 8; // WHITE/WHITE Motor enable logic. Write HIGH for motor 
ON, LOW for motor OFF - Needs both logic enable HIGH on L298N to operate 
motor 
int M2_enable = 9; // PINK / PINK Motor enable logic. Write HIGH for motor ON, 
LOW for motor OFF - Needs both logic enable HIGH on L298N to operate motor 
 
//int stepDelay = 20; // Delay between steps in milliseconds 
float stepDelay = 1.5; // Delay between steps in milliseconds 
int current_position = 1000;  //This keeps track of the overall position of the actuator 
 
/*Defining Experimental parameters*/ 
 
#define PI 3.141592654 
#define frequency 0.0167 //(frequency is in Hz) 
#define magnitude 12 //(magnitude is in steps) 
#define phase_difference 1 //difference in threads between actuators, if any 
#define duration 3600 //duration of stimulation, in seconds 
 
void setup() { 
  Serial.begin(9600); 
 
  // Here, the pin assignments are declared as inputs or outputs. 
  // The 4 switches are inputs, everything else is output. 
 
 
  pinMode (red_LED, OUTPUT); 
  pinMode (yellow_LED, OUTPUT); 
  pinMode (green_LED, OUTPUT); 
 
  pinMode (start, INPUT); 
  pinMode (back, INPUT); 
  pinMode (forward, INPUT); 
  pinMode (manual, INPUT); 
 





  pinMode (M2_enable, OUTPUT); 
 
  pinMode(M1inA1, OUTPUT); 
  pinMode(M1inA2, OUTPUT); 
  pinMode(M1inB1, OUTPUT); 
  pinMode(M1inB2, OUTPUT); 
 
  pinMode(M2inA1, OUTPUT); 
  pinMode(M2inA2, OUTPUT); 
  pinMode(M2inB1, OUTPUT); 
  pinMode(M2inB2, OUTPUT); 
 
  digitalWrite(M2_enable, LOW); 




// ************define the stepper "steps" for each motor 
 
void M1step1() { 
 
  digitalWrite(M1inA1, LOW); 
  digitalWrite(M1inA2, HIGH); 
  digitalWrite(M1inB1, HIGH); 
  digitalWrite(M1inB2, LOW); 
  delay(stepDelay); 
 
} 
void M1step2() { 
 
  digitalWrite(M1inA1, LOW); 
  digitalWrite(M1inA2, HIGH); 
  digitalWrite(M1inB1, LOW); 
  digitalWrite(M1inB2, HIGH); 
  delay(stepDelay); 
 
} 
void M1step3() { 
 
  digitalWrite(M1inA1, HIGH); 
  digitalWrite(M1inA2, LOW); 
  digitalWrite(M1inB1, LOW); 
  digitalWrite(M1inB2, HIGH); 
  delay(stepDelay); 
 
} 
void M1step4() { 
 
  digitalWrite(M1inA1, HIGH); 





  digitalWrite(M1inB1, HIGH); 
  digitalWrite(M1inB2, LOW); 
  delay(stepDelay); 
 
} 
void M1stopMotor() { 
 
  digitalWrite(M1inA1, LOW); 
  digitalWrite(M1inA2, LOW); 
  digitalWrite(M1inB1, LOW); 
  digitalWrite(M1inB2, LOW); 
} 
 
void M2step1() { 
 
  digitalWrite(M2inA1, LOW); 
  digitalWrite(M2inA2, HIGH); 
  digitalWrite(M2inB1, HIGH); 
  digitalWrite(M2inB2, LOW); 
  delay(stepDelay); 
 
} 
void M2step2() { 
 
  digitalWrite(M2inA1, LOW); 
  digitalWrite(M2inA2, HIGH); 
  digitalWrite(M2inB1, LOW); 
  digitalWrite(M2inB2, HIGH); 
  delay(stepDelay); 
} 
void M2step3() { 
 
  digitalWrite(M2inA1, HIGH); 
  digitalWrite(M2inA2, LOW); 
  digitalWrite(M2inB1, LOW); 
  digitalWrite(M2inB2, HIGH); 
  delay(stepDelay); 
} 
void M2step4() { 
 
  digitalWrite(M2inA1, HIGH); 
  digitalWrite(M2inA2, LOW); 
  digitalWrite(M2inB1, HIGH); 
  digitalWrite(M2inB2, LOW); 
  delay(stepDelay); 
} 
void M2stopMotor() { 
 
  digitalWrite(M2inA1, LOW); 





  digitalWrite(M2inB1, LOW); 
  digitalWrite(M2inB2, LOW); 
} 
 
//**********************Stepper motor "steps" definition ends 
 
//**********************Aggregate the stepper steps into a simple "forwards" 




  digitalWrite(M1_enable, HIGH); 
  M1step1(); 
  M1step2(); 
  M1step3(); 
  M1step4(); 





  digitalWrite(M1_enable, HIGH); 
  M1step3(); 
  M1step2(); 
  M1step1(); 
  M1step4(); 






  digitalWrite(M2_enable, HIGH); 
  M2step1(); 
  M2step2(); 
  M2step3(); 
  M2step4(); 





  digitalWrite(M2_enable, HIGH); 
  M2step3(); 
  M2step2(); 
  M2step1(); 
  M2step4(); 







//**********************Aggregate the stepper steps into a simple "forwards" 
"backwards" command set for the 2 motors ends 
 
//**************** Define manual operation function 
 
int manual_operation(int bposition) 
{ 
  int int_position; 
  startbuttonstate = 0; //As soon as manual control is enabled, set the startbuttonstate 
to zero. Code lines at the top of void loop will detect the state change and allow the 
preset program to run. 
 
 
  digitalWrite(yellow_LED, LOW); 
  digitalWrite(M1_enable, HIGH); 
  digitalWrite(M2_enable, HIGH); 
 
  while (analogRead(manual) > 500) 
  { 
    digitalWrite(red_LED, HIGH); 
    digitalWrite(green_LED, LOW); 
    if (analogRead(forward) < 500) 
    { 
      bposition++; 
    } 
 
    if (analogRead(back) < 500) 
    { 
      bposition--; 
    } 
    digitalWrite(M1_enable, HIGH); 
    digitalWrite(M2_enable, HIGH); 
    digitalWrite(yellow_LED, HIGH); 
    int_position = ((bposition) % 4); 
    set_position(int_position); 
    digitalWrite(yellow_LED, LOW); 
    digitalWrite(M1_enable, LOW); 
    digitalWrite(M2_enable, LOW); 
    delay(100); 
    Serial.print("Bposition = "); 
    Serial.println(bposition); 
    return bposition; 
  } 
  //******************************Ends definition of manual operation 
 
}  //Void setup ends 
 
// This is the loop routine that runs over and over again forever: 
void loop() { 





  unsigned long timenow; 
  float aposition; 
  int i = 0; //local looping variable 
  int n; //local variable 
  int int_position = 0; 
  int start_position; 
 
  int dutycycle = 200; //proportion of 1 second (in milliseconds) that motors are 
actuated 
  if ((analogRead(manual) < 500) && (startbuttonstate == 0)) 
  { 
    digitalWrite(red_LED, HIGH); 
    digitalWrite(yellow_LED, HIGH); 
    digitalWrite(green_LED, HIGH);  //Set indicator lights for the condition where 
manual/auto is set back to auto but the start light is not pressed - all LEDs on. 
    Serial.print("StepD ");  
    } 
    Serial.print("StepA "); 
  if ((analogRead(start) < 500) && (analogRead(manual) < 500)) 
  { 
    startbuttonstate = 1; //Set the start button pressed flag to 1 if auto enable button is 
pressed AND auto/manual selector is at AUTO 
 
    timeistarted = millis(); 
        Serial.print("StepE "); 
  } 
    Serial.print("StepB "); 
  //Motor control by sinusoidal stimulation 
  //This uses the sinusoidal waveform to move forward and backward: controlling 
parameters are 
  //frequency, magnitude, and stimulation time 
  if (startbuttonstate == 1) 
  { 
        Serial.print("StepC "); 
    digitalWrite(red_LED, LOW); 
    digitalWrite(yellow_LED, HIGH); 
    digitalWrite(green_LED, HIGH); // Set indicator lights for automatic operation - 
green on only. 
    //******************Move actuator towards origin by magnitude*0.5 to de-
tension the gel 
    i = int(magnitude * 0.5 + 1); 
    while (i > 0) 
    { 
      int_position = (current_position % 4); 
      set_position(int_position); 
      delay(500); //makes up delay to move gradually to start point 
      current_position--; 
      Serial.print("Current position = "); 
      Serial.println(current_position); 





      i--; 
      timeistarted = millis();  
    } 
    //***********************************Set motor position by current time 
    timenow = millis() - timeistarted; 
    start_position = current_position; 
    while (timenow < (1000 * duration)) 
    { 
 
      if ((millis() % 1000) < dutycycle) //check system clock to set duty cycle for 
motors 
      { 
        digitalWrite(M1_enable, HIGH); 
        digitalWrite(M2_enable, HIGH); 
      } 
      else 
      { 
        digitalWrite(M1_enable, LOW); 
        digitalWrite(M2_enable, LOW); 
      } 
      aposition = (magnitude * 0.5) - (0.5 * magnitude * cos(PI * frequency * timenow 
/ 500)); 
      current_position = start_position + aposition; 
      Serial.print("Current position = "); 
      Serial.println(current_position); 
      int_position = ((int(current_position)) % 4); 
       
      set_position(int_position); 
      timenow = millis() - timeistarted; 
    }//end of while loop; 
    // This next part of the code returns the actuator to the rest position 
    i = 0; 
    n = int((magnitude * 0.5) + 1); 
    while (i < n) 
    { 
      int_position = (current_position % 4); 
      set_position(int_position); 
      delay(2000 / (magnitude * frequency) - 500); //makes up delay to move gradually 
to start point 
      current_position++; 
      i++; 
    } 
 
    startbuttonstate = 0; //resets start button state 




    while (analogRead(manual) > 500) 





      current_position = manual_operation(current_position); 
    } // < End of "while" loop for auto/manual 
 
      Serial.print("Current position "); 
      Serial.println(current_position); 
 
} //End of loop 
 
void set_position(int i) { 
  switch (i) 
  { 
    case 0: 
      M1step1(); 
      M2step1(); 
      delay(100); 
      break; 
    case 1: 
      M1step2(); 
      M2step2(); 
      delay(100); 
      break; 
    case 2: 
      M1step3(); 
      M2step3(); 
      delay(100); 
      break; 
    default: //default is case 3! 
      M1step4(); 
      M2step4(); 
      delay(100); 
      break; //end of switch-case structure 
  } 
  M1stopMotor(); 
  M2stopMotor(); 
  Serial.println(i); 
} 
 
